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ABSTRACT 
 
Aromatic compounds have traditionally been generated via petroleum feedstocks and have wide 
ranging applications in a variety of fields such as cosmetics, food, plastics, and pharmaceuticals.  
Substantial improvements have been made to sustainably produce many aromatic chemicals from 
renewable sources utilizing microbes as bio-factories.  By assembling and optimizing native and 
non-native pathways to produce natural and non-natural bioproducts, the diversity of biochemical 
aromatics which can be produced is constantly being improved upon.  One such compound, 2-
Phenylethanol (2PE), is a key molecule used in the fragrance and food industries, as well as a 
potential biofuel. Here, a novel, non-natural pathway was engineered in Escherichia coli and 
subsequently evaluated.  Following strain and bioprocess optimization, accumulation of inhibitory 
acetate byproduct was reduced and 2PE titers approached 2 g/L – a ~2-fold increase over 
previously implemented pathways in E. coli.  Furthermore, a recently developed mechanism to 
allow E. coli to consume xylose and glucose, two ubiquitous and industrially relevant microbial 
feedstocks, simultaneously was implemented and systematically evaluated for its effects on L-
phenylalanine (Phe; a precursor to many microbially-derived aromatics such as 2PE) production.  
Ultimately, by incorporating this mutation into a Phe overproducing strain of E. coli, improvements 
in overall Phe titers, yields and sugar consumption in glucose-xylose mixed feeds could be 
obtained.  While upstream efforts to improve precursor availability are necessary to ultimately reach 
economically-viable production, the effect of end-product toxicity on production metrics for many 
aromatics is severe.  By utilizing a transcriptional profiling technique (i.e., RNA sequencing), key 
insights into the mechanisms behind styrene-induced toxicity in E. coli and the cellular response 
systems that are activated to maintain cell viability were obtained.  By investigating variances in 
the transcriptional response between styrene-producing cells and cells where styrene was added 
exogenously, better understanding on how mechanisms such as the phage shock, heat-shock and 
membrane-altering responses react in different scenarios.  Ultimately, these efforts to diversify the 
collection of microbially-produced aromatics, improve intracellular precursor pools and further the 
understanding of cellular response to toxic aromatic compounds, give insight into methods for 
improved future metabolic engineering endeavors. 
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CHAPTER 1. EMERGING TOOLS, ENABLING TECHNOLOGIES, AND FUTURE 
OPPORTUNITIES FOR THE BIOPRODUCTION OF AROMATIC CHEMICALS 
 
Abstract 
Aromatic compounds, which are traditionally derived from petroleum feedstocks, represent a 
diverse class of molecules with a wide range of industrial and commercial applications.  Significant 
progress has been made to alternatively and sustainably produce many aromatics from renewable 
substrates using microbial biocatalysts.  While the construction of both natural and non-natural 
pathways has expanded the number and diversity of aromatic bioproducts, pathway modularization 
in both single- and multi-strain systems continues to support the enhancement of key production 
metrics towards economically-viable levels.  While product toxicity persists as a key challenge 
limiting the production of many aromatics, various successful strategies have been demonstrated 
towards improving tolerance, including via membrane and efflux pump engineering as well as by 
exploiting alternative production hosts.  Finally, as a further step towards sustainable and 
economical aromatic bioproduction, non-model substrates including lignin-derived compounds 
continue to emerge as viable feedstocks. This chapter highlights recent and notable achievements 
related to such efforts while offering future outlooks towards engineering microbial cell factories for 
aromatic production. 
 
 
 
This chapter contains sections from the published work below: 
Machas, M., Kurgan, G., Jha, A.K., Flores, A., Schneider, A., Coyle, S., Varman, A., Wang, X., 
Nielsen, D.R. Emerging Tools, Enabling Technologies, and Future Opportunities for the 
Bioproduction of Aromatic Chemicals. J Chem Technol Biotechnol 2018, doi: 10.1002/jctb.5762. 
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1.1  Introduction 
Aromatic chemicals represent a diverse and important class of conventional petrochemicals with a 
wide range of commercial and industrial applications.  It has been estimated that about 40% (by 
mass) of bulk petrochemicals contain aromatic functionality (i.e., one or more substituted benzene 
rings) 1, serving, for example, as monomers for synthesizing highly durable and thermostable 
polymers and coatings, building blocks for active pharmaceutical ingredients, and even fuel 
additives.  In recent years, significant and growing interest has emerged in the development of 
alternative, microbial production routes for aromatic chemicals from renewable, biomass-derived 
substrates.  Such efforts have been aided by advancements in metabolic engineering, protein 
engineering, and systems and synthetic biology 2,3, which continue to guide both rational and 
combinatorial approaches towards efficient biocatalyst development.  As a result, the de novo 
biosynthesis of a diversity of different aromatic chemicals is now a reality, with applications that, 
like their petroleum-derived counterparts, include bulk chemicals and plastics, specialty chemicals, 
flavors and fragrances, and pharmaceuticals and nutraceuticals (Figure 1.1). 
Several notable reviews have reported on recent and important progress made towards the 
microbial biosynthesis of aromatic chemicals 4-9, predominantly focusing on key developments in 
both host and pathway engineering that have enabled the high-level biosynthesis of a growing list 
of aromatic products.  In particular, these reviews comprehensively summarize the diversity of 
different aromatic biochemicals that have been produced to date, as well as comparing different 
carbon sources, host strains/organisms, culture conditions and important metabolic engineering 
strategies employed; illustrating key progress made with respect to engineering microbial 
production of both naturally occurring (i.e., amino acids) and novel aromatic biochemicals.  
Accordingly, with the goal of complementing rather than duplicating these existing works, the 
objective of this chapter is more specifically to highlight the role of emerging tools and enabling 
technologies as applied to this end, while also identifying potential avenues for future 
advancements in this area.  As will be discussed, this includes the use of modular engineering 
strategies for improving biosynthetic function, tolerance engineering to increase strain robustness, 
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and alternative biomass feedstocks to improve economic viability and sustainability.  Finally, while 
the primary focus will be related to the bioproduction of molecules with aromatic functionality, select 
products derived from aromatic biosynthesis (e.g., cis,cis-muconic acid) will also be highlighted as 
illustrative examples, where appropriate. 
 
Figure 1.1 Bioproduction of Aromatic Chemicals from Renewable Substrates. 
Metabolic and pathway engineering strategies have enabled the de novo microbial production of 
an array of aromatic biochemicals with a range of possible end uses.  In addition to glucose, other 
biomass-derived sugars, lignin, and lignin-derived monomers have been investigated as renewable 
substrates to this end. 
1.2 Modular Engineering Strategies for Optimizing Pathway Flux and Function 
Microbial production of aromatic chemicals has largely been enabled via pathway engineering, 
generally consisting of either: a) the functional reconstruction of naturally-occurring but non-native 
(often plant) pathways, or b) the bottom-up construction of novel pathways comprised of individual 
enzymes derived from a diversity of heterologous sources.  Recent examples include the 
successful engineering of microbes capable of the de novo production of, in the first case, 
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flavonoids (usually consisting of two phenyl groups and a heterocyclic ring) 10,11, stilbenes (ethylene 
moiety with two phenyl groups) 12,13, and coumarins (containing a 1,2-benzopyrone backbone) 14,15, 
and, in the second case, numerous aromatic aldehydes, alcohols, and acids 16-21, styrenics 22-25, 
and phenolics 26-33.  In most cases, these heterologous pathways stem from natively produced 
aromatic chemicals such as the aromatic amino acids (i.e., L-phenylalanine, L-tyrosine, and L-
tryptophan) or their precursors (e.g., chorismate; derived from the shikimate pathway).  Irrespective 
of the target, both approaches require the synchronous function of multiple enzymatic ‘steps’, each 
with net activities precisely tuned so as to balance metabolite flux and avoid formation of 
undesirable bottlenecks.  For a multi-step pathway, achieving this outcome often requires the 
construction and screening of a large number of unique pathway variants.  As has been 
demonstrated for the case of other, non-aromatic biochemicals 34-36, the identification of optimal 
pathway configurations can often be facilitated through modularization of the biosynthesis scheme.  
Two main approaches have been explored to this end, including the engineering of: i) modular 
pathways, and ii) modular cells. 
1.2.1 Engineering Modular Aromatic Biosynthesis Pathways  
Modular pathway engineering involves compartmentalizing a multi-step pathway into discrete 
modules in order to facilitate the combinatorial screening of relevant expression parameters for the 
collective purpose of achieving optimal expression levels and maximal pathway flux.  Juminaga et 
al., for example, successfully implemented such an approach towards the efficient production of 
tyrosine in Escherichia coli 37. Specifically, the entire tyrosine biosynthesis pathway – from 
erythrose-4-phosphate (E4P) and phosphoenolpyruvate (PEP) to tyrosine – was decomposed into 
two modules: i) the ‘shikimate module’ (comprised of aroG*, aroB, aroD, and ydiB, along with ppsA 
and tktA), and ii) the ‘tyrosine module’ (comprised of aroK, aroA, aroC, tyrA*, and tyrB), split at the 
intermediate shikimate (* indicates a gene encoding a feedback-resistant mutant).  In the final 
design, constructs were systematically optimized with respect to each of the plasmid copy number, 
promoter strength, gene codon usage, and the relative placement of genes in each operon, 
ultimately leading to the production of >2 g/L tyrosine at 80% of the theoretical yield.   
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Analogous strategies have also been adopted to enhance microbial production of naringenin which, 
like other flavonoids, displays important human health benefits (e.g., anti-cancer, anti-oxidant), and 
is naturally produced in plants from endogenous malonyl-CoA and phenylpropanoid precursors 38.  
Wu et al., for example, constructed a naringenin biosynthesis pathway in E. coli comprised of three 
modules expressing: 1) tyrosine ammonia lyase and 4-coumaroyl-CoA ligase, 2) chalcone 
synthase and chalcone isomerase, and 3) malonate synthetase and malonate carrier protein 39.  In 
this case, by simultaneously varying both plasmid copy number and promoter strength across all 
three modules, final naringenin titers were improved by almost 3-fold, reaching up to 100 mg/L.  
These efforts built upon the important preceding works of Santos et al. who also demonstrated a 
modular approach towards flux balancing of the naringenin pathway, in their case by varying the 
enzyme sources and tuning expression levels 40.  More recently, modular pathway engineering has 
also been extended to aid production of aromatic bulk chemicals, including styrene 25, for example.  
In addition to aiding the systematic and simultaneous optimization of multiple expression 
parameters for a single pathway/product, modular pathway engineering strategies can also be used 
to facilitate targeting of additional products of interest.  In particular, from common intermediates, 
different modules can be combined to create multiple pathways.  Chorismate, for example, is a 
versatile endogenous intermediate with the potential to be converted to various aromatic end 
products.  Following extensive host engineering to enhance endogenous chorismate production, 
Noda and co-workers introduced seven unique downstream pathway modules to produce seven 
unique chorismate-derived products, including salicylate, phenol, 3-hydroxybenzoate, and cis,cis-
muconic acid, among others 41.  This approach was further exploited by Shen et al., in this case to 
convert chorismate to either salicyl alcohol (precursor to the anti-inflammatory, salicin) or gentisyl 
alcohol (an antioxidant and antibiotic); both through salicylate as a common intermediate 42. 
1.3 Metabolic Control Strategies for Enhancing Aromatic Bioproduction 
Various different metabolic control strategies have recently emerged as powerful tools for use in 
scenarios where classical gene knockouts are incompatible. This includes not only enabling 
individual growth essential genes to be targeted for tunable downregulation, but also, as such 
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methods are typically amenable to multiplexing, parallel targeting of multiple distinct processes with 
minimal strain engineering required.   To date, the most promising strategies involve the use of: i) 
antisense RNAs (asRNAs), ii) synthetic small RNAs (sRNAs), iii) clustered regularly interspaced 
short palindromic repeats interference (CRISPRi), and iv) conditional gene expression using 
synthetic circuits.  
1.3.1 Application and Potential of asRNA and Synthetic sRNAs for Aromatic Bioproduction 
Both asRNA and synthetic sRNAs can be designed to target specific mRNA sequences, binding to 
transcripts and, as a result, inhibiting translation.  sRNA, however, offers potential benefits such as 
improved silencing efficiency and longer half-lives due to association with and stabilization by an 
RNA chaperone 43.  Na et al., were among the first to report on the utility of synthetic sRNAs for 
biochemical production, doing so to enhance tyrosine biosynthesis.  Specifically, by constructing 
sRNAs to simultaneously inhibit production of both TyrR and CsrA in E. coli, final tyrosine titers 
reaching 2 g/L were realized 44.  The same system was later utilized as a platform for phenol 
bioproduction, with final titers of 1.69 g/L reported for fed-batch cultures following introduction of 
tyrosine-phenol lyase (TPL) 45.  On the other hand, naringenin production in E. coli, for example, 
has been enhanced via the use of asRNA.  Specifically, using anti-fabB/fabF asRNAs targeting 
various positions in the 5’-UTR to tune the level of down-regulation and balance malonyl-CoA flux 
between fatty acid biosynthesis and flavonoid production, final naringenin titers were increased by 
431% 46.  Later, Yang et al. also utilized asRNAs to target not only fabB and fabF but also fabD and 
fabH as a strategy to similarly enhance malonyl-CoA availability and improve naringenin 
production, as well as that of 4-hydroxycoumarin and resveratrol (note: both fabB and fabD are 
growth essential) 47.   
1.3.2 Application and Potential of CRISPRi for Aromatic Bioproduction 
Similar to asRNA- and synthetic sRNA-based approaches, CRISPRi enables targeting of desired 
genes for tunable down-regulation, in this case via the design and introduction of custom single 
guide RNAs (sgRNAs) which associate with a catalytically-inactive version of Streptococcus 
pyogenes Cas9 (dCas9) to inhibit transcription 48,49.  Notable examples employing CRISPRi to 
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enhance aromatic bioproduction are again seen with respect to flavonoids.  In a series of studies 
by Wu et al., for example, CRISPRi was employed to preserve malonyl-CoA availability in E. coli 
by targeting both fabB and fabF, along with several other less intuitive targets (e.g., fumC, sucC, 
adhE, eno) in a multiplexed manner.  As a result, production of naringenin was improved 7.4-fold 
50 and that of pinocembrin was improved 9.8-fold 51.  Similar strategies have since also been used 
to support pinosylvin production in E. coli 52 and naringenin production in S. cerevisiae 53. 
Meanwhile, in addition to S. pyogenes dCas9, the use of alternative CRISPR systems have also 
been employed.  For instance, Cress et al. recently reported on the development of CRISPathBrick, 
which instead utilizes Type II-A CRISPR arrays to rapidly assemble multiplexed modules for gene 
repression 54.  Validation of this alternative system was achieved by demonstrating improved 
production of naringenin.  
1.3.3 Application and Potential of Synthetic Gene Circuits for Aromatic Bioproduction 
Shikimate is a valuable precursor for the synthesis of oseltamivir phosphate (i.e., Tamiflu®) and 
other high-value pharmaceuticals 55.  However, it is also a key intermediate of the shikimate 
pathway and thus is a precursor to several growth essential compounds (e.g., aromatic amino 
acids).  As deletion of genes immediately downstream of shikimate cannot be accomplished without 
generating multiple auxotrophies, these genes (i.e., encoding shikimate kinase) are ideal targets 
for emerging metabolic control strategies 56.  Gu et al., for example,  developed a synthetic gene 
circuit to function as a switch for controlling expression of aroK (encoding the main shikimate kinase 
in E. coli) 57.  In this case, the native aroK promoter was replaced with PLtetO1 and tetR expression 
was controlled by PBAD, thus allowing arabinose addition to tunably down-regulate aroK expression 
at desired times and levels.  As a result, the culture could be controlled through initial growth and 
subsequent production phases, enabling production of 13.15 g/L shikimate from glucose in fed-
batch culture.   
One shortcoming experienced by at least the majority of the above examples is the need to add an 
exogenous inducer molecule which in turn increases overall costs.  This requirement has been 
circumvented by others, for example, by instead incorporating quorum sensing (QS) to control 
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induction of the synthetic gene circuit.  By modulating the efficacy of QS circuits, gene expression 
profiles can be altered to respond in a tunable manner to increasing cell densities, making them 
suitable for use in different applications.  In a recent demonstration, Williams et al. engineered a 
synthetic QS circuit in S. cerevisiae to improve the production of 4-hydroxybenzoate 58.  Here, the 
QS circuit was coupled to various RNA interference (RNAi) 59 modules to down-regulate key genes 
responsible for consuming phosphoenolpyruvate (CDC19, PYK2) and chorismate (ARO7), thereby 
enhancing chorismate availability and resulting in a 37-fold increase in 4-hydroxybenzoate titer. 
1.4 Biosensor-Based Approaches for Improving Aromatic Chemical Production  
Microbes have evolved various mechanisms for sensing and responding to extracellular and 
intracellular chemical changes, including through the use of numerous small molecule-responsive 
transcription factors and their cognate promoters 60.  When linked to an appropriate readout (e.g., 
fluorescent reporter or antibiotic resistance gene), such a machinery can be used to construct in 
vivo biosensors useful for detecting and responding to the intracellular presence of various products 
61 (or intermediates 62,63) of interest, typically with high selectivity and sensitivity, as well as in a 
dose-dependent manner 64 (Figure 1.2). 
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Figure 1.2 Biosensors Facilitate Optimization of Aromatic Bioproduction. 
(A) An aromatic biosensor can be constructed by using an aromatic-responsive transcriptional 
regulator that, in the absence of an aromatic, binds to its cognate transcription factor operator 
(TFO), blocking RNA polymerase (RNApol) and thus expression of a suitable reporter (e.g., GFP).  
In the presence of a recognized aromatic, transcriptional repression is released and reporter 
expression is “turned on”.  (B) Such biosensors can be used to facilitate library screening (e.g., 
RBS and/or enzyme) allowing, for example, flux bottlenecks to be overcome.  In the example 
shown, the most effective combination of RBS and enzyme (e2) variants will produce the most 
product ‘D’ which, once detected by the biosensor, will yield the highest output signal.   
1.4.1 Development of Aromatic-Responsive Biosensors 
To date, a diversity of naturally-evolved transcriptional regulators have been identified to control 
gene expression in response to the presence of various aromatic compounds of interest. These 
regulators are largely derived from soil bacteria where they serve to control the expression of 
aromatic degradation pathways 65-67 and tolerance mechanisms 68,69. A comprehensive review by 
Diaz and Prieto summarizes the characterized function of a wide range of aromatic-responsive 
regulators, including aromatic effectors that are also bioproduct targets of interest (e.g., phenol, 
salicylate, benzoate, and styrene) 66.  More recently, Xue et al. further probed the response of four 
such previously identified regulators (NahR, XylS, HbpR, and DmpR) towards a panel of 20 unique 
aromatic compounds, also including select bioproducts (e.g., phenol, catechol, and 2-
phenylacetate) 70, whereas others have since also been reported in the literature (e.g., QsuR for 
chorismate 71 and MarR for salicylate 72).  Taken together, these examples provide a glimpse of the 
spectrum of aromatic chemicals that can currently be detected using just naturally-evolved, 
transcriptional regulators.  In addition to transcription factor-based biosensors, meanwhile, 
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regulatory RNA-based riboswitches have also been developed as small molecule-inducible gene 
expression activators 73,74, and hold similar potential with respect to detecting and responding to 
aromatic biochemicals.  Although the diversity of aromatic effectors reported thus far is limited, 
promising results with tryptophan 74, dopamine and 2,4-dinitrotoluene 75, for example, bode well for 
the future potential of such devices.  
1.4.2 Improving Aromatic Bioproduction Using in vivo Biosensors as Screening Tools 
Once developed and optimized, in vivo biosensors can be used to facilitate the 
engineering/evolution of strains with improved bioproduction phenotypes via the use of high-
throughput screening 76 (Figure 1.2).   For example, by utilizing E. coli’s native TyrR (a 
transcriptional repressor that controls expression of multiple genes in the shikimate pathway), to 
sense elevated phenylalanine levels and drive yfp expression from its cognate tyrP promoter, a 
screening platform was developed to improve phenylalanine biosynthesis 77.  The same platform 
was further employed to sequentially screen both a ribosome binding site (RBS) library (expressing 
aroD, a known bottleneck in the shikimate pathway 78) and a whole cell random mutagenesis library 
(generated by atmospheric and room-temperature plasma), together leading to the isolation of 
strains capable of ~290% greater phenylalanine production (9.29 g/L vs. 3.21 g/L).  Other 
successful examples have also been reported outside of E. coli.  For example, a shikimate 
biosensor was recently developed in Corynebacterium glutamicum using the native transcriptional 
regulator ShiR for shikimate and GFP as reporter and used to screen an RBS library for optimal 
precursor supply.  Using FACS to facilitate selection, a 2.4-fold improvement in final titer was 
ultimately attained 79.  
Finally, in addition to reporters offering externally detectable feedback (e.g., GFP), genes conferring 
a fitness advantage can alternatively be expressed to enable cell screening under selective 
conditions.  Raman et al., employed such an approach utilizing a TtgR-TolC “sensor-selector” to 
screen targeted genome-wide mutagenesis libraries (generated by multiplexed automated genome 
engineering, MAGE 80) to improve naringenin production in E. coli by 36-fold 81.  Chou and Keasling, 
meanwhile, recently reported a novel strain evolution platform wherein TyrR regulated the 
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expression of a mutator protein encoded by mutD5 via a modified aroF promoter.  This scheme 
enabled higher mutD5 expression and thus higher mutation rates in strains producing low levels of 
tyrosine, and the mutD5 expression reduced as tyrosine levels rose 82.  This ‘feedback-regulated 
evolution of phenotype’ (FREP) method enabled the isolation of an evolved strain capable of 5-fold 
increased tyrosine titers. 
1.5 Future Outlooks 
Aromatic biochemicals remain as attractive bioproduction targets due to their broad utility in 
chemical, pharmaceutical and food industries, as well as, in some cases, their high commercial 
value and difficulties associated with their chemical synthesis 9.  Accordingly, pathway engineering 
efforts are expected to continue in this area, including with respect to both the reconstitution of 
naturally-occurring routes and de novo construction of novel ones. In both cases, these efforts will 
continue to be fueled by both the discovery and engineering of unique enzyme chemistries.  
Recently, for example, Beller and co-workers applied a metagenomics and metaproteomics 
approach towards the discovery of a novel phenylacetate decarboxylase (encoded by phdB) 83.  
Isolated from anoxic lake sediments, PhdB (a glycyl radical enzyme) is responsible for the 
biosynthesis of toluene, an aromatic bulk chemical and potential fuel additive, from phenylacetate.  
Additional product diversity is also possible via the interfacing of enzymatic and non-enzymatic 
processes.  For example, Wallace and Balskus recently reported on the coupling of styrene 
production by E. coli with an in situ cyclopropanation reaction (catalyzied by iron(III) phthalocyanine 
in biocompatible micelles) to demonstrate production of non-natural phenyl cyclopropanes from 
glucose 84. 
Once pathways are developed, strains must then be optimized to achieve meaningful production 
metrics. As efficient strain optimization demands more rapid design-build-test cycles, emerging 
tools supporting more precise metabolic control will play an increasingly important role by 
supporting facile implementation for rapid hypothesis testing and multiplexing for high-throughput 
screening.  Meanwhile, , new approaches  relying upon, for example, genome-wide sgRNA 
libraries85-88 for CRISPRi applications will surely continue to accelerate the strain optimization 
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process.  Furthermore, new insights gained by studying naturally-occurring microbial and fungal 
consortia will support the discovery of novel products of interest as well as new strategies for 
engineering co-cultures using ‘modular’ cells 89.   Such efforts will likely find future applications for 
aromatic bioproduction, in particular for the biosynthesis of high-value natural products whose 
synthesis relies upon complex and difficult to optimize pathways.  As a result of these and other 
collective efforts, the list of aromatic compounds that can be produced as renewable bioproducts 
will undoubtedly continue to grow. 
As aromatic toxicity remains a persistent challenge, the further development of strategies for 
increasing strain robustness will be important to achieving competitive product titers and yields.  
This will no doubt include, for example, the prospecting for as well as engineering of efficient 
aromatic efflux pumps. Meanwhile, as known trade-offs exist with respect to the overexpression of 
membrane transporters, for which an optimal balance between function and burden has been 
reported 90, more sophisticated control strategies for transporter expression in response to aromatic 
production levels might play a key role towards circumventing this caveat 91,92.  Such prospective 
applications, meanwhile, also further highlight the importance of developing aromatic biosensors 
and their potential utility for allowing cells to autonomously respond to their changing production 
environment. Further identification and engineering of alternative hosts with greater inherent 
aromatic tolerance will also be important to addressing product toxicity.  Several bacteria with 
enhanced tolerance to other membrane disruptive compounds have already been identified, for 
example, including species of Clostridium 93, Lactobacillus 94, Zymomonas 93,95, and Deinococcus 
96.  Although, to the best of our knowledge, these have not yet been investigated as potential hosts 
for aromatic bioproduction, they and others might indeed prove useful to this end. 
Finally, in addition to expanding biochemical diversity and improving production metrics, the 
utilization of alternative feedstocks remains as an alluring prospect due to the potential for lower 
costs and, in some cases, higher theoretical yields.  Important to this outcome is the exploitation of 
non-model organisms that can naturally depolymerize and metabolize lignin to directly produce 
high value aromatic products.  Key to this will be further understanding of the involved pathways 
13 
 
and their regulation, as well as the continued identification and elimination of associated pathway 
bottlenecks 97,98.  Thus, further discovery of non-conventional microbes and development of genetic 
tools for their subsequent engineering will be critical to achieving this goal. 
1.6 Conclusions 
Through extensive metabolic engineering efforts, microbial bioproduction of a multitude of aromatic 
products is currently possible and will only continue to grow.  Progress to this end continues to be 
enabled by the development of versatile synthetic and systems biology tools, as well as the 
discovery of novel biomolecules, phenotypes, and strains.  Though much work surely remains, 
continued efforts in this area will undoubtedly lead to the commercialization of bio-based aromatic 
products, in some cases supplanting their conventional, petroleum-derived predecessors. 
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CHAPTER 2. EXPANDING UPON STYRENE BIOSYNTEHSIS TO ENGINEER A NOVEL 
ROUTE TO 2-PHENYLETHANOL 
 
Abstract 
2-Phenylethanol (2PE) is a key molecule used in the fragrance and food industries, as well as a 
potential biofuel. In contrast to its extraction from plant biomass and/or more common chemical 
synthesis, microbial 2PE production has been demonstrated via both native and heterologous 
expression of the yeast Ehrlich pathway.  Here, a novel alternative to this established pathway was 
systematically engineered in Escherichia coli and evaluated as a more robust and efficient route.  
This novel pathway was constructed via the modular extension of a previously-engineered styrene 
biosynthesis pathway, proceeding from endogenous L-phenylalanine in five steps and involving 
four heterologous enzymes.  This ‘styrene-derived’ pathway boasts a ~10-fold greater 
thermodynamic driving force than the Ehrlich pathway, and enables reduced accumulation of 
acetate byproduct.  When directly compared using a host strain engineered for L-phenylalanine 
over-production, preservation of phosphoenolpyruvate, and reduced formation of byproduct 2-
phenylacetic acid, final 2PE titers via the styrene-derived and Ehrlich pathways reached 1817 and 
1164 mg/L, respectively, at yields of 60.6 and 38.8 mg/g.  Following optimization of induction timing 
and initial glucose loading, 2PE titers by the styrene-derived pathway approached as high as 2 g/L 
– a ~2-fold increase over prior reports for 2PE production by E. coli employing the Ehrlich pathway. 
 
This chapter contains work published in: 
Machas, M.S., McKenna, R., Nielsen, D.R. Expanding Upon Styrene Biosynthesis to Engineer a 
Novel Route to 2-Phenylethanol Biotechnol J 2017 (12)10. doi: 10.1002/biot.201700310. 
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2.1 Introduction 
With its ‘rose-like’ aroma, 2-phenylethanol (2PE) is an important molecule in the flavor and 
fragrance industries 16,99.  More specifically, 2PE is used in the production of various foods and 
beverages and, most notably, remains the most used fragrance compound in the cosmetics and 
perfume industries 100.  Meanwhile, in addition to its traditional usage as a specialty chemical, 2PE 
has also garnered recent interest as a potential biofuel molecule due to its low volatility, high energy 
density and non-hygroscopic properties 101, or alternatively as a fuel additive helpful for preventing 
knocking as a result of its high octane number and reduced gas-phase reactivity 102,103.  Altogether, 
annual global demand for 2PE exceeds 10,000 tons 99, with a market size expected to reach $700 
million by 2019 104.  Traditional 2PE production methods involve its extraction from the essential 
oils of many flowering plant species – most notably, rose oil, which contains up to 60% 2PE 105.  
Although extraction is still practiced to obtain the natural product, this process is expensive and 
poorly scalable, and thus the bulk of 2PE production instead presently occurs via its chemical 
synthesis from petrochemical feedstocks.  Though cheaper, 2PE production in such a manner is 
both non-renewable and unsustainable, and furthermore employs carcinogenic precursors (i.e., 
benzene 99) as feedstocks; undesirable from a ‘green chemistry’ perspective and a feature that 
imposes usage restrictions, especially in flavor/fragrance applications 105. 
In light of the above limitations, microbiological production of 2PE via a variety of synthesis routes 
has recently been explored as a more sustainable alternative. A natural fermentation product of 
several yeast strains (albeit typically at only trace levels), 2PE is in large part responsible for the 
‘floral’ aromas present in many fermented foods and beverages 106,107.  In yeast, 2PE is produced 
via the Ehrlich pathway 108,109; a two-step pathway stemming from phenylpyruvate, an intermediate 
of the shikimic acid (SA) pathway and direct precursor to L-phenylalanine (Phe).  First, 
phenylpyruvate decarboxylase (PPDC) serves to convert phenylpyruvate to 2-phenylacetaldehyde 
which is subsequently reduced to 2PE by an alcohol dehydrogenase (Figure 2.1).  In S. cerevisiae, 
for example, Aro10p, a thiamine pyrophosphate-dependent enzyme, catalyzes the first step 110 
whereas reduction of 2-phenylacetaldehyde to 2PE occurs by the aid of one or more native 
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dehydrogenases (including ADH1-5) 111.  Achieving high levels of 2PE via their native Ehrlich 
pathway, however, typically requires select yeast strains (e.g., S. cerevisiae 111,112, Kluyveromyces 
marxianus 113) to be cultured under nitrogen limited conditions while supplementing the medium 
with excess exogenous Phe 105,112 (note: Phe transaminase (e.g., ARO9 in S. cerevisiae 114) 
converts Phe and 2-ketoglutarate to phenylpyruvate and L-glutamate, the latter being degraded to 
provide nitrogen for growth).  However, as Phe is a relatively expensive feedstock with limited 
scalability, 2PE production directly from renewable biomass sugars could represent a more 
promising approach. 
To date, microbial 2PE production from glucose has focused predominantly on expanded 
applications of the Ehrlich pathway, most commonly via its functional reconstruction in other, 
heterologous microbes.  For example, Atsumi et al. first reported the functional reconstruction of 
the Ehrlich pathway in E. coli (comprised of kivd from Lactococcus lactis and ADH2 from S. 
cerevisiae), demonstrating production of 57.3 mg/L 2PE from 36 g/L glucose (a yield of 1.59 mg/g) 
using a wild-type background 101.  Kang et al. later also reconstructed the Ehrlich pathway in E. coli 
(in this case instead using kdc and ADH1 from Pichia pastoris and S. cerevisiae, respectively) and, 
following deregulation of metabolite flux through the SA pathway, reported 2PE titers as high as 
285 mg/L 115.  Finally, expressing the Ehrlich pathway composed instead of ipdC from Azospirillum 
brasilense and yahK from E. coli in a Phe over-producing host, Koma et al. engineered E. coli for 
direct 2PE production from glucose at titers reaching 940.6 mg/L and a yield of 94.06 mg/g 16.  To 
the best of our knowledge, this output represents the highest 2PE production from glucose by 
engineered E. coli reported to date. 
For several years, our research has focused on the engineering of non-natural pathways for the 
renewable production of various bulk and specialty aromatic chemicals 19,32,116, including a recent 
series of studies demonstrating: i) engineering of a novel pathway for styrene biosynthesis from 
glucose (Figure 2.1; from Phe, comprised of PAL2 from Arabidopsis thaliana and FDC1 from S. 
cerevisiae) 117, and ii) subsequent extension of the styrene pathway to (S)-styrene oxide (i.e., by 
additional co-expression of styAB from Pseudomonas putida S12, encoding styrene 
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monooxygenase (SMO)) 118.  Common to numerous Pseudomonas sp., SMO serves as the first 
step in one of the principle aerobic styrene degradation pathways 119.  Following SMO, styrene 
oxide isomerase (SOI; encoded by styC in P. putida S12, for example) is subsequently responsible 
for converting (S)-styrene oxide to 2-phenylacetaldehyde before further catabolism then takes 
place.  Recognizing, however, that 2-phenylacetaldehyde also serves as precursor to 2PE (as in 
the Ehrlich pathway), as further illustrated in Figure 2.1, it was postulated that a novel, ‘styrene-
derived’ pathway could also be engineered for de novo 2PE production from glucose.  Accordingly, 
this non-natural pathway, which couples styrene biosynthesis with its subsequent, partial aerobic 
degradation, was systematically engineered and comparatively evaluated as an alternative to the 
established Ehrlich pathway. 
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Figure 2.1 2-Phenylethanol Bioproduction Routes in E. coli. 
Comparing 2PE biosynthesis via the established Ehrlich and proposed styrene-derived pathways.  
Endogenous pathway steps shown with black arrows whereas heterologous steps are shown in 
gray. In the case of aroG and pheA, ‘X’ indicates alleviation of allosteric inhibition caused by Phe 
due to the presence of feedback resistant mutants of these genes in E. coli NST74.  In the case of 
feaB, ‘X’ indicates its chromosomal deletion.  Inset: Comparing the change in Gibbs free energy 
due to reaction (ΔrG’°) with progress through each of the two pathways (Ehrlich pathway, blue 
squares; styrene-derived pathway, red circles) from phenylpyruvate to 2PE. 
 
19 
 
2.2 Materials and Methods 
2.2.1 Microorganisms 
All strains used in this study are listed in Table 2.1. E. coli NEB 10-beta was obtained from New 
England Biolabs (NEB; Ipswich, MA) and was used for cloning and the propagation of all plasmids. 
E. coli NST74 (ATCC 31884), a feedback resistant mutant of E. coli which overproduces Phe 120, 
and P. putida S12 (ATCC 700801), which served as the genetic source of styABC, were both 
purchased from the American Type Culture Collection (ATCC; Manassas, VA). S. cerevisiae W303, 
which served as the genetic source of ARO10, was a kind gift from Prof. Kristala Prather (MIT).  E. 
coli strains JW1380-1, JW1843-2, JW1666-3, and JW2410-1 were obtained from the Coli Genetic 
Stock Center (CGSC; New Haven, CT) and served as the genetic source for the feaB::FRT-kanR-
FRT, pykA::FRT-kanR-FRT, pykF::FRT-kanR-FRT, and crr::FRT-kanR-FRT deletion cassettes, 
respectively, along with wild-type E. coli BW25113.  Chromosomal in-frame gene deletions in E. 
coli and subsequent kanR marker removal were accomplished via a method modified from that of 
Datsenko and Wanner 121, as previously described 32. 
Table 2.1 Strains, Plasmids, and Pathways Constructed and/or Used for 2PE Production. 
Strains Description Source 
E. coli NST74 
aroH367, tyrR366, tna-2, lacY5, aroF394(fbr), malT384, 
pheA101(fbr),pheO352, aroG397(fbr) 
ATCC 
31884 
E. coli BW25113 
Δ(araD-araB)567, ΔlacZ4787::rrnB-3, λ-, rph-1, Δ(rhaD-
rhaB)568, hsdR514 
CGSC 
E. coli NEB-10 
beta 
araD139 ∆(ara,leu)7697 fhuA lacX74 galK16 galE15 
mcrA f80d(lacZ∆M15)recA1 relA1 endA1 nupG rpsL rph 
spoT1∆(mrr-hsdRMS-mcrBC) 
NEB 
S. cerevisiae 
W303 
Source of ARO10, FDC1 
Prather 
Lab, MIT 
P. putida S12 Source of styABC 
ATCC 
700801 
E. coli NST74 
ΔfeaB  
ΔfeaB mutation in E. coli NST74  
This 
study 
E. coli NST74 
ΔfeaB Δcrr  
Δcrr mutation in E. coli NST74 ΔfeaB  
This 
study 
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E. coli NST74 
ΔfeaB Δcrr 
ΔpykA  
ΔpykA mutation in E. coli NST74 ΔfeaB Δcrr  
This 
study 
E. coli NST74 
ΔfeaB Δcrr 
ΔpykF  
ΔpykF mutation in E. coli NST74 ΔfeaB Δcrr  
This 
study 
E. coli NST74 
ΔfeaB Δcrr 
ΔpykA ΔpykF  
ΔpykF mutation in E. coli NST74 ΔfeaB Δcrr ΔpykA  
This 
study 
Plasmids Features and/or Construction Source 
pTrcColaK ColA ori, lacIq, Kanr, PTrc 118  
pBbA5a p15A ori, lacI, Ampr, PlacUV5; derived from pY3 37 
pCP20 FLP, ts-rep, [cI857](lambda)(ts), Ampr CGSC  
pKD46 repA101(ts) and R101 ori, Ampr, araC, araBp  CGSC 
pTpal-fdc 
PAL2 from A. thaliana and FDC1 of S. cerevisiae inserted 
into the NcoI and XbaI and SbfI and HindIII sites of 
pTrc99A 
118 
pY-PAL2FDC1 
PAL2-FDC1 operon from pTpal-fdc inserted into the BglII 
and XhoI sites of pY3 
This 
study 
pTrcColaK-styC 
styC from P. putida S12 inserted into the PstI and HindIII 
sites of pTrcColaK 
This 
study 
pTrcColaK-
styABC 
styABC from P. putida S12 inserted into the XbaI and 
HindIII sites of pTrcColaK 
This 
study 
pY-ARO10 
ARO10 from S. cerevisiae inserted into the BglII and XhoI 
sites of pY3 
This 
study 
Pathway Composed of plasmids Source 
Ehrlich pY-ARO10 
This 
study 
Styrene-derived pY-PAL2FDC1, pTrcColaK-styABC 
This 
study 
   
   
2.2.2 Plasmid Construction 
All plasmids constructed and used in this study are listed in Table 2.1.  Plasmid pY3 (Addgene 
plasmid #50606), originally derived from pBbA5a, was a gift from Prof. Jay Keasling (UC-Berkeley).  
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Custom DNA oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA).  
Genomic DNA (gDNA) was prepared from cell cultures using the ZR Fungal/Bacterial DNA 
MiniPrep (Zymo Research, Irvine, CA) according to vendor protocols.  All genes were PCR 
amplified with Q5 High-Fidelity DNA Polymerase (NEB) using standard protocols.  Amplified linear 
DNA fragments were purified using the Zymo Research DNA Clean & Concentrator Kit (Zymo 
Research) according to manufacturer protocols.  Once purified, DNA fragments were then digested 
with appropriate restriction endonuclease enzymes at 37°C for > 6 h (NEB).  Digested fragments 
were gel purified using the Zymoclean Gel DNA Recovery Kit (Zymo Research, Irvine, CA) and 
ligated at room temperature for >1 h using T4 DNA ligase (NEB).  Ligation reactions were 
transformed into chemically-competent E. coli NEB 10-beta (NEB) and selected by plating on Luria-
Bertani (LB) solid agar containing appropriate antibiotics.  Transformant pools were subsequently 
screened by colony PCR and restriction digest mapping. 
2.2.3 Assaying SOI Activity in Whole Resting Cells 
SOI activity was assayed in whole resting cells engineered to express styC from P. putida S12.  
More specifically, E. coli BW25113 was first transformed with either pTrcColaK-styC or pTrcColaK 
(as control).  Seed cultures were prepared by growing individual colonies from LB-agar plates in 3 
mL of LB for ~12 h at 32°C. Seed cultures were used to inoculate 50 mL of LB broth supplemented 
with 35 mg/L kanamycin in a 250 mL shake flask.  Flasks were cultured at 32°C with shaking for 
~8 h, at which time they were induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) 
at a final concentration of 0.2 mM.  Following induction, cultures were incubated at 32°C overnight, 
after which cells were then harvested by centrifugation at 3,000 x g.  The cell pellet was washed 
twice with pH 7.4 phosphate buffered saline (PBS) solution, and resuspended in 50 mL pH 7.4 PBS 
solution to a final cell density determined as an optical density at 600 nm (OD600) of ~4.  For the 
assay, a series of resting cell suspensions, each with a total volume of 50 mL in a 250 mL shake 
flask, were prepared at final cell densities of OD600 ~0.01, 0.03, and 0.07 (i.e., by resuspending an 
appropriate volume of the above stock suspension) in fresh pH 7.4 PBS solution supplemented 
with (S)-styrene oxide at an initial concentration of 1300 mg/L.  Over the course of 6.5 h, flasks 
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were incubated at 32°C with shaking at 200 RPM while samples (each 0.5 mL) were periodically 
taken for HPLC analysis to determine concentrations of residual (S)-styrene oxide and produced 
2-phenylacetaldehyde, as described below. 
2.2.4 Assaying 2PE Toxicity 
The effects of 2PE on E. coli growth rate and yield was determined by monitoring the impacts of its 
exogenous addition at increasing final concentrations on growing cultures.  Approximately 1 ml of 
an E. coli NST74 seed culture was used to inoculate 50 ml of LB broth in a 250 mL shake flask.  
When cultures reached OD600 ~0.6, 2PE was added to the flasks at an array of final concentrations 
ranging from 0 to 2 g/L. Culturing then resumed for an additional 6 h with periodic monitoring of 
OD600. 
2.2.5 Production of 2PE from Glucose by Engineered E. coli 
Seed cultures were grown in 3 mL LB broth supplemented with appropriate antibiotics at 32oC for 
12 – 16 h.  Next, 0.5 mL of seed culture was used to inoculate 50 mL (in 250 mL shake flasks) of 
pH 6.8 MM1 – a phosphate-limited minimal media adapted from McKenna and Nielsen 117, with the 
following recipe (in g/L): glucose (20), MgSO4·7H2O (0.5), (NH4)2SO4 (4.0), MOPS (24.7), KH2PO4 
(0.3), and K2HPO4 (1.0), as well as 1 mL/L of a trace mineral solution containing (in g/L): Thiamine 
HCl (0.101), MnCl2·4H2O (1.584), ZnSO4·7H2O (0.288), CoCl2·6H2O (0.714), CuSO4 (0.1596), 
H3BO3 (2.48), (NH4)6Mo7O24·4H2O (0.370), and FeCl3 (0.050).  Once inoculated, cultures were 
grown at 32oC while shaking at 200 RPM until reaching an OD600 of 0.8 (~8 h), at which time they 
were induced by addition of IPTG at a final concentration of 0.2 mM.  Following induction, strains 
were cultured for a total of 72 h (unless otherwise stated), during which time samples were 
periodically withdrawn for cell growth and metabolite analysis.  Meanwhile, intermittently throughout 
each culture, pH was increased back to its initial value by adding a minimal volume (typically ~0.2-
0.4 mL) of 0.4 g/L K2HPO4 solution. 
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2.2.6 Analytical Methods 
Cell growth was measured as OD600 using a UV/Vis spectrophotometer (Beckman Coulter DU800, 
Brea, CA).  Culture samples were centrifuged at 11,000 x g for 4 min to pellet cells, after which 
0.25 mL of the resulting supernatant was then transferred to a glass HPLC vial containing an equal 
volume of 1 N HCl before being sealed with a Teflon-lined cap.  Analysis of all aromatic metabolites 
was performed via high performance liquid chromatography (HPLC; Agilent 1100 series HPLC, 
Santa Clara, CA) using a diode array (UV/Vis) detector.  Separation was achieved on a reverse-
phase 5μm Hypersil Gold C18 column (4.6 mm x 100 mm; Thermo Fisher, USA) operated at 45oC 
using mobile phase consisting of water with 0.1% formic acid (A) and methanol (B), flowing at a 
constant rate of 0.75 mL/min according to the following gradient:  5% B at 0 min, 5% to 80% B from 
0 to 10.67 min, 80% B from 10.67 to 13.33 min, 80% to 5% B from 13.33 to 18.67 min, and 5% B 
from 18.67 to 20 min. The eluent was monitored using a diode array detector (DAD) set at 215 nm 
for detection of Phe, trans-cinnamic acid, styrene and (S)-styrene oxide, and 258 nm for detection 
of 2-phenylacetaldehyde, 2-phenylacetic acid, and 2PE.  Glucose and acetate analysis, meanwhile, 
was performed using the same HPLC system equipped with a refractive index detector (RID) and 
an Aminex HPX-87H column (BioRad, Hercules, CA) operated at 35ºC.  The column was eluted 
using 5 mM H2SO4 as the mobile phase at a constant flow rate of 0.55 mL/min for 20 min. External 
calibrations were prepared and used to quantify each species of interest. 
2.2.7 Thermodynamic Analysis 
To compare relative pathway energetics, net changes in Gibbs free energy due to reaction, ΔrG’°, 
were determined for each reaction using the eQuilibrator online tool 122, at a reference state of 
25oC, pH 7, and ionic strength of 0.1 M. 
2.3 Results  
2.3.1 Comparative Assessment of Alternative 2PE Pathways 
As seen in Figure 2.1, both the proposed, styrene-derived and established, Ehrlich pathways stem 
from precursors in the SA pathway, namely Phe and phenylpyruvate, respectively.  As such, both 
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pathways share the same theoretical yield, estimated as 0.36 g/g on glucose (with functional PTS, 
based on estimates derived from Varma et al. 123).  Moreover, both pathways converge at 2-
phenylacetaldehyde before its reduction to 2PE, as has been reported to readily occur via one or 
more native, NADPH-dependent alcohol dehydrogenases (ADHs; e.g., yqhD, yahK, yjgB) and/or 
aldo-keto reductases (AKRs; e.g., dkgA, dkgB, yeaE) 17,124.  However, between the last common 
precursor (i.e., phenylpyruvate) and 2PE, the two pathways differ greatly and in several important 
ways.  For instance, unlike the Ehrlich pathway, which employs only one foreign enzyme, the 
styrene-derived pathway is instead composed of four heterologous steps.  However, despite its 
length, the thermodynamic driving force associated with the styrene-derived pathway is nearly 10-
fold greater than that of the Ehrlich pathway.  More specifically, when compared from 
phenylpyruvate to 2PE, the net change in Gibbs free energy of reaction (ΔrG’°) for the Ehrlich 
pathway is -50.9 kJ/mol compared to -474.4 kJ/mol for the styrene-derived pathway (Figure 2.1 
inset); the bulk of the difference being due to the highly favorable conversion of styrene to (S)-
styrene oxide via styrene monooxygenase (NADH-dependent, encoded by styAB), which 
contributes -419.4 kJ/mol (or 88%) to the total ΔrG’° of the pathway 122.  As a consequence, 
however, the styrene-derived pathway consumes twice as many reducing equivalents (1 NADH 
and 1 NADPH per molecule of 2PE produced) than the Ehrlich pathway (only 1 NADPH).  
Accordingly, whereas similarities certainly exist, both 2PE pathways appear to possess their own 
unique and inherent merits and limitations, the likes of which were next experimentally investigated. 
2.3.2 Engineering 2PE Pathways 
Construction of the styrene-derived 2PE pathway began from a previously-engineered (S)-styrene 
oxide pathway, comprised of PAL2 from A. thaliana, FDC1 from S. cerevisiae, and styAB from P. 
putida S12 118.  To convert (S)-styrene oxide to 2-phenylacetaldehyde, however, it was first 
necessary to identify a suitable gene encoding SOI activity.  Of particular interest was styC from P. 
putida S12 125 which, together with styAB, functions as part of its native styrene degradation 
pathway 126,127.  Following the cloning and subsequent expression of styC in E. coli BW25113 
pTrcColaK-styC, a whole resting cell assay was performed wherein, as seen in Figure 2.2, 
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recombinant SOI activity was demonstrated via the conversion of exogenous (S)-styrene oxide to 
2-phenylacetaldehyde (note: control experiments using E. coli BW25113 pTrcColaK showed no 
conversion of (S)-styrene oxide; data not shown).  Initially, the assay was performed at a high cell 
density (i.e., OD600 ~4; representing that of a typical culture), however, under such conditions 100% 
conversion was achieved in <10 min at stoichiometric yield (data not shown).  To slow the net 
reaction rate and allow for improved monitoring, the experiment was repeated at lower cell 
densities; specifically, OD600 of 0.01, 0.03, and 0.07.  In this case, increasing cell density expectedly 
resulted in faster rates of (S)-styrene oxide consumption and 2-phenylacetaldehyde production, 
with the former reaching as high as 5.6 g/L-h.  For comparison, when previously assayed under 
analogous conditions, styAB-expressing E. coli resting cells produced (S)-styrene oxide from 
exogenous styrene at rates reaching only as high as ~0.1 g/L-h; albeit at much higher cell densities 
(OD600 ~1).  Consequently, it was expected that recombinant StyC activity would be sufficiently 
high so as to avoid a potential flux bottleneck at this step. 
Based on this result, styC was cloned for expression as part of the full, styrene-derived pathway, 
in this case as part of the natural styABC operon (encoding both SMO and SOI) and expressed via 
a Ptrc promoter in plasmid pTrcColaK-styABC.  Plasmid pY-PAL2FDC1 was constructed by cloning 
a previously assembled operon composed of PAL2 from A. thaliana and FDC1 from S. cerevisiae 
from pTpal-fdc 118 behind the PlacUV5 promoter of pBbA5a 37.  In the case of the Ehrlich pathway, 
meanwhile, PPDC plays a key role as the first committed pathway step.  Previously, Atsumi et al. 
evaluated 5 different PPDC isozymes (namely those encoded by ARO10, PDC6 and THI3 from S. 
cervisiae, kivd from L. lactis, and pdc from C. acetobutylicum) in E. coli, ultimately finding Aro10p 
to support the greatest 2PE production from glucose 101.  Accordingly, ARO10 was fused to a PlacUV5 
promoter in pBbA5a, resulting in pY-ARO10.   
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Figure 2.2 Resting Cell Assay of StyC activity in E. coli for Conversion of (S)-Styrene Oxide. 
Screening styrene oxide isomerase enzyme activity using E. coli BW25113 pColaK-styC whole 
resting cells.  Conversion of (S)-styrene oxide (open shapes, dotted line) to 2-phenylacetaldehyde 
(solid shapes, solid line) by StyC using three different cell densities (OD600 ~ 0.01, 0.03, and 0.07 
are blue squares, red circles, and black diamonds, respectively).  Error bars reported at one 
standard deviation from triplicates experiments. 
2.3.3 Demonstrating and Comparing 2PE Production via Alternative Pathways 
The Ehrlich and styrene-derived pathways were both constructed as described in Table 2.1 and 
first introduced and expressed in E. coli NST74 (a previously-engineered, Phe-overproducing strain 
120), with the resulting strains producing 158 ± 12 and 182 ± 4 mg/L of 2PE, respectively.  However, 
in addition to 2PE, both strains also co-produced 2-phenylacetic acid as a major byproduct, whose 
final titers reached 352 ± 12 and 503 ± 21 mg/L, respectively.  In E. coli, 2-phenylacetaldehyde is 
converted to 2-phenylacetic acid via a native, NAD+-dependent 2-phenylacetaldehyde 
dehydrogenase, encoded by feaB (Figure 2.1) 128.  In this case, the ~1.5-fold greater 2-
phenylacetic acid production accompanying the styrene-derived pathway was likely due to its 
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aforementioned increased redox requirement, which would be partially balanced via oxidation of 2-
phenylacetaldehyde to 2-phenylacetic acid (regenerating 1 NADH; Figure 2.1).  To eliminate 
undesirable accumulation of 2-phenylacetic acid, feaB was next deleted from NST74.  When 
introduced and expressed in NST74 ΔfeaB, 2-phenylacetic acid production was no longer detected 
for either the Ehrlich or styrene-derived pathway and, after 72 h, 2PE titers now reached 552 ± 14 
and 643 ± 29 mg/L, respectively; in both cases at similar glucose yields (35.1 ± 0.5 and 37.7 ± 1.2 
mg/g, or 9.7 and 10.5% of the theoretical maximum).  
To assess if 2PE production in these initial strains was perhaps limited by end-product inhibition, a 
growth challenge study was performed to characterize the response of E. coli growth to the addition 
of exogenous 2PE at a range of increasing final concentrations (Figure 2.3).  While growth rate 
and yield were reduced in the presence of as little as 1 g/L 2PE, severe growth inhibition did not 
occur until reaching about 2 g/L 2PE.  This compares well with prior reports wherein 2PE was 
reported to inhibit E. coli at levels of ~1 g/L 115, and suggests that, at least in these initial strains, 
2PE production by either pathway was likely not yet limited by end-product inhibition. 
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Figure 2.3 Toxicity assay of 2PE on E. coli NST74. 
Growth response of E. coli NST74 following exogenous 2PE addition at final concentrations of 0 
g/L (control; squares), 1 g/L (circles), 1.25 g/L (upright triangles), 1.5 g/L (diamonds), 1.75 g/L 
(inverted triangles) and 2 g/L (right triangles). Error bars reported at one standard deviation from 
triplicate experiments. 
2.3.4 Host Strain Engineering to Increase Precursor Availability 
Robust 2PE production by either pathway depends on ample production of SA pathway precursors 
(Figure 2.1), which in turn is known to benefit from increased availability of phosphoenolpyruvate 
(PEP).  Noda et al. previously reported deletion of both pykF and pykA (encoding pyruvate kinase 
isozymes I and II, respectively, which convert PEP to pyruvate, producing ATP) as an effective 
strategy for both promoting PEP availability while reducing acetate yield (by as much as 4.5-fold), 
in their case also enhancing the production of various chorismate-derived aromatic products 129.  
Meanwhile, it has been further demonstrated that PEP availability can be improved via the partial 
inactivation of the glucose-specific phosphotransferase system (PTS; which facilitates glucose 
uptake via its phosphorylation at the expense of PEP), as can be achieved by deleting crr (encoding 
IIAGlc) 130.  This mutation also further benefits the culture by reducing rates of glucose uptake which, 
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in turn, also decreases overflow metabolism and the associated production of unwanted (and 
potentially inhibitory) acetate 130,131.  Accordingly, NST74 ΔfeaB was further engineered to 
systematically introduce ΔpykA, ΔpykF, and Δcrr mutations, upon which the resulting strains were 
tested for their relative ability to support 2PE production via the two pathways.  The resulting 2PE 
titers are compared in Figure 2.4, along with the relative effects of the same mutations on Phe 
production by each host strain (i.e., in the absence of either pathway) for comparison.  As can be 
seen, compared to the above results using NST74 ΔfeaB as host, deletion of crr had a significant 
effect on 2PE production by both the Ehrlich and styrene-derived pathways, improving final titers 
by 77% and 67%, respectively.  Deletion of crr also resulted in expected reductions in acetate 
accumulation, in each case by 45-60%.  Meanwhile, the additional, combined deletion of pykA and 
pykF led to even further improvements in 2PE production by both the Ehrlich and styrene-derived 
pathways, reaching 1163 ± 3 and 1468 ± 47 mg/L (or 9.52 ± 0.02 and 12.02 ± 0.38 mM), 
respectively, after 72 h (increases of 19% and 37% relative to using NST74 ΔfeaB Δcrr as host).  
Interestingly, as is most prominent in the case of the styrene-derived pathway, individual deletion 
of just pykA or pykF alone gave little or no improvement, suggesting that full inactivation of pyruvate 
kinase activity was necessary to realize the beneficial effects of this strategy.  That said, analogous 
experiments in the absence of the pathway (i.e., for Phe production) suggest the ΔpykA mutation 
to perhaps be most important (Figure 2.4); a surprising observation given that PykF has been 
reported to provide the dominant pyruvate kinase activity during aerobic growth on glucose 132.  For 
comparison, in the absence of either pathway, NST74 ΔfeaB Δcrr ΔpykA ΔpykF produced a total 
of 2076 ± 19 mg/L (12.57 ± 0.11 mM) Phe.  Accordingly, and assuming constant flux through the 
SA pathway in each case, this suggests that the styrene-derived pathway was more efficient than 
the Ehrlich pathway (96 vs. 76%) at assimilating and ultimately converting their corresponding 
endogenous precursor to 2PE. 
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Figure 2.4 2PE Titers for the Ehrlich and Styrene-derived Pathways with Gene Deletions. 
Final titers of 2PE after 72 h of culturing for the Ehrlich (blue) and styrene-derived (red) pathways 
in E. coli NST74 strains harboring various deletions of genes feaB, crr, pykA and pykF (left and 
center, respectively). Right: Final Phe titers by the same host strain in the absence of either 
pathway (green).  Final acetate concentrations are also shown (n.d. indicates not detected). Error 
bars reported at one standard deviation from triplicate experiments. 
Interestingly, acetate production via the styrene-derived pathway was minimal regardless of which 
host background was used and, in all cases, was 14- to 71-fold lower than when expressing the 
Ehrlich pathway.  Most strikingly, although in the absence of either pathway acetate accumulation 
was undetected with NST74 ΔfeaB Δcrr ΔpykA ΔpykF, upon introduction of the Ehrlich pathway, 
acetate levels rose back up to 5.23 ± 0.06 g/L (compared to just 0.29 ± 0.02 g/L with the styrene-
derived pathway).  Given this substantial difference, it was hypothesized that acetate production 
could perhaps be occurring as a result of Aro10p promiscuity.  Decarboxylation of pyruvate, for 
example, yields acetaldehyde which, in turn, could be oxidized to acetate via E. coli’s NADP+-
dependent aldehyde dehydrogenase (encoded by aldB) 133.  To provide an initial assessment of 
this proposed phenomena, control cultures were prepared of E. coli BW25113 pY-ARO10 grown 
in the absence or presence of 6 g/L exogenously-supplied sodium pyruvate.  After 48 h, 
accumulated acetate levels were 3.8-fold higher following sodium pyruvate addition (5.41 vs. 1.41 
g/L; Table 2.2).  While more detailed characterizations are needed, these findings certainly support 
the proposed, ARO10-associated mechanism of increased acetate accumulation. 
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Table 2.2 Acetate Accumulation in Wild-Type E. coli Expressing ARO10 with Pyruvate Feeding. 
Acetate accumulation in cultures of E. coli BW25113 pY-ARO10 grown in pH 6.8 MM1 minimal 
media supplemented with sodium pyruvate at a total concentration of 0 or 6 g/L (note: sodium 
pyruvate was added to the culture at a final concentration of 2 g/L at each of 8, 18 and 27 h, 
resulting in 6 g/L total). 
 
2.3.5 Optimizing Culture Conditions to Further Improve 2PE Production 
Induction timing and initial substrate concentration were next optimized to further improve 2PE 
production.  In the first case, the timing of IPTG-induced expression of the Ehrlich and styrene-
derived pathways in NST74 ΔfeaB Δcrr ΔpykA ΔpykF was investigated at six different points (from 
inoculation to late exponential phase), the results of which are compared in Figure 2.5.  In both 
cases, induction at inoculation gave the greatest final 2PE titers, suggesting greater net flux through 
each pathway was realized when each was given maximal time to compete for endogenous 
precursors (consistent with observations of reduced biomass production at earlier inductions; 
Figure 2.5).  In contrast, when induced too late (i.e., at 19 h or beyond), neither pathway effectively 
competed for its requisite precursor, which instead was then assimilated into additional biomass 
and/or accumulated Phe. In the case of the Ehrlich pathway, net acetate accumulation followed a 
similar pattern to that of 2PE production (Figures 2.5 and 2.6, respectively), with less build-up 
occurring for later inductions (note: final acetate and 2PE levels were 66% and 71% lower, 
respectively, when cultures were induced after 29 h versus at inoculation).  This observation further 
supports the above hypothesis that significant acetate byproduct formation is perhaps occurring 
due to Aro10p promiscuity. 
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Figure 2.5 Effect of Induction Timing on 2PE Production. 
Effect of induction timing on production of 2PE and Phe as well as growth after 72 h by both 
pathways when expressed in E. coli NST74 ΔfeaB Δcrr ΔpykA ΔpykF. Upper panels: final OD600 
(solid, dark blue/red) and OD600 at time of induction for the Ehrlich (striped, light blue) and styrene-
derived (striped, light red) pathways. Lower panels: Final concentrations of 2PE (solid, maroon) 
and Phe (striped, gold). Error bars reported at one standard deviation from duplicate experiments. 
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Figure 2.6 Accumulation of Acetate in E. coli Cells Producing 2PE via the Ehrlich Pathway. 
Acetate accumulation after 72 h by E. coli NST74 ΔfeaB Δcrr ΔpykA ΔpykF expressing the Ehrlich 
pathway, as a function of induction timing. Error bars reported at one standard deviation from 
duplicate experiments. 
All of the above 2PE production studies were performed by initially supplying each culture with 20 
g/L glucose which, in all cases, was fully consumed within 72 h (data not shown).  As this suggests 
a possible substrate limitation, a series of batch experiments were next performed wherein 
increasing amounts of initial glucose (5 to 50 g/L) were instead supplied, in all cases using the best-
performing host strain (i.e., NST74 ΔfeaB Δcrr ΔpykA ΔpykF) and optimal induction timing (i.e., at 
inoculation).  Figure 2.7 compares glucose consumption, along with 2PE yield and final titers for 
both pathways.  In all cases, glucose is fully consumed when initially supplied at 5 to 30 g/L, with 
higher initial glucose levels expectedly resulting in increased 2PE titers.  At higher initial glucose 
concentrations (i.e., 40 and 50 g/L), however, clear differences emerge with respect to the two 
pathways.  Though also declining (perhaps due to a nutrient limitation or onset of substrate 
inhibition), greater conversion at higher glucose loadings and, as a result, increased 2PE titers and 
yields remain possible via the styrene-derived pathway.  Ultimately, when supplied with 50 g/L 
glucose, 2PE titers via the styrene-derived pathway reached their maximum level of 1941 ± 13 
mg/L at a yield of 60.5 ± 0.3 mg/g (16.8% of theoretical); a final 2PE titer ~2-fold greater than the 
highest value reported to date for E. coli expressing the Ehrlich pathway.  
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Figure 2.7 Effect of Initial Glucose Concentration on Production of 2PE. 
Various initial concentrations of glucose (ranging from 5 to 50 g/L) for 2PE production of E. coli 
NST74 ΔfeaB Δcrr ΔpykA ΔpykF induced at inoculation. Glucose consumed as a percentage of 
glucose fed (striped, gold) and mass yield of 2PE from glucose (solid, maroon) after 96 h of culturing 
for the Ehrlich and styrene-derived pathways (left and center, respectively). Right: 2PE titers for 
the Ehrlich (solid, blue) and styrene-derived (striped, red) pathways at the 96 h mark are shown for 
various concentrations of initial glucose. Error bars reported at one standard deviation from 
triplicate experiments. 
A series of batch cultures were lastly performed to investigate the dynamics of 2PE production via 
both pathways, in each case utilizing NST74 ΔfeaB Δcrr ΔpykA ΔpykF as host while supplying 30 
g/L glucose (to ensure full utilization) and performing induction at inoculation.  Figure 2.8 compares 
glucose consumption, 2PE and acetate production, and biomass accumulation in each case.  
Initially, rates of sugar consumption as well as 2PE and biomass production were slower for the 
styrene-derived pathway.  Notably, for instance, while expressing the Ehrlich pathway, average 
volumetric rates of glucose consumption and 2PE production during the first 24 h were 401 ± 9 and 
28.1 ± 2.3 mg/L-h, respectively, compared to just 230 ± 30 and 15.6 ± 0.6 mg/L-h for the styrene-
derived pathway.  However, by ~36 h, 2PE production by the Ehrlich pathway (which occurred 
coincidently with cell growth) levels off, whereas production continues for an additional ~30 h via 
the styrene-derived pathway (during which time cell growth had already entered the stationary 
phase).  Ultimately, after 87 h, final 2PE titers reached 1817 ± 15 and 1164 ± 85 mg/L for the 
styrene-derived and Ehrlich pathways, respectively, at yields of 60.6 ± 0.5 and 38.8 ± 2.8 mg/g.  It 
should also be noted that by 36 h, acetate accumulation in cultures expressing the Ehrlich pathway 
approached 2 g/L while still remaining below 0.5 g/L for the styrene-derived pathway, suggesting 
that the ability of the styrene-derived pathway to maintain longer periods of productivity and greater 
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net 2PE production may be due in part to its ability to minimize inhibitory byproduct accumulation. 
Notably, and in contrast to the results of Figure 2.4, by 87 h, acetate levels still accumulated to 
appreciable levels (3.32 g/L, or a net increase of ~3 g/L) for strains expressing the styrene-derived 
pathway. However, it was further noted that a similar net increase in acetate production (2.2 g/L) 
was also realized for strains expressing the Ehrlich pathway when supplied with 30 vs. 20 g/L 
glucose (Table 2.3).  These behaviors suggest that, in spite of the introduced Δcrr ΔpykA ΔpykF 
mutations, increased acetate production might still be occurring due to overflow metabolism 134. 
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Figure 2.8 Time Course of 2PE, Cell Biomass, and Acetate Production and Glucose Consumption 
for the Ehrlich and Styrene-derived Pathways. 
Time course analysis of 2PE production and relevant culture metrics over 87 h for the Ehrlich (blue 
squares) and styrene-derived (red circles) pathways in E. coli NST74 ΔfeaB Δcrr ΔpykA ΔpykF 
supplied with 30 g/L glucose and induced at inoculation. First: glucose consumption. Second: 2PE 
production. Third: Acetate production.  Fourth: Cell growth as represented by OD600. Error bars 
reported at one standard deviation from triplicate experiments. 
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Table 2.3 2PE Production Metrics for the Ehrlich and Styrene-derived Pathways. 
Relevant culture performance and 2PE production metrics for both the Ehrlich and styrene-derived 
pathways at 72 h when supplied with an initial glucose concentration of either 20 or 30 g/L. Both 
pathways were expressed in E. coli NST74 ΔfeaB Δcrr ΔpykA ΔpykF. These data have been 
compiled for comparison from the results of Figure 2.4 (for 20 g/L glucose) and Figure 2.8 (for 30 
g/L glucose). 
 
2.4 Discussion 
Through the continued, modular extension of a previously-engineered styrene biosynthesis 
pathway, a novel route to 2PE has been engineered as a robust and efficient alternative to the 
established, Ehrlich pathway.  Ultimately, for example, when compared under otherwise analogous 
conditions (Figure 2.8), 2PE titers and yields were about 56% greater via the styrene-derived 
versus Ehrlich pathway, with final titers capable of approaching ~2 g/L with additional glucose 
supplementation.  As characterized via both in silico analyses and experimental studies, relative to 
the Ehrlich pathway, the styrene-derived 2PE pathway was found to possess its own unique and 
notable advantages, as well as certain caveats.  For example, as has been previously 
characterized with respect to (S)-styrene oxide production (also produced via styrene, as in Figure 
2.1) 118, the highly favorable SMO reaction (which is largely responsible for the ~10-fold greater 
thermodynamic driving force of the styrene-derived pathway), serves to effectively ‘pull’ more 
precursor (i.e., Phe) into the pathway.  This phenomenon is further supported in the case of 2PE 
production, noting that conversion of endogenous precursors via the styrene-derived pathway was 
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96% versus just 76% by the Ehrlich pathway.  Additionally, and in contrast to the Ehrlich pathway, 
which branches off from native metabolism (i.e., at phenylpyruvate), the styrene-derived pathway 
instead extends from a terminal pathway metabolite (i.e., Phe; Figure 2.1).  In this way, the styrene-
derived pathway also importantly avoids introducing a competitive ‘branch point’.  In the Ehrlich 
pathway, as PPDC (e.g., Aro10p, Km = 100 µM 135) must directly compete against native Phe 
aminotransferase (i.e., TyrB, Km = 12 µM 136) for available phenylpyruvate, kinetic limitations can in 
turn reduce the flux of metabolites that enter the pathway at its first committed step.  While deletion 
of tyrB can eliminate such competition, preserving phenylpyruvate for the Ehrlich pathway, such a 
mutation significantly impairs both Phe and Tyr biosynthesis, thereby necessitating their 
supplementation or the use of rich media which increases costs and reduces scalability. Meanwhile, 
however, construction of the styrene-derived pathway requires the simultaneous expression of four 
heterologous genes.  Though perhaps not apparent under the conditions examined here, this could 
ultimately lead to reduced host fitness and decreased production metrics as a result of increased 
metabolic burden.   
One of the most significant differences between employing the two 2PE pathways concerns not the 
product, but rather a byproduct, namely acetate. As evidenced by the results of Figure 2.4, even 
when using a host background virtually deficient in acetate accumulation (i.e., NST74 ΔfeaB Δcrr 
ΔpykA ΔpykF), significant acetate production reemerged upon introduction of the Ehrlich pathway, 
reaching final concentrations as high as 5.23 ± 0.06 g/L (in experiments with 20 g/L glucose).  
Previous studies have found that acetate concentrations above 1 g/L can deter biomass and protein 
production, reduce protein stability, and lower pH, causing cell lysis 137.  Accordingly, and 
regardless of the specific mechanism, the ability to significantly reduce acetate byproduct 
accumulation when employing the styrene-derived pathway is postulated as a significant reason 
for the ability of this pathway to support superior 2PE production metrics.  Though still warranting 
further investigation, acetate byproduct accumulation when expressing the Ehrlich pathway is 
thought to be a result of Aro10p promiscuity.  Although prior reports suggest that, at least with 
respect to its native expression in S. cerevisiae, Aro10p displays minimal activity on pyruvate (with 
in vitro assays reporting kcat/Km = 200 and 0.035 mM-1·s-1 for phenylpyruvate and pyruvate, 
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respectively 135), here, experimental evidence might suggest otherwise, at least with respect to its 
recombinant, in vivo function in E. coli.  
With final 2PE titers via the styrene-derived pathway ultimately approaching ~2 g/L (at high glucose 
loading), and in contrast to preliminary cultures, said output now approaches the toxicity limit of 
2PE.  As the mode of aromatic toxicity against bacteria has most commonly been reported to be 
associated with their accumulation within and disruption of the cytoplasmic membrane 138, a similar 
phenomenon was also anticipated here. In fact, with a toxicity threshold determined as ~2 g/L, the 
present observations of 2PE toxicity agree well with previously-reported model used to predict the 
toxicity of various aromatic bioproducts (e.g., styrene, (S)-styrene oxide, and various phenolics) 
based on estimates of the membrane-water partitioning coefficient (KM/W) 118.  Accordingly, future 
improvements in 2PE production will likely necessitate strategies designed to increase inherent 
tolerance to 2PE or to circumvent its toxic effects (e.g., via its in situ removal).  It was recently 
reported that tolerance to and thus production of styrene, for example, could be improved via 
rigidification of E. coli’s cytoplamsmic membrane, in this case by increasing the proportion of trans 
unsaturated fatty acids (as achieved by expressing heterologous cis-trans isomerase, encoded by 
cti from P. aeruginosa) 139. Meanwhile, various strategies for in situ 2PE removal have also been 
investigated, including, for example, via its extraction in a biphasic ionic liquid system which gave 
3- to 5-fold increases in 2PE production by S. cerevisiae 140.   Other approaches, meanwhile, 
including pervaporation 141 and solid-phase extraction (i.e., using hydrophobic resins) 142 have 
shown as high as 10-fold improvements in 2PE production. 
Finally, whereas the styrene-derived pathway for 2PE production represents a novel alternative to 
the Ehrlich pathway, two additional routes to 2PE have also recently been reported.  In one case, 
for example, phenylacetaldehyde synthase (PAAS) from Rosa hybrid was expressed in E. coli to 
convert Phe to 2-phenylacetaldehyde, which was then subsequently reduced to 2PE.  Although 
this route could, in theory, be expressed in a Phe over-producing host to enable 2PE production 
directly from glucose, applications to date have been limited just to 2PE production via 
biotransformation of exogenous Phe (with up to 0.39 g/L 2PE produced in this manner) 143.  That 
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said, however, while this pathway has the advantage of only requiring one heterologous step, PAAS 
is a pyridoxal 5’-phosphate (PLP) dependent enzyme and its expression in E. coli would thus 
necessitate external cofactor addition or introduction of a PLP production pathway.  A second 
alternative 2PE production pathway was also recently discovered in tomato.  In this case, Phe 
decarboxylase first converts Phe to phenylethylamine which is then further converted to 2-
phenylacetaldehyde via an ammonia-lyase 100. To our knowledge, this pathway has not yet been 
expressed in microbes for the purposes of 2PE production, but could provide yet another alternative 
route for 2PE biosynthesis.  
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CHAPTER 3. BIOPROCESSING AND GENETIC ALTERATIONS TO IMPROVE PRODUCTION 
OF L-PHENYLALANINE UTILIZING XYLOSE AND GLUCOSE FEEDSTOCKS 
 
Abstract 
A significant and persistent challenge faced by most microbial biocatalysts reamins the ability to 
convert multiple feedstocks (e.g., different sugars) into a single product in a resourceful manner.  
Glucose and xylose, for example, are produced from lignocellulosic biomass and represent the 
most abundant carbon sources in nature.  Unfortunately, however, the metabolism of many 
microbes (including E. coli), is subject to carbon catabolite repression (CCR) - a natural regulatory 
mechanism that precludes their ability to utilize more than one sugar at a time.  Recently, it was 
discovered that (R121C, P363S) mutations in XylR (xylose regulator) released glucose-induced 
CCR of xylose utilization under anaerobic conditions, allowing strains expressing the mutated xylR 
to efficiently and simultaneously co-utilize glucose and xylose.  Here, the efficacy of this strategy 
was investigated for the first time under aerobic conditions in E. coli, and as a proof-of-concept, 
used to demonstrate enhanced production of phenylalanine from glucose-xylose mixtures. 
Additionally, the versatility of aromatic amino acids such as phenylalanine to be enzymatically 
transformed into industrially relevant and value-added compounds makes the demonstration of 
glucose and xylose co-utilization of great applicability to potentially improve production metrics of 
many aromatic compounds.  Ultimately, by implementing XylR* into NST74, a L-phenylalanine 
overproducing strain, along with other mutations known to affect sugar assimilation 
rates/mechanisms (i.e., Δcrr) and enhanced intracellular pools of a key precursor (i.e., ΔpykAF, 
which promotes phosphoenolpyruvate, PEP), 3509 ± 465 mg/L L-phenylalanine was produced from 
a 2% (w/v) sugar mixture containing 67% glucose and 33% xylose.  Overall, the approach shows 
promise to improve the production of other aromatic chemicals from biomass-derived sugars 
mixtures. 
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3.1 Introduction 
Lignocellulose derived from plant biomass represents a potentially vital renewable resource to 
serve as substrates for microbially-catalyzed conversion to valuable chemicals and fuels 144.  While 
the predominant sugar utilized for the demonstration of bioproduction in E. coli is glucose, there is 
a need and desire to consume other sugars as well.  As many challenges remain in terms of 
breaking down and converting lignocelluose into usable substrates for E. coli 145, extensive effort 
has been put into engineering microbes to efficiently utilize these substrates for the production of 
value-added chemicals.  Glucose (via cellulose) makes up the plurality of biomass in lignocellulose 
(30-40% by weight) but other sugars are present as well, including xylose (the predominant portion 
of hemicellulose) 146.  Therefore, upon improvement of lignocellulose-degrading technology one 
goal for improving bioproduction is the utilization of all basal components of plant biomass, most 
predominantly glucose and xylose.   
However, in E. coli, a major impediment exists to the co-utilization of both glucose and xylose – 
namely, carbon catabolite repression (CCR).  CCR is a phenomenon that exists in bacteria that 
causes cells to consume sugars in a sequential basis with the sugar that leads to the fastest growth 
rates usually being consumed first and the many regulatory mechanisms controlling CCR has been 
reviewed 147.  As E. coli growth on xylose is usually slow and inefficient relative to glucose 148, E. 
coli cultures fed with a feedstock containing both sugars will not consume xylose until all glucose 
is depleted 149.  Although CCR is important for evolutionary and survival purposes, it can often limit 
production metrics in bioproduction scenarios.  Several strategies have been utilized to overcome 
this phenomenon.  One early example demonstrates the utilization of microbial co-cultures to 
consume both glucose and xylose concurrently.  Here, two E. coli strains were engineered – one 
with mutation of genes necessary to consume glucose (i.e., glk, ptsG, manZ) and one with a 
mutation in xylA, which is necessary to consume xylose 150.  When cultured together, one strain 
was able to consume glucose while the other simultaneously consumed xylose, leading to improved 
sugar consumption rates.  Another example of overcoming CCR via co-cultures is in the production 
of cis,cis-muconic acid (MA).  Here, one strain of E. coli was able to only consume xylose for the 
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purpose of producing the MA intermediate DHS, while a second strain utilized only glucose and 
could import and convert DHS into MA 151.  This allowed for elimination of CCR in MA production 
with improvements in titers up to 4.7 g/L with yields as high as 0.35 g/g-total sugar. 
While the utilization of co-cultures is useful to overcome CCR, it necessitates the need to multiple 
strains and careful balancing of the two in culture.  Therefore, effort has been put into genetic 
engineering methods to overcome CCR between xylose and glucose.  Previously, the production 
of the shikimic acid pathway-derived compound 4-hydroxymandelic acid (via 4-
hydroxyphenylpyruvic acid and the expression of shmaS from Amycolatopsis orientalis) utilizing a 
co-sugar mixture of glucose and xylose has been demonstrated in E. coli 152.  The deletion of ptsG 
led to a reduction of CCR between the two sugars and further mutations in pykAF, pheA, aspC, 
tyrB and tyrR allowed for titers reaching 15.8 g/L of 4-hydroxymandelic acid in a fed-batch setting.  
The deletion of ptsG also allows for improvements in PEP availability and ultimately flux through 
the aromatic amino acid synthesis pathway via inactivation of the PTS system (converts PEP to 
pyruvate for the import and phosphorylation of glucose) 153.  Ultimately, after examining various 
ratios of glucose-xylose mixtures, researchers determined that the maximum titers were achieved 
at a 50-50% (by mass) ratio of glucose and xylose. 
One such mutation to reduce the effects of CCR is in the gene xylR in E. coli, which was identified 
by Sievert et al. via adaptive laboratory evolution 154.  XylR (the production of xylR) is a xylose-
specific activator which induces expression of xylose-utilizing genes in E. coli upon the presence 
of xylose 155.  Sievert et al. found that introducing mutations into native xylR (R121C and P363S) 
(henceforth referred to as xylR*)  led to activation of xylose-utilizing genes (i.e., xylA and xylB, 
which encode for a xylose isomerase and xylose dehydrogenase, respectively, and xylFGH which 
encode for a xylose ABC transporter) even in the presence of glucose and allowed for 
improvements in xylose consumption rates.  When implemented in a D-lactate producer, 94% of 
sugars in a 50-50% (by mass) mixture of glucose and xylose mixture were utilized when cultured 
anaerobically and D-lactate titers increased by 50% 154.  While xylR* implementation in E. coli 
allowing for improved rates of utilization of xylose has previously been demonstrated in anaerobic 
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fermentations for lactate and ethanol production 154,156, to the best of my knowledge, this mutation 
has not been utilized for aerobic culturing purposes. 
3.2 Materials and Methods 
3.2.1 Microorganisms 
E. coli NST74 (ATCC 31884), a feedback resistant mutant of E. coli which overproduces Phe 120 
was purchased from the American Type Culture Collection (ATCC; Manassas, VA).  E. coli strains 
JW2410-1, JW1843-2, and JW1666-3 were obtained from the Coli Genetic Stock Center (CGSC; 
New Haven, CT) and served as the genetic source for the crr::FRT-kanR-FRT, pykA::FRT-kanR-
FRT and pykF::FRT-kanR-FRT deletion cassettes.  E coli W-variant LN6 154, which served as the 
template for the cloning of mutations (R121C, P363S) into wild-type xylR, was a generous gift from 
the Xuan Wang lab.  Chromosomal in-frame gene deletions in E. coli and subsequent kanR marker 
removal were accomplished utilizing the plasmid pSIJ8 via a method adapted from Jensen et al. 
157 with 5% (w/v) L-arabinose for induction of λ red recombinase and 50 mM rhamnose for induction 
of the FLP recombinase.  E. coli W3110 variant T-SACK 158, which served as a template for tetA-
sacB, was a generous gift from the Donald Court lab.  
3.2.2 DNA Cassette Construction 
Custom DNA oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA).  
Genomic DNA (gDNA) was prepared from cell cultures using the ZR Fungal/Bacterial DNA 
MiniPrep (Zymo Research, Irvine, CA) according to vendor protocols.  All genes were PCR 
amplified with Q5 High-Fidelity DNA Polymerase (NEB) using standard protocols.  Amplified linear 
DNA fragments were purified using the Zymo Research DNA Clean & Concentrator Kit (Zymo 
Research) according to manufacturer protocols. 
Table 3.1 shows the primers utilized for incorporation of mutations into xylR.  Utilizing methods 
adapted from Datsenko and Wanner 121, as previously described 32, tetA-sacB was integrated into 
the xylR locus.  Colonies were selected from on LB-agar plates containing 10 ng/uL tetracycline.  
Positive clones were checked for insertion of tetA-sacB into the xylR locus via colony PCR.  
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Subsequently, correct clones were then subjected to a secondary integration of xylR (R121C, 
P363S) from LN6 and screened for insensitivity to 10% (w/v) sucrose in liquid LB media followed 
by plating on LB-agar plates containing 6% (w/v) sucrose 158,159.  Colonies were subsequently 
verified via colony PCR. 
Table 3.1 Primers for the Insertion of xylR (R121C, P363S) into Production Strains. 
Primer Name Sequence (5' -> 3') Purpose 
F - xylR 
(R121C, 
P363S) from 
LN6 
gtgggaagcgttgccgg 
Cloning of xylR (R121C, 
P363S) from LN6 R - xylR 
(R121C, 
P363S) from 
LN6 
cctgatgtgacgccgacaattctc 
F - tetA-sacB 
into xylR 
tttgagtttttgcatgattcagcaggaaaagaacctcctaatttttgttg
acactctatc Cloning of tetA-sacB from 
T-SACK R - tetA-sacB 
into xylR 
gttacctgatgtgacgccgacaattctcatcatcgatcaaaggga
aaactgtccatatgc 
F - xylR (780 
bp homology) 
ctgtatcccccaccagcgcc 
Cloning of homology 
arms for tetA-sacB from 
T-SACK and xylR 
(R121C, P363S) from 
LN6 and colony PCR 
R - xylR (790 
bp homology) 
ggaaaaaggcgtttctccggaccg 
F - xylR 
helper 
cgatgatgagaattgtcggcg 
Helper primers for cloning 
of homology arms for 
tetA-sacB from T-SACK 
and xylR (R121C, P363S) 
from LN6 
R - xylR 
helper 
ggttcttttcctgctgaatcatgc 
 
3.2.3 Production of Phe by Engineered E. coli 
Seed cultures were grown in 3 mL LB broth at 32oC for 12 – 16 h.  Next, 0.25 mL of seed culture 
was used to inoculate 25 mL (in 125 mL shake flasks) of pH 6.8 MM1 – a phosphate-limited minimal 
media adapted from McKenna and Nielsen 117, with the following recipe (in g/L): MgSO4·7H2O (0.5), 
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(NH4)2SO4 (4.0), MOPS (24.7), KH2PO4 (0.3), and K2HPO4 (1.0), as well as 1 mL/L of a trace 
mineral solution containing (in g/L): MnCl2·4H2O (1.584), ZnSO4·7H2O (0.288), CoCl2·6H2O 
(0.714), CuSO4 (0.1596), H3BO3 (2.48), (NH4)6Mo7O24·4H2O (0.370), and FeCl3 (0.050).  The type 
of carbon source (i.e., glucose or xylose) and concentration used for each experiment is noted in 
the text. 
Once inoculated, cultures were grown at 32oC while shaking at 200 RPM.  Following inoculation, 
strains were cultured until the time stated in the text, during which time, samples were periodically 
withdrawn for cell growth and metabolite analysis.  Meanwhile, intermittently throughout each 
culture, pH was increased back to its initial value by adding a minimal volume (typically ~0.1-0.3 
mL) of 0.4 g/L K2HPO4 solution. 
3.2.4 Analytical Methods 
Cell growth was measured as OD600 using a UV/Vis spectrophotometer (Beckman Coulter DU800, 
Brea, CA).  Culture samples were centrifuged at 11,000 x g for 4 min to pellet cells, after which 
0.25 mL of the resulting supernatant was then transferred to a glass HPLC vial containing an equal 
volume of 1 N HCl before being sealed with a Teflon-lined cap.  Analysis of Phe was performed via 
high performance liquid chromatography (HPLC; Agilent 1100 series HPLC, Santa Clara, CA) using 
a diode array (UV/Vis) detector.  Separation and analysis of phenylalanine was achieved on a 
reverse-phase 5μm BDS Hypersil C18 column (3 mm x 250 mm; Thermo Electron, USA) operated 
at 45oC using a mobile phase consisting of 85% 5 mM H2SO4 and 15% acetonitrile, flowing at a 
constant rate of 0.5 mL/min for 6.5 min.  The eluent was monitored using a diode array detector 
(DAD) set at 215 nm for detection of phenylalanine.  Glucose, xylose and acetate analysis, 
meanwhile, was performed using the same HPLC system equipped with a refractive index detector 
(RID) and an Aminex HPX-87H column (BioRad, Hercules, CA) operated at 35ºC.  The column 
was eluted using 5 mM H2SO4 as the mobile phase at a constant flow rate of 0.55 mL/min for 20 
min. External calibrations were prepared and used to quantify each species of interest.  Data 
reported here is a result of triplicate experiments, unless otherwise noted, along with one standard 
deviation. 
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3.3 Results and Discussion 
3.3.1 Comparison Between Utilization of Glucose and Xylose for Production of L-Phenylalanine 
The production of L-phenylalanine (Phe) in E. coli necessitates the production of two intracellular 
metabolites that funnel into the shikimic acid pathway – erythrose-4-phosphate (E4P) and 
phosphoenolpyruvate (PEP) – which are converted to 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP), the precursor to all three aromatic amino acids (AAAs), via three enzymes in 
E. coli – AroG, AroF and AroH.  Figure 3.1 shows pertinent reactions, substrates, co-factors and 
products in E. coli to convert glucose and/or xylose to Phe (one of the AAAs).  Therefore, to 
maximize production of aromatic amino acids – and the production of their derivatives – a careful 
balance between the pools of PEP and E4P must be maintained.  While ideally, the production 
rates of both metabolites will be maximized, without a consistent, simultaneous supply of both PEP 
and E4P, final production of aromatic amino acids will suffer.  Additionally, as a second PEP 
molecule is consumed during the production of the aromatic amino acids (i.e., shikimate-3-
phosphate + PEP → 5-enolpyruvoyl-shikimate 3-phosphate + phosphate via AroA), the flux towards 
PEP and the buildup of a pool of this molecule is critical to enchancing production of AAAs. 
While E4P is predominately utilized for production of aromatic amino acids and as a part of the 
pentose phosphate pathway, PEP plays a significant role in both glycolysis and glucose transport 
into the cell.  While a large portion of PEP pools are predominantly produced during glycolysis, 
PEP also serves as the direct precursor to pyruvate (reaction catalyzed by pyruvate kinase – PykA 
and PykF in E. coli) where pyruvate is subsequently converted into acetyl-CoA and funneled into 
the TCA cycle.  Additionally, PEP is converted to pyruvate via a different enzyme to facilitate 
glucose uptake in the phosphotransferase system (PTS) of E. coli which serves as another sink for 
PEP pools.  Conversely, E4P is mainly produced in the pentose phosphate pathway.  Additionally, 
E4P can serve as a substrate in the reversible transketolase reaction (encoded by tktAB in E. coli) 
which converts E4P and xylulose-5-phosphate (X5P) into fructose-6-phosphate (F6P) and 
glyceraldehyde-3-phosphate (G3P).  In 13C-flux analysis studies of wild-type cells, when grown on 
glucose, the flux through the pentose phosphate pathway, and ultimately, E4P, was quite low 160.  
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For glucose, the ratio of flux from S7P to E4P compared to the flux from 3-phosphoglycerate to 
PEP was ~1:23.7 while this ratio when grown on xylose was ~1:3.5 160.  Therefore, even though 
the number of PEP molecules to produce one Phe is twice the number of E4P needed, the severe 
difference in flux towards PEP when grown on glucose may ultimately limit Phe production.  The 
production of aromatic amino acids (such as Phe) representatives a potentially useful application 
and test case due to the need for two intracellular precursors (one E4P and two PEP molecules) to 
produce one molecule of the aromatic amino acid.   
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Figure 3.1 Metabolic Pathway of E. coli from Glucose and Xylose to Phenylalanine. 
Metabolic pathway of glucose and xylose metabolism to phenylalanine (Phe).  Single enzymatic 
steps are shown as solid lines, pathways with multiple steps are shown as dashed lines.  Lines 
which have arrows are either end illustrate reversible reactions.   The genes which encode each 
step are shown next to the enzymatic line in italics.  Co-factors for each reaction are shown in green 
(if produced) and red (if consumed).  G6P = glucose-6-phosphate, F6P = fructose-6-phospate, FBP 
= fructose-1,6-biphosphate, DHAP = dihydroxy-acetone-phosphate, G3P = glyceraldehyde-3-
phosphate, 6PGNL = 6-phosphogluconolactone, 6PGNT = 6-phosphogluconate, KDPG = 2-keto-
3-deoxy-6-phosphogluconate, Ru5P = ribulose-5-phosphate, X5P = xylulose-5-phosphate, R5P = 
ribose-5-phosphate, S7P = seudoheptulose-7-phosphate, E4P = erythrose-4-phosphate, G1,3P = 
glyceraldehyde-1,3-phosphate, 3PG = 3-phosphoglycerate, 2PG = 2-phosphoglycerate, PEP = 
phosphoenolpyruvate, DAHP = 3-deoxy-D-arabino-heptulosonate-7-phosphate, Acetyl-P = acetyl-
phosphate, OAA = oxaloacetate, MAL = malate.  Note: G3P and F6P appear twice on this pathway 
map for clarity purposes.  
3.3.2 Utilization of Xylose and Glucose for Production of Phenylalanine in E. coli 
To analyze the production capacity of either xylose or glucose for the bioconversion to 
phenylalanine, NST74, a Phe overproducing strain, was utilized and the time course of pertinent 
performance metrics are shown in Figure 3.2.  Either 2% (w/v) of glucose or xylose was fed to cells 
and with glucose as the sole substrate, NST74 produced 567 ± 25 mg/L Phe at a mass yield of 
28.4 ± 2.8 mg-Phe/g-glucose after 96 h of culturing (cells were grown to 120 h but Phe titers were 
maximized after 96 h).  Utilizing xylose as the sole substrate, NST74 produced 1315 ± 65 mg/L 
Phe at a mass yield of 63.1 ± 3.1 mg-Phe/g-xylose after 138.5 h of culturing.  Other than the large 
differences in titer and yield, there were other variations observed when NST74 was grown on the 
two substrates such as those observed in terms of sugar consumption and Phe production rates.  
Overall, NST74 consumed 100% of the original glucose at an overall rate of 0.181 g glucose/L-h 
(after 120 h).  When only xylose was fed, 100% of the original xylose was also consumed at a 
surprisingly quicker rate of 0.217 g xylose/L-h (after 95 h).  In terms of overall rates, the production 
of Phe ran concurrently to the rate of sugar consumption.  Cells produced Phe at a much slower 
degree as production from glucose occurred at an overall rate of 5.9 ± 0.3 mg Phe/L-h (after 96 h) 
while overall Phe production rates from xylose were 9.5 ± 0.5 mg Phe/L-h (over 138.5 h).  While 
strains utilizing only glucose reached near maximum production levels at around 50 h after 
inoculation (i.e., ~92% of final titers of Phe was produced in the first 50 h of culturing), cells growing 
only on xylose took much longer to reach final production concentrations as only ~77% of total Phe 
production was accomplished in the first 50 h of culturing.  Even so, the concentrations of Phe at 
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this time point (50 h) were 523 ± 27 and 1010 ± 45 mg/L Phe from glucose and xylose, respectively, 
indicating the high production capabilities of Phe overproducing strains from xylose.  It is likely that 
the abundance of E4P plays a key role in the high production on xylose, as the availability of E4P 
is much higher on this substrate. 
 
Figure 3.2 Time Course of NST74 Phe Production on 2% (w/v) Xylose or Glucose. 
Time course of NST74 production of Phe on xylose or glucose as measured by (Top) OD600 
(dashed line) and acetate (g/L; solid line) and (Bottom) sugar consumption (g/L; solid line) and Phe 
production (mg/L; dashed line).  Data of strains grown on xylose are shown in green while data 
from glucose is shown in maroon.  Error bars reported as one standard deviation from triplicate 
experiments. 
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While growth on 100% glucose or xylose is possible at the lab scale, as biomass sugars typically 
consist of sugar mixtures, this approach is likely less viable at the large scale.  For typical sources 
of lignocellulosic biomass, the ratio between glucose and xylose is approximately 2:1 
(glucose:xylose).  Accordingly, this same ratio was next employed in model glucose-xylose 
mixtures and evaluated with respect to Phe production by NST74 (Figure 3.3).  Here, 13.4 and 6.6 
g/L of glucose and xylose, respectively, were initially fed to NST74 for an overall sugar 
concentration of 2% (w/v).  After 141.5 h of culturing, 559 ± 105 mg/L Phe was produced at a mass 
yield of 37.8 ± 7.1 mg-Phe/g-total sugar.  In this case, no xylose was consumed during the culture, 
even after 100% of glucose was utilized indicating the significant impact of CCR on cell growth.  
This ultimately limited Phe production, as the strain was unable to take advantage of the benefits 
of xylose for aromatic amino acid production. 
  
Figure 3.3 Time Course of NST74 Phe Production on Glucose-Xylose (67%-33%) Feed. 
Time course of NST74 production of Phe on mixed sugar feed (67% glucose, 33% xylose; total 
sugar concentration = 20 g/L) as measured by OD600 (solid black line, triangle), acetate (g/L; solid 
gold line, diamond), glucose remaining (g/L; solid maroon line, circle), xylose remaining (g/L; solid 
green line, square) and Phe production (mg/L; dashed blue line, square).  Error bars reported as 
one standard deviation from triplicate experiments. 
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3.3.3 Effect of xylR Mutation on Aerobic Xylose Consumption Rates and Phenylalanine Production 
It was previously demonstrated under anaerobic conditions that the introduction of XylR* effectively 
eliminated glucose CCR, allowing for efficient and simultaneous consumption of both glucose and 
xylose 154,156.  To examine the effects of XylR* on aerobic growth and production of Phe, xylR 
(R121C, P363S) was integrated into NST74 at its native locus, resulting in NST74xylR*.  When a 
sugar mixture of glucose (67%) and xylose (33%) was fed to these cells, xylose utilization was 
improved upon and Phe production increased as seen in Figure 3.4.  When compared to NST74 
(Figure 3.3), both strains consumed 100% of the supplied glucose fed, no xylose was consumed 
by NST74 whereas NST74xylR* utilized 100% of supplied xylose, occurring in parallel with glucose 
consumption.  Consequently, it is clear that introduction of XylR* not only alleviates glucose CCR 
during anaerobic fermentations, but under aerobic conditions as well.  Ultimately, the co-utilization 
of both sugars led to improved titers and yields for NST74xylR* when compared to NST74, as 
NST74xylR* produced over 3-fold more Phe (1755 ± 91 versus 559 ± 105 mg/L) at a significantly 
higher yield (83.1 ± 4.3 versus 37.8 ± 7.1 mg Phe/g sugar).  This is due to the efficient co-utilization 
of xylose in NST74xylR* (100% xylose utilized by 71.5 h) compared to NST74 which consumed no 
xylose even after 141.5 h of culturing. 
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Figure 3.4 Time Course of NST74xylR* Phe Production on Glucose-Xylose (67%-33%) Feed. 
Time course of NST74xylR* production of Phe on mixed sugar feed (67% glucose, 33% xylose; 
total sugar concentration = 20 g/L) as measured by OD600 (solid black line, triangle), acetate (g/L; 
solid gold line, diamond), glucose remaining (g/L; solid maroon line, circle), xylose remaining (g/L; 
solid green line, square) and Phe production (mg/L; dashed blue line, square).  Error bars reported 
as one standard deviation from triplicate experiments. 
3.3.4 Genetic Modifications to Improve Phe Production in Xylose-Utilizing Cells 
Although NST74xylR* consumed more sugar by mass than NST74, it produced 53% less acetate 
even after 141.5 h.  Along with differences in the metabolic pathways for conversion of glucose and 
xylose into central metabolism, the increased rate of glucose consumption compared to xylose may 
play a role in increased acetate accumulation 134.  Therefore, one reason that NST74xylR* may 
display reduced production of acetate compared to NST74, is a decrease in glucose assimilation 
rates.  When compared Figure 3.3 and Figure 3.4, it can be seen that the rate at which glucose is 
consumed from the culture media is slower in NST74xylR* compared to NST74.  In fact, over the 
first 53 h of culturing, when xylose is still present, glucose is consumed at a rate of 0.140 ± 0.007 
g glucose/L-h in NST74xylR* compared to 0.216 ± 0.002 g glucose/L-h for NST74.  This difference 
in glucose consumption rates is only observed in the presence of xylose as NST74 and NST74xylR* 
grown in media containing only 2% (w/v) glucose showed similar consumption rates (data not 
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shown).  In contrast, however, NST74xylR* accumulated ~61.4% more biomass when compared 
to NST74, an interesting phenomenon that may simply be due to an increase in total sugar 
consumed. 
As the increased production of Phe depends on improving the availability of intracellular 
metabolites PEP and E4P, further genetic mutations were investigated for their effect on NST74 
and NST74xylR* and the abilities of these strains to consume pure xylose and glucose-xylose 
feedstocks.  Previously, pykF and pykA, which encode for pyruvate kinase enzymes, have been 
utilized to improve the production of a variety of compounds derived from the shikimic acid pathway 
and its derivatives as well as reduce acetate accumulation via reduced pyruvate production 18,129,152.  
As two PEP molecules are needed to produce one Phe molecule (compared to only one E4P 
molecule), it is thought that improvements in PEP pools, rather than E4P, may be more effective at 
boosting titers of Phe, especially in feedstocks containing xylose due to its more significant flux 
through E4P 161. 
Additionally, as the observed acetate accumulation arises as glucose is introduced into the feed, a 
genetic modification to reduce overflow metabolism from glucose catabolism was implemented.  
The crr gene encodes for IIAGlc, an important member of the glucose:PTS 130, and can work to 
reduce acetate accumulation rates as discussed in Chapter 2 130,131.  Previously, in a glucose-only 
feed, the introduction of this mutation reduced glucose uptake rates and acetate production in the 
media significantly decreased.  This deletion may also have the effect of improving PEP availability 
with feedstocks containing glucose as the removal of crr seems to “slow down” glucose assimilation 
into the cell, allowing PEP pools to build up for further enzymatic conversion to the SA pathway.  In 
an effort to investigate the effects of minimizing acetate production via upstream modifications and 
improve the availability of PEP, crr, pykA and pykF were deleted from NST74xylR* ΔpykAF to 
produce NST74xylR* Δcrr ΔpykAF.  When comparing NST74xylR* to NST74xylR* Δcrr ΔpykAF, 
as seen in Table 3.2, it can be observed that 100% of sugar fed is consumed in both strains, 
however, NST74xylR* Δcrr ΔpykAF produceds almost 2 times the amount of Phe as NST74xylR*, 
indicating that these mutations are helpful in a mixed sugar feed scenario, not only with a pure 
56 
 
glucose feed.  Additionally, a comparison between NST74 Δcrr ΔpykAF and NST74xylR* Δcrr 
ΔpykAF in terms of sugar consumption, acetate and biomass accumulation, and Phe production 
was investigating as shown in Figure 3.5. 
 
Figure 3.5 Time Course of NST74 Δcrr ΔpykAF and NST74xylR* Δcrr ΔpykAF Phe Production on 
Glucose-Xylose (67%-33%) Feed. 
Time course of NST74 Δcrr ΔpykAF and NST74xylR* Δcrr ΔpykAF production of Phe on mixed 
sugar feed (67% glucose, 33% xylose; total sugar concentration = 20 g/L) as measured by (Top) 
OD600 (dashed line) and acetate (g/L; solid line) and (Bottom) glucose consumption (g/L; double 
dashed line, half-moon), xylose consumption (g/L, solid line, square) and Phe production (mg/L; 
dashed line).  Data of from NST74 Δcrr ΔpykAF is shown in black, data from NST74xylR* Δcrr 
ΔpykAF is shown in red.  Error bars reported as one standard deviation from triplicate experiments. 
Here, the most obvious differences are observed in terms of glucose consumption and initial growth 
rate.  For NST74 Δcrr ΔpykAF, 100% of glucose fed is consumed by 41 h into culturing while 
NST74xylR* Δcrr ΔpykAF has only consumed ~2 g/L glucose after 65.5 h of culturing.  
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Correspondingly, the growth rates show similar differences as NST74 Δcrr ΔpykAF and 
NST74xylR* Δcrr ΔpykAF  have reached OD600 values of 5.80 ± 0.17 and 0.75 ± 0.03, respectively 
after 41 h.  However, overall, 100% glucose is consumed by both strains after 137 h and the final 
OD600 values are relatively similar.  For both strains, xylose consumption rates are nearly identical 
throughout culturing and interestingly, the changes in Phe production rates seem to be similar to 
the differences in growth rates throughout culturing.  This may indicate that production of 
intermediates of interest (i.e., PEP and/or E4P) is somewhat tied to growth in these strains and 
conditions.  Surprisingly, in contrast to previous results, the strain with the wild-type xylR gene was 
able to consume 100% of xylose, although seemingly only after glucose was fully utilized. 
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Figure 3.6 Time Course of NST74, NST74 ΔpykAF and NST74Δcrr ΔpykAF Phe Production on 
Xylose Feed. 
Time course of NST74, NST74 ΔpykAF and NST74x Δcrr ΔpykAF production of Phe on 2% (w/v) 
xylose feed as measured by (Top) OD600 (dashed line) and acetate (g/L; solid line) and (Bottom) 
xylose consumption (g/L, solid line) and Phe production (mg/L; dashed line).  Data of from NST74 
is shown in black, data from NST74 ΔpykAF is shown in red and data from NST74 Δcrr ΔpykAF is 
shown in blue.  Error bars reported as one standard deviation from triplicate experiments. 
 
To further investigate the interesting effects of these genetic mutations on Phe titers and yields, the 
mutations (e.g., ΔpykAF and Δcrr) were placed into NST74 and grown on 2% (w/v) xylose.  The 
performance metrics are shown in Figure 3.6.  Here, it can be seen that upon introduction of each 
subsequent mutation xylose assimilation rates are reduced.  For NST74, NST74 NST74 ΔpykAF, 
and NST74 Δcrr ΔpykAF, the xylose consumption rates over the first ~43 h were 0.318 ± 0.006, 
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0.199 ± 0.008, 0.035 ± 0.011 g xylose/L-h, respectively.  However, the overall Phe production (in 
terms of titers and yields) showed corresponding increases upon addition of these mutations.  
Clearly a key aspect to enhance Phe production (i.e., yield) from xylose (and glucose), may be the 
ability to slow down sugar utilization rates and cell growth.  A summary of all experiments and 
relevant production metrics is shown in Table 3.2. 
Table 3.2 Summary of Phe Production Metrics for NST74 and Various Genetic Variations. 
Summary of data showing the strain, percentage of sugar used, Phe titers, culture time, Mass yield, 
growth as measured by OD600 and acetate accumulation at the end of culturing.  All data is with 2% 
(w/v) total sugar and error bars represent one standard deviation from triplicate experiments. “n.d.” 
= “not detected”. 
Strain 
Time 
(h) 
Phe Titer 
(mg/L) 
Phe 
Mass 
Yield 
(mg-
Phe/g-
total 
sugar) 
% Total 
Glucose 
Used 
% Total 
Xylose 
Used 
Final 
OD600 
Final 
Acetate 
(g/L) 
100% Glucose 
NST74 120 
567 ± 29 
(at 96 h) 
28.4 ± 
2.8 (at 96 
h) 
100% N/A 
4.37 ± 
0.28 
5.88 ± 
0.13 
100% Xylose 
NST74 138.5 
1315 ± 
65 
63.1 ± 
3.1 
N/A 100% 
4.22 ± 
0.43 
1.71 ± 
0.47 
NST74 
ΔpykAF  
138.5 
2870 ± 
209 
137.7 ± 
10.0 
N/A 100% 
5.14 ± 
0.57 
n.d. 
NST74 Δcrr 
ΔpykAF  
137 
3234 ± 
377 
348.4 ± 
70.7 
N/A 
45.6 ± 
4.6% 
2.34 ± 
0.43 
n.d. 
67% Glucose/33% Xylose 
NST74 141.5 
559 ± 
105 
37.8 ± 
7.1 
100% 0% 
3.66 ± 
0.32 
3.30 ± 
0.26 
NST74xylR* 141.5 
1755 ± 
91 
83.1 ± 
4.3 
100% 100% 
5.96 ± 
0.19 
1.56 ± 
1.37 
NST74 Δcrr 
ΔpykAF  
137 
2875 ± 
286 
127.8 ± 
12.7 
100% 100% 
6.95 ± 
0.88 
n.d. 
NST74xylR* 
Δcrr ΔpykAF  
137 
3509 ± 
465 
156.0 ± 
20.7 
100% 100% 
8.25 ± 
1.27 
n.d. 
Strain 
Time 
(h) 
Phe Titer 
(mg/L) 
Phe 
Mass 
Yield 
(mg-
Phe/g-
total 
sugar) 
% Total 
Glucose 
Used 
% Total 
Xylose 
Used 
Final 
OD600 
Final 
Acetate 
(g/L) 
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3.4 Discussion 
One factor that may be severely limiting overall Phe production is the co-accumulation of byproduct 
acetate; a problem often exacerbated by higher rates of and overall consumption of sugars 
(especially glucose).  For instance, NST74 grown on glucose produced 5.88 ± 0.13 g/L acetate 
after 120 h with levels reaching over 1 g/L (the level where reduction in cell growth and protein 
stability commonly occurs 137) within 25 h of culturing (as seen in Figure 3.2).  In contrast, for cells 
grown on xylose, overall accumulation of acetate only reached a maximum of 1.71 ± 0.47 g/L 
(occurring at the end of culturing).  This may help play a role in the fact that NST74 continues to 
produce Phe into stationary phase when grown on xylose while cells grown on glucose stop 
producing significant levels of Phe at an earlier time point.  As acetate accumulation is known to 
inhibit E. coli growth 137, additional strain engineering to reduce acetate production was expected 
to improve Phe production.  Acetate production at levels of 0.5 g/L have been shown to reduce E. 
coli growth rates while concentrations above 2 g/L are severely inhibitory 162,163.  High levels of 
acetate production in these scenarios here may play an even more significant role here compared 
to glucose-based production as it has previously been observed that inhibition caused by acetic 
acid in E. coli production runs has a more pronounced effect on hindering xylose utilization than 
with glucose 164. 
Additionally, one important by-product of the pyruvate kinase reaction is ATP.  In wild-type, 
signficant carbon flux flows through this reaction 161 as it is one of the main pathways by which cells 
funnel carbon into the TCA cycle.  While, in wild-type, significant levels of ATP is generated in this 
reaction, the removal of these enzymes may reduce intracellular ATP levels.  As ATP is needed to 
import xylose into E. coli through XylFGH 155 (although, alternatively, XylE, a xylose:H+ symporter, 
can also uptake xylose into the cell), the decrease in available intracellular pools of ATP may 
potentially limit the rate of xylose uptake and utilization and flux through the pentose phosphate 
pathway.  In fact, through in silico models of shikimic acid (SA) production in E. coli from various 
carbon sources, researchers estimated that the the ATP demand for SA from xylose when utilizing 
XylFGH for import was 2.27 mol ATP/mol SA compared to that from glucose (utilzing the native 
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PTS system) which was 1.97 mol ATP/mol SA 165.  To further test this theory, the ΔpykAF mutation 
was placed in NST74 and grown on 100% xylose.  Here, over the first 49 h, NST74 consumed 
xylose at a rate of 0.346 ± 0.010 g xylose/L-h.  Comparatively, NST74 ΔpykAF only utilized xylose 
at a rate of 0.231 ± 0.009 g xylose/L-h (Figure 3.6). 
In addition to the possible explanation of limited ATP availability to explain reduced titers, the 
production of pyruvate may also play a role.  Pyruvate kinase is the main mechanism by which 
pyruvate is produced in growing, wild-type E. coli cells.  Upon removal of this enzymatic reaction, 
other avenues through which pyruvate (and subsequently acetyl-CoA) can be be produced become 
vital.  When cells are grown on glucose, pyruvate can be generated via the 
glucose:phosphotransferase system (PTS) which simultaneously phosphorylates and imports 
glucose by converting PEP into pyruvate.  However, when grown on xylose, this reaction does not 
occur.  In this scenario, pyruvate can be generated by two mechanisms (as seen in Figure 3.1): 1) 
conversion of PEP into oxaloacetate via phosphoenolpyruvate carboxylase (encoded by ppc; an 
essential gene in E. coli grown in minimal media on glucose) followed by a multi-step process in 
the TCA cycle to produce malate which can subsequently be converted in pyruvate via malate 
dehydrogenase (encoded by maeA and maeB), and 2) the catabolism of xylose via the pentose 
phosphate pathway 166, followed by gluconeogenic steps to produce glucose-6-phosphate (G6P) 
from fructose-6-phosphate via G6P isomerase (encoded by pgi), and subsequent conversion into 
glyceraldehyde-3-phosphate (G3P) and pyruvate in the Entner-Doudoroff pathway 167 (reactions: 
G6P → 6-phosphogluconolactone (6PGNL) via G6P dehydrogenase (encoded by zwf); 6PGNL → 
phosphogluconate (6PGNT) via 6-phosphoglucocnolactonase (encoded by pgl); 6PGNT → 2-keto-
3-deoxy-6-phosphogluconate (KDPG) via phosphogluconate dehydratase (encoded by edd); 
KDPG → G3P + pyruvate via KDPG aldolase (encoded by eda).  As these two mechanisms are 
complex, involving multiple enzymatic steps, it may be likely that pyruvate (and acetyl-CoA) 
limitations upon growth on a glucose-xylose mixed feed ultimately play a role in affecting Phe 
production. 
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The removal of crr led to increases in Phe yields and titers and as well as the elimination of acetate 
accumulation.  Interestingly, crr (i.e., its gene product IIAGlc) plays a pivotal role not only in the 
mechanism of glucose uptake via the PTS system but also affects xylose catabolism and is the 
central component of regulating carbon catabolite repression.  The phosphorylation state of IIAGlc 
regulates the levels of cAMP as IIAGlc-P binds to and subsequently activates adenylate cyclase in 
the cell, which can then convert ATP into cAMP 147,168.  High levels of cAMP will bind to CRP which 
can later activate genes of other, non-glucose sugars (e.g., xylose).  In the presence of glucose, 
the phosphate group from IIAGlc-P is donated to the PTS system to allow for glucose to be imported 
into the cell and converted into glucose-6-phosphate.  In this case, levels of IIAGlc-P are low which 
no longer activates adenylate cyclase and subsequently, leaves xylose-utilizing genes inactive.  
However, when no glucose is present, IIAGlc-P dominates, and the above cascade is induced 
leading to activation of xylose-utilizing genes (i.e., xylAB, xylFGH) 211.  Furthermore, CRP-cAMP 
coactivates these genes with XylR 155, indicating that, at least in a wild-type strain, both systems 
are necessary to fully induce the xylose-utilizing operons.  However, upon deletion of crr, IIAGlc is 
no longer present and activation of adenylate cyclase cannot occur in the manner previously 
described.  So, while glucose uptake and utilization rates are reduced, the removal of crr may also 
negate the improvements seen in xylose utilization rates when the xylR* mutation is introduced.  
Surprisingly, in NST74 Δcrr ΔpykAF with a mixed sugar feed, cells consumed 100% of both xylose 
and glucose fed, whereas in NST74 and NST74 ΔpykAF, cells utilized 100% of glucose but no 
consumption of xylose was detected.  As the above discussion indicates that the presence of IIAGlc 
plays a significant role in activating xylose-utilizing genes, it is unexpected that the removal of crr 
allows for the consumption of xylose in these feeds compared to its parent strains.  This may 
indicate further mechanisms at play affecting xylose consumption post-glucose assimilation, such 
as the presence of significant acetate levels in the media. 
Furthermore, as NST74 is a mutated strain maintain various single-nucleotide polymorphisms 
(SNPs), insertions and deletions, there may be differences in terms of regulatory mechanisms 
concerning glucose and xylose interactions compared to a wild-type strain.  For example, in NST74, 
a mutation replacing two codons in the gene encoding for adenylate cyclase (i.e., cyaA) is present 
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(data not shown).  Two codons starting 831 nucleotides into the gene (CCA and CGT encoding for 
proline and arginine, respectively) are replaced with GTC (encodes for valine).  This change may 
play some effect on the activity and functionality of adenylate cyclase in NST74.  Also, NST74 
contains a codon change in the gene crp (K29T), which may affect the activity of this gene product 
on inducing xylose-utilizing genes.  Nonetheless, introduction of the xylR* mutation into NST74 
allows for the co-utilization of both glucose and xylose as previously observed in other wild-type 
and production strains 154, indicating the complexity of the regulatory mechanisms which govern 
sugar utilization and carbon catabolite metabolism in E. coli. 
3.5 Conclusions 
While the co-consumption of industrially relevant carbon sources is critical to future efforts to 
enhance titers and yields of Phe-derived compounds, it seems that a delicate balance must be 
maintained.  Sugar consumption at too rapid of a pace is inefficient for Phe production and 
ultimately leads to accumulation of inhibitory acetate levels.  From the above results, a slower 
consumption of sugar (especially xylose), seems to be more beneficial for Phe titers and yields.  
However, as an ideal, economically viable production scenario would consist of rapid production 
and purification of Phe (or its derivatives), a strain that very slowly consumes sugars and produces 
the desired product may not be idyllic.  Therefore, future efforts to improve Phe production metrics 
may focus on engineering strains to consume sugars at increased rates while maintaining high 
intracellular pools of E4P and PEP for Phe production-use only.  By perhaps investigating methods 
to tie Phe production directly to growth, such as allowing sugar catabolism only upon conversion of 
E4P and PEP into DAHP, Phe titers and yields may be maximized. 
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CHAPTER 4. TRANSCRIPTIONAL ANALYSIS OF ESCHERICHIA COLI RESPONSE TO 
STYRENE EXPOSURE 
 
 
 
Abstract 
Transcriptomic profiling is an important tool that can help to reveal key insights regarding how cells 
react and respond to different environmental stimuli, including the presence of inhibitory biofuels 
and biochemicals.  Here, the transcriptional response of E. coli to the aromatic biochemical styrene 
was determined by performing RNA sequencing (RNA-seq) analysis.  Furthermore, the potential 
influence of the source of exposure was comparatively evaluated by applying RNA-seq analysis to 
both styrene-producing and styrene-exposed cells.  In both cases a systems-level assessment of 
transcriptional response was performed, with special attention given to response and potential role 
of different general tolerance mechanisms, as well as to the identification of possible gene markers 
displaying unique patterns of differential expression in one exposure mode versus the other.  Genes 
involved in the phage shock protein response (e.g., pspABCDE/G), general stress regulators (e.g., 
marA, rpoH), and several membrane-altering genes (notably, bhsA, ompR, ldtC) showed up-
regulation in response to styrene exposure.  Overall, the expression profiles of external addition 
and internal production of styrene were similar with some differences observed in the magnitude of 
differential expression for some important genes (e.g., up-regulated genes such as pspABCDE/G, 
recA, marA, micF) and expression of some genes involved in amino acid biosynthesis.  
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4.1 Introduction 
Through metabolic engineering and synthetic biology strategies, significant effort has been put into 
producing value-added chemicals or bioenergy alternatives from renewable sources.  Through the 
engineering of industrially relevant strains to enhance the production of native metabolic 
precursors, remove pathways that produce harmful or unnecessary byproducts and alter native flux 
regulation processes, the bioproduction of both natural and non-natural compounds in microbes 
has been improved upon 169.  One significant group of potentially vital bioproducts are aromatics, 
which contain one or more substituted benzene rings.  Aromatics have many industrially relevant 
purposes such as precursors to pharmaceuticals, plastic monomers and biofuel alternatives so 
recent research has focused on improving the diversity of aromatics that can be produced in 
microbes as well as developing methods which can improve production metrics of these chemicals 
as has been recently reviewed 5,6,170. 
One limitation in the quest for improved microbial production of aromatics is end-product toxicity 
21,117,171,172.  Often, aromatics are highly lipophilic and have many solvent-like properties that lend 
themselves to poor biocompatibility by causing changes in membrane integrity and inhibiting 
function of membrane proteins 173-176.  While the goal of tolerance engineering is ultimately to 
enhance production of the target biochemical, many times, chemical tolerance does not necessarily 
lead to production improvements.  In some cases, the resulting fitness improvements enabled by 
tolerance engineering strategies do not lead to increases in titers and yields 177,178.  Clearly, such 
phenotypes are often very complex and multi-genic in nature, as well as difficult to fully and 
independently resolve.   
One such complication pertains to understanding if, how, when and to what degree various 
tolerance-related mechanisms are turned on when exposed to various stresses.  As the first steps 
in cellular adaptation to environmental changes involve sensing the change and performing 
alterations on the transcriptional level, transcriptomic data (obtained by microarray analysis or RNA 
sequencing) provides the most comprehensive datasets needed to elucidate and understand what 
role native tolerance strategies might play in solvent tolerance.  Examination of gene families which 
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are up- or down-regulated can be utilized to illuminate mechanisms of toxicity and subsequently, 
help develop synthetic engineering strategies to improve tolerance and cell fitness.  
Transcriptomics-based strategies have been utilized to investigate the transcriptional effect of 
exposure to compounds such as isobutanol 179, acetate 180, 1,4-butanediol 181, ethanol 182 and free 
fatty acids 183 among others 184-186. 
Several studies have investigated the transcriptional response of microbes when stressed with 
aromatic chemical toxicity such as in E. coli, with most research focusing on antibiotics (e.g., 
triclosan, sulfamethoxazole, tetracycline) 187.  However, the transcriptional effects of more 
industrially-relevant aromatic compounds have also been examined in E. coli such as toluene 188, 
p-hydroxybenzoic acid 189 and cinnamaldehyde 185,190 (along with the 2-phenylethanol stress 
response in S. cerevisiae 191).  In response to 0.02% (v/v) toluene exposure, for example, 
researchers found 641 differentially expressed genes, with many of them involved in Fe/S assembly 
and oxidative and universal stress responses (flagella biogenesis and assembly related genes were 
also significantly down-regulated) 188.  When exposed to salicylate, an industrially relevant aromatic 
acid, E. coli activated global stress response systems such those mediated by the marRAB operon 
184. 
To gain a more complete understanding of transcriptomic response to aromatic exposure, RNA-
seq analysis has been performed on E. coli under styrene-induced stress and two distinct exposure 
modes: extracellular addition versus intracellular production.  The differences between 
exogenously added solvent versus internally produced solvent may be significant as, for many 
industrial processes, the internal production condition is much more relevant.  Fundamental modes 
of toxicity may be different within the cell versus outside the cell and tolerance engineering 
strategies that succeed in one scenario may not help in others.  Toxicity of styrene in E. coli, for 
example, has previously been investigated in terms of these different conditions when exposed to 
the chemical.  Using membrane leakage as an analogue for membrane integrity, researchers found 
that less than 10% of cells exposed to styrene addition demonstrated membrane leakage while 
more than 50% of styrene-producing cells showed damaged membranes (although researchers 
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found no membrane fluidity changes caused by styrene production) 192.  In said study, however, no 
comparisons of transcriptional responses between the two different styrene-exposure modes were 
performed. 
In particular, specific emphasis has been given to: i) comparing and contrasting the effect of 
different styrene exposure modes (i.e., P vs. A) on the cellular response, ii) elucidating which known 
tolerance mechanisms E. coli attempts to employ for inherent styrene resistance and which remain 
unchanged or inactivated, and iii) understanding the overall physiological response of E. coli 
following exposure to inhibitory concentrations of styrene.  Overall, the objective of this work is to 
obtain an improved understanding as to how E. coli naturally responds to styrene toxicity, gives 
input on how cells respond differently when producing a toxin versus when they are externally 
exposed to it, identifies native machinery that might serve to construct aromatic-inducible 
transcriptional elements, and provides clues on possible future directions for improvements to 
engineer E. coli for aromatic tolerance. 
4.2 Materials and Methods 
4.2.1 Strains and Cultivation Conditions Used 
E. coli NST74 (a phenylalanine-overproducing strain) 120 carrying pTrcColaK-PAL2 and pTrc99A-
FDC1 (expressing PAL2 from Arabidopsis thaliana and FDC1 from Saccharomyces cerevisiae, 
respectively, to collectively convert endogenous phenylalanine to styrene) was used as the styrene 
producing strain.  E. coli NST74 cells carrying the empty vectors pTrcColaK and pTrc99A were 
utilized as a non-producing strain for exogenous styrene addition and unexposed control 
conditions.  Seed cultures were grown in 3 mL LB broth supplemented with appropriate 100 g/mL 
ampicillin and 30 g/mL kanamycin at 32oC while shaking at 200 rpm for 12 – 16 h.  Seed cultures 
were used to inoculate 50 mL of pH 6.8 MM1 minimal media supplemented with 1.5% glucose in 
100 mL Teflon-capped corning bottles (to prevent styrene loss via evaporation) at a starting OD600 
of ~0.01.  MM1, a phosphate-limited minimal media adapted from McKenna and Nielsen 117, was 
prepared according to the following recipe (in g/L): MgSO4·7H2O (0.5), (NH4)2SO4 (4.0), MOPS 
(24.7), KH2PO4 (0.3), and K2HPO4 (1.0), as well as 1 mL/L of a trace mineral solution containing 
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(in g/L): MnCl2·4H2O (1.584), ZnSO4·7H2O (0.288), CoCl2·6H2O (0.714), CuSO4 (0.1596), H3BO3 
(2.48), (NH4)6Mo7O24·4H2O (0.370), and FeCl3 (0.050).  Furthermore, exogenous phenylalanine (1 
mL of 20 g/L stock) was added to all conditions to boost styrene production to even further toxic 
levels in the P condition (the C and A conditions do not contain pathway enzymes so phenylalanine 
addition would have no effect on styrene accumulation). 
Upon reaching OD600 ~1.0 , all cultures were induced by the addition of 0.2 mM IPTG, after which 
culturing continued at 32°C and 200 rpm for a total of 27 h.  In the case of exogenous styrene 
addition, styrene (99%, stabilized with 10-15ppm 4-tert-butyl-catechol; Alfa Aesar, Tewksbury, MA, 
USA) was added to the culture according to the following schedule (listed values represent final 
concentrations after each addition): 0 mg/L at 0 h, 25 mg/L at 13 h, 65 mg/L at 23 h, 165 mg/L at 
25 h.    
4.2.2 RNA-seq Data Collection and Analysis 
At 27 h after inoculation, cells were harvested for RNA extraction using the RNeasy Mini Kit 
(Qiagen, Germantown, MD, USA) following vendor’s protocols.  Two biological replicates were 
pooled at equimolar concentrations to create a single sample and duplicates were sequenced for 
each condition.  RNA degradation and contamination were monitored on 1% agarose gels.  After 
rRNA depletion using a RiboZero kit (Illumina), random hexamer priming was used to generate 
cDNA and library preparation was performed using a Nextera library prep kit (Illumina) according 
to the manufacturer instructions. Paired end sequencing (2 x 150) was performed using an Illumina 
NextSeq at the DNASU Sequencing Core at Arizona State University. Reads had adapters 
removed and were quality trimmed using the default settings of Trim Galore prior to being mapped 
to the E. coli MG1655 genome using STAR. Differential gene expression analysis was performed 
using edgeR.  From these RNA-seq results, comparisons were made for both styrene 
production/addition relative to the no styrene control.  Differences in transcript levels are indicated 
as log2-fold changes with positive numbers indicating up-regulation in the styrene-exposed cells 
and negative numbers indicating down-regulation.  Significant differential expression (DE) is 
reported as those genes which maintain a p-value < 0.05 when compared to the no styrene control. 
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4.2.3 Gene Ontology and KEGG Pathway Analysis 
For gene ontology (GO) term analysis, GeneSCF 193 was utilized, employing all three databases 
for GO analysis (i.e., biological process, molecular function, cellular components) and the E. coli 
organism database.  For KEGG pathway analysis and identification of enriched pathways, KOBAS 
3.0 (KEGG Orthology Based Annotation System) was utilized 194,195.  Only differentially expressed 
genes below the p-value of 0.05 cut-off were included in the GO term and KEGG pathway analyses.  
Significantly over-represented GO terms or KEGG pathways are reported if, when compared to all 
the genes in the E. coli K-12 genome, the p-value was < 0.05. 
4.3 Results 
4.3.1 Characterizing the Overall Transcriptomic Response of E. coli to Styrene Exposure 
To elucidate the effect of styrene exposure on E. coli cells, as depicted in Figure 4.1A, a total of 
three conditions representing different styrene exposure modes were investigated in this study: 
styrene production (P), styrene addition (A), and a no styrene (production or addition) control (C).   
During A, the schedule of styrene addition was designed to mimic the profile of its accumulation 
during a typical production culture (Figure 4.1B).  In each case, cells were harvested after 27 h, 
after which their total RNA was extracted and sequenced.  There were 30.59 and 37.15 M reads 
generated for C runs (83.3% and 82.3% of reads mapped to genome, respectively), 28.41 and 
42.91 M reads generated for A runs (81.7% and 82.6% of reads mapped to genome, respectively) 
and 35.49 and 37.23 reads generated for P runs (83.9% and 83.3% of reads mapped to genome, 
respectively).  Changes (all relative to C) in global transcriptomic patterns arising in each case were 
then identified via bioinformatic analysis of the obtained RNA-seq data. 
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Figure 4.1 A) Three Conditions upon which RNA was Extracted and, B) Styrene Accumulation in 
Production Strain and Styrene Addition in Styrene-Added Strain. 
A) Three conditions were used here: No styrene present (C), styrene added exogenously (A) and 
styrene produced internally (P). B) Approximate time-course of extracellular styrene concentration 
in the three conditions. 
In total, 1,674 and 980 differentially expressed (DE) genes were identified for A and P (both relative 
to C), respectively (Figure 4.2A).  Among these, approximately 50% of DE genes were up-
regulated for A, compared to 56% in the case of P.  Among up-regulated genes, the average 
magnitudes of differential expression were much higher for P than for A (~1.52 log2-fold change vs. 
~1.11 log2-fold change) whereas, for down-regulated genes, the average magnitudes of differential 
expression were closer though still slightly higher for P compared to A (~-1.26 log2-fold change vs. 
~-1.18 log2-fold change). The observed difference in magnitude, especially among up-regulated 
genes, could suggest that, at least amongst this subset of DE genes, sensitivity to styrene exposure 
is elevated when styrene originates from inside the cell, perhaps resulting due to its higher apparent 
intracellular concentration and/or limitations associated with its extracellular export.  Meanwhile, a 
total of 652 genes were DE under both styrene exposure modes, compared to 1022 and 328 genes 
were only DE for P and A, respectively (Figure 4.2B). 
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Figure 4.2 Overall Statistics for RNA-seq Analysis Showing DE Genes and Common DE Genes 
between Modes of Styrene Exposure. 
A) The number of differentially expressed (DE) genes is shown for both modes of styrene exposure 
compared to the control.  The red bars (and numbers inside) show the number of DE genes which 
were upregulated for that condition while the blue bars (and numbers inside) show the number of 
DE genes which were downregulated for that condition.  Only genes which showed a p-value < 
0.05 are included.  B) Venn diagram (created with Venny 2.1.0 196) showing the number of genes 
which were DE in only the Addition condition (blue), the number of genes which were DE in only 
the Production condition (yellow) and the number of genes which were DE in both conditions 
(green). C) Of the genes which were DE in both conditions, the number of genes which were down-
regulated under both conditions (light blue), the number of genes which were up-regulated under 
both conditions (pink) and the number of genes which showed DE in opposite directions for the two 
conditions (green).  The percentage of common DE genes which are grouped in each category is 
also listed next to the number of genes. 
Among the 652 commonly DE genes, 345 were up-regulated and 274 were down-regulated under 
both A and P (Figure 4.2C).  Interestingly, however, 33 genes were DE in opposite directions for 
P versus A; a difference that again points to the likelihood that E. coli experiences styrene differently 
depending upon the source of exposure (i.e., internal vs. external).  However, and perhaps 
unsurprisingly, the limited number of oppositely DE genes between P and A likely suggests that 
the overall experienced difference is relatively small. 
The functions of DE genes were further analyzed based on gene ontology (GO) terms, 
revealing that, in total, 44 and 63 GO terms were over-represented for A and P, respectively, among 
which 26 were over-represented in both conditions.  GO terms shared by both conditions 
unsurprisingly include those which are very broad (e.g., “GO:0005829~cytosol” and 
“GO:0005515~protein binding” which contain 1028 and 1016 genes in E. coli, respectively), but 
also more specific terms such as “GO:0017148~negative regulation of translation” and 
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“GO:0005525~GTP binding”, which contain only 12 and 16 genes in E. coli, respectively.  Figure 
4.3 shows some of the GO terms of particular interest for this study along with the percentage of 
genes in each term that were significantly repressed or induced upon styrene addition or 
production.  Some noteworthy terms are those related to cell division, response to DNA damage 
via the SOS response and cellular response to various stresses (e.g., heat, radiation). 
Additional KEGG pathway analysis, meanwhile, revealed that 8 and 17 KEGG pathways were over-
represented for A and P, respectively.  Of these, 5 KEGG pathways were over-represented in both 
conditions, including ‘ribosome’ (eco03010), ‘metabolic pathways’ (eco01100), ‘homologous 
recombination’ (eco03440), ‘biosynthesis of secondary metabolites’ (eco01110), and ‘pyrimidine 
metabolism’ (eco00240).  Similarly to the GO terms, a multitude of relevant KEGG pathways and 
the percentage of genes that are induced or repressed for both styrene conditions are illustrated in 
Figure 4.4.  KEGG pathways of significant interest include those related to the biosynthesis of 
amino acids, genes involved in central metabolism and those related to the production of 
membrane components (e.g., fatty acids, peptidoglycan).  Further analysis and discussion 
regarding many of the GO terms and KEGG pathways, as well as the genes involved in each, is 
included in the following sections. 
To gain a more detailed understanding of how E. coli responds to and is affected by styrene, a 
subset of the most statistically significant as well as generally interesting outcomes from the 
RNAseq results were selected for more detailed analysis and discussion in the following sections, 
as organized according to major cellular functions, systems, or roles.  Overall, most behaviors were, 
at least qualitatively, conserved between A and P.  Therefore, to facilitate the discussion the focus 
is first on the outcomes of just A, after which a comparison of notable differences between A and 
P is presented.  
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Figure 4.3 List of Relevant GO Terms for DE Genes after Exposure to Styrene. 
A selection of Gene Ontology (GO) Terms.  The total number of genes in each GO term in the E. 
coli genome is listed in parenthesis next to the GO term.  The x-axis indicates the percentage of 
total genes in the GO term which were significantly repressed (left, blue) or induced (right, red) for 
each styrene exposure condition compared to the control.  The addition condition is shown as light 
red or blue (with stripes) while the production condition is dark red or blue.  The superscript ‘A’ or 
‘P’ indicates that the GO term was significantly over-represented (p-value < 0.05) for the addition 
or production conditions, respectively, compared to the E. coli genome.  GO term analysis was 
accomplished via GeneSCF 193. 
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Figure 4.4 List of Relevant KEGG Pathways for DE Genes after Exposure to Styrene. 
A selection of KEGG pathways.  The total number of genes in each KEGG pathway in the E. coli 
genome is listed in parenthesis next to the KEGG pathway.  The x-axis indicates the percentage of 
total genes in the KEGG pathway which were significantly repressed (left, blue) or induced (right, 
red) for each styrene exposure condition compared to the control.  The addition condition is shown 
as light red or blue (with stripes) while the production condition is dark red or blue.  The superscript 
‘A’ or ‘P’ indicates that the GO term was significantly over-represented (p-value < 0.05) for the 
addition or production conditions, respectively, compared to the E. coli genome.  GO term analysis 
was accomplished via KOBAS 3.0 194,195. 
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4.3.2 DNA Synthesis, Replication, and Repair 
One emergent pattern gleaned from overall dataset is that styrene exposure appears to trigger the 
shutdown of cell growth in a ‘bottom up’ manner, beginning with the synthesis and replication of 
DNA.  Specifically, numerous DE genes were found to be associated with the “DNA replication” 
(GO:0006260) GO term, including those encoding for DNA polymerase (dnaX, DNA polymerase III 
subunit) and the replication initiator protein (dnaA), along with members of the primosome (priA 
and priB, primosomal replication factor and protein, respectively; which work to restart stalled DNA 
replication), all of which were significantly repressed.  Meanwhile, pathways used to supply 
precursors to DNA synthesis were also repressed. For example, purR encodes a transcriptional 
repressor involved in regulating purine and pyrimidine nucleotide biosynthesis.  While expression 
of purR was found to be mostly unchanged in the presence styrene, of the 31 known PurR-
repressed genes, 23 were DE for A, all of which were downregulated.  In concordance with the 
above data, the GO term “purine nucleotide biosynthetic process” (GO:0006164) showed 4 of the 
6 total genes were down-regulated for the A condition.  Since purine and pyrimidine biosynthesis 
is quite energy intensive, downregulation of these pathways may represent an attempt by the cell 
to conserve and possibly redistribute energy resources to other processes of more critical 
importance to aiding in survival. 
Beyond simply inhibiting DNA replication, styrene exposure also appears to elicit DNA damage 
(e.g., double-strand breaks), in a manner similar to exposure to UV radiation or DNA-arresting 
chemicals 197,198.  In response to such damage, the SOS response is commonly activated as a 
mechanism to repair the damage through homologous recombination and DNA replication 198,199.  
Analysis of genes associated with the “SOS response” (GO:0009432) GO term revealed that 10 of 
22 were DE for A, 9 of which were upregulated.  The gene recA (log2fold change = 0.46) encodes 
a recombinase that plays a major role of the SOS response 197.  Meanwhile, SOS-induced DNA 
polymerases (such as Pol IV and Pol V, encoded by dinB and umuDC, respectively), which enable 
replication through various damage and lesions that DNA polymerase III cannot 200, were also DE 
with dinB and umuD showing log2-fold changes of 0.82 and 0.80 for A, respectively.  However, 
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since SOS-induced DNA polymerases are considered to be of lower fidelity 200, this suggest the 
cells might use this response as a mechanism to incorporate mutations that might improve the 
chance of survival. 
4.3.3 Protein and Amino Acid Biosynthesis 
Styrene exposure also caused the differential expression of several genes associated with 
ribosomal activity, suggesting that, like DNA synthesis, protein biosynthesis was also decreased.  
For example, in the case of A, 69% of all genes involved in the “ribosome” KEGG pathway 
(eco03010) were DE, 100% of which were repressed.  Similarly, many genes associated with the 
biosynthesis of precursor amino acids were also DE, however, the resulting trends were not as 
clear or widespread.  Specifically, analysis of the “biosynthesis of amino acids” KEGG pathway 
(eco01230) showed that 22% and 19% of the 118 total genes in this pathway were upregulated 
and downregulated, respectively, in response to styrene exposure.  For example, of the 17 genes 
involved with converting α-ketoglutarate into the amino acids, L-glutamate, L-proline, L-arginine, L-
glutamine, 12 were downregulated while none were upregulated.  Genes such as glnA (encoding 
glutamine synthetase) and argI (encoding ornithine carbamoyltransferase) showed a log2-fold 
change of -4.77 and -3.27, respectively.  Additionally, expression of all three subunits of the 
glutamine ABC transporter (encoded by glnQHP) were highly downregulated (log2-fold change = -
3.58, -4.58 and -3.47, respectively).  Shutdown of pathways competing for α-ketoglutarate might 
represent a strategy used by the cells to increase energy generation by enhancing flux through the 
TCA.  Conversely, 7 genes involved in the biosynthesis of aromatic amino acids (i.e., L-
phenylalanine, L-tyrosine, L-tryptophan) were upregulated while only two were downregulated.  In 
fact, regarding the KEGG pathway for “phenylalanine, tyrosine and tryptophan biosynthesis” 
(eco00400), 33% of genes were upregulated for A, while only 10% were downregulated.  This 
could, at least in part, be an experimental artifact, derived from the fact that the host strain (NST74) 
is a L-phenylalanine over-producing strain that carries a tyrR deletion, along with several additional 
point mutations in key shikimate pathway genes. 
 
77 
 
4.3.4 Cell Replication 
In addition to its aforementioned role in facilitating DNA repair, the SOS response also influences 
cell division, notably via the inhibitor protein encoded by sulA (which disrupts cell division and can 
lead to loss of cell viability 201), whose expression was also increased (log2-fold change = 0.86) 
following styrene addition.  Meanwhile, other genes associated with the GO term “cell division site” 
(GO:0032153), of which there are 32 in total, were also mostly repressed.  Specifically, 15 genes 
were downregulated upon exposure to styrene, whereas 2 (ftsL and zapC) were upregulated.  To 
date, over 3 dozen proteins have been identified to make up the so-called ‘divisome’ in E. coli 202.  
Several vital components of the divisome belong to the dcw cluster: an operon consisting of 16 
genes that each play key roles in controlling cell division, synthesizing cell wall components or the 
production/transport of peptidoglycan (PG) precursors (e.g., lipid II) 203.  Eight genes in this cluster 
were significantly downregulated following styrene exposure, including (log2 fold change shown in 
parentheses): lpxC (-0.44), mraY (-0.54), murE (-0.56), ftsW (-0.95), ddlB (-0.95), ftsQ (-0.97), 
murG (-1.10) and murC (-1.11). Among these, ftsW, ftsQ, and ftsL all belong to the dozen total 
genes that are essential for cell division 202. Other genes involved in synchronizing cell envelope 
division, controlling elongation machinery, and mediating cell wall synthesis also showed significant 
downregulation (log2-fold change in parentheses), including mreB (-1.22; encoding a dynamic 
cytoskeletal protein that controls PG biosynthesis 204), as well as those genes making up the Tol 
system (tolA (-1.50), tolQ (-1.11), tolR (-1.23), tolB (-1.04) and pal (-1.05)) which controls initiation 
of outer membrane (OM) constriction 204.  Previously, it has been shown that damage to any part 
of the Tol system leads to decreased OM integrity and periplasmic leakage, thus leading to 
increased sensitivity to drugs and other stresses 204.  As the initiation of cell division processes and 
constriction of the OM are often the most vulnerable moments for E. coli cells when exposed to 
various stresses 205, cells may be attempting to reduce expression of cell envelope organization 
genes upon styrene exposure to reduce times when cells are most susceptible to stress-induced 
damage.  Furthermore, by downregulating genes involved in cell division and protein production, 
cells may be able to focus resources on stress responses and energy generation perhaps in an 
effort to move from a growth to survival mode. 
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4.3.5 Central Metabolic Pathways 
The main KEGG pathways associated with central metabolism were also analyzed, revealing a 
wide distribution of genes were DE following styrene, including 21% upregulated and 19% 
downregulated for “glycolysis/gluconeogenesis” (eco00010; 42 genes total), 20% upregulated and 
33% downregulated for “pentose phosphate pathway” (eco00030; 30 genes total), and 22% 
upregulated and 11% downregulated for “citrate cycle (TCA cycle)” KEGG pathway (eco00020; 27 
genes total).  One particularly interesting behavior revealed by this analysis pertains to the 
production (from pyruvate) and subsequent consumption (to citrate and into the TCA cycle) of 
acetyl-CoA by the pyruvate dehydrogenase complex (PDH; encoded by aceEF-lpd) and citrate 
synthase (encoded by gltA).  Expression of PDH is negatively regulated by the dual regulator PdhR, 
whose own expression was also significantly upregulated (log2-fold change = 2.12) in the case of 
A.  Previously, activation of PdhR has been reported for E. coli in response to a variety of acid 
stresses 206.  Binding of PdhR to its cognate operator is influenced by the availability of pyruvate.  
More specifically, when present, pyruvate binds to and releases the transcriptional repression 
caused by PdhR.  In the case of A, each of aceE, lpd and gltA were upregulated (log2-fold change 
= 1.06, 0.89 and 1.30, respectively).  In addition to PDH, meanwhile, PdhR has been also shown 
to negatively regulate ndh – a key gene involved in respiration – although its expression was 
upregulated in A (log2-fold change = 0.82) perhaps in an effort to support flux through the TCA 
cycle.  Overall, these collective behaviors suggest that the cells are attempting to increase energy 
generation by shuttling more carbon to pyruvate and, in turn, into the TCA cycle.  Consistent with 
the above indicators of α-ketoglutarate preservation, these changes further support of a model 
suggesting that styrene exposure causes a shift towards increased energy generation by increasing 
carbon flux into and through the TCA cycle. Interestingly, this behavior differs from what has been 
previously reported for the case of octanoic acid stress in E. coli, for which flux analysis revealed a 
diversion of pyruvate flux from the TCA cycle and towards acetate via the more thermodynamically 
favorable pyruvate oxidase (PoxB) 207.  
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4.3.6 Global Stress Response 
Unsurprisingly, several known and common stress response systems were also found to be 
activated in response to styrene addition.  This included significant upregulation of several DE 
genes from GO terms including “response to radiation” (GO:0009314; 61% of 49 total genes), 
“response to UV” (GO:0009411; 67% of 15 total genes), “response to heat” (GO:0009498; 44% of 
54 total genes), “response to osmotic stress” (GO:0006970; 78% of 18 total genes), and “response 
to drug” (GO:0042493; 58% of 24 total genes).  The gene marA, for example, which is part of the 
marRAB locus and encodes a dual transcriptional regulator responsible for modulating expression 
of several genes involved in resistance to multiple antibiotics and other inhibitory 
compounds/conditions 208, was found to be up-regulated upon styrene addition (log2-fold change = 
1.08).  This is consistent with previous transcriptomic analyses focused on characterizing the 
response of E. coli to a variety of inhibitory conditions, where marA expression was almost always 
upregulated (93% of the time), including in the case of exposure to phenolic compounds 187,209.  
MarA has been shown to directly and indirectly activate expression of as many as 47 different 
genes while repressing expression of at least 15 additional genes, including OM proteins like the 
porin-encoding ompF 210. Surprisingly, however, several genes whose expression is known to be 
regulated by MarA, and which typically play key roles in E. coli’s tolerance mechanisms, were not 
upregulated in the case of A.  This includes acrAB and tolC (encoding for the multi-drug efflux 
transporter AcrAB-TolC), as well as and soxS (encoding for a stress-responsive transcriptional 
regulator).  In fact, expression of acrB was actually repressed (log2-fold change = -0.84) following 
styrene addition.  This seemingly conflicting behavior may be due to the fact that the MarA regulon 
is governed by a “cascade”-like regulation where, for example, certain genes (e.g., micF, sodA and 
marRAB; all upregulated in A) are activated at low MarA levels  whereas others (e.g., tolC) are 
induced only at higher concentrations 211,212.  
The global stress response of E. coli is partially governed by the universal stress protein 
superfamily comprised of six proteins encoded by uspACDEFG, all of which are separately 
transcribed 213.  Increased transcription of these genes has been shown to be induced to a wide 
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variety of stresses, however, such as exposure to heat, ethanol and several antibiotics 213.  
Meanwhile, whereas UspA and UspD have been implicated in protecting against superoxide stress, 
overall, the physiological roles of these genes are not well known.  Here, styrene addition resulted 
in upregulation of each of uspC, uspD, uspE and uspG, however, uspA and uspF showed no DE.  
E. coli’s heat shock response also appears to be activated in response to styrene exposure.  For 
instance, transcript levels for the heat shock responsive sigma factor, σ32 (encoded by rpoH), also 
showed significant upregulation (log2-fold change = 1.48).  Expression of rpoH and its regulon have 
also been reported to respond to similar stresses, including ethanol 214 and n-butanol 215 addition.  
Two of the most upregulated genes in the dataset were ibpA and ibpB, both of which are part of 
the σ32 regulon and encode small heat shock chaperones 216 (log2-fold change = 2.27 and 3.94, 
respectively).  Deletion of these genes is known to increase sensitivity to heat shock 217 while their 
overexpression correspondingly improves resistance 218.  Upregulation of the heat-responsive gene 
yibA (log2 fold change = 1.83) was also observed.  While not well characterized, strains lacking 
YibA showed increased sensitivity to nalidixic acid, tetracycline, mitomycin 219, and UV- and X-
radiation 220 while overexpression of yibA increased tolerance of E. coli to n-butanol by ~13% 221. 
4.3.7 Membrane Stress Response 
Aromatic chemicals, including styrene, have commonly be reported to cause membrane damage 
and stress 138,176,192.  Thus, unsurprisingly, several stress responses known to be associated with 
membrane-related damage were also found to be activated.  For example, in E. coli, five main 
envelope stress response systems have been identified,  including the Psp, Cpx, Bae, Rcs and σE 
signaling pathways, which collectively work to restore the cell envelope upon damage, as well as 
maintain cell envelope stability and integrity 222.  The conditions under which these  pathways are 
activated have previously been studied via induction of representative promoters 223.  In this case, 
styrene addition was found to upregulate expression of both the Psp and σE signaling pathways. 
Conserved in multiple different bacteria, the Psp (phage shock protein) system has been shown to 
respond to multiple stresses, including exposure to ethanol, methanol and other hydrophobic 
solvents (e.g., n-hexane, cyclohexane) 224,225.  In the present study, those genes comprising the 
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pspABCDE and pspG operons (which, along with pspF, collectively make up the Psp system) were 
among the most highly upregulated overall (log2 fold change = 5.18 to 5.99).  Although the Psp 
system is responsive to a variety of stresses, unlike other cell envelope-based stress responses, 
its effect is self-contained (i.e., not global) 46.   Although several induction signals and mechanisms 
have been proposed for the Psp system, including dissipation of the proton motive force, changes 
in redox state of the quinone pool, and stored curvature elastic stress on the membrane, no one 
signal has been proven to be correct 47.  E. coli mutants lacking the psp operon, meanwhile, have 
been reported to display reduced biofilm formation, a common survival mechanism employed in 
response to solvent and other stresses 226.  Perhaps more interestingly, psp null mutants have also 
been found to display difficulties in maintaining proton motive force when exposed to different 
stresses, suggesting that this system plays a role in helping to maintain inner membrane stability 
and rigidity under stress 224,225. 
The sigma factor σE (encoded by rpoE), meanwhile, has been shown to be responsive to outer 
membrane stresses and membrane protein misfolding and controls expression of several genes 
related to membrane stress 227.  Upon styrene exposure, rpoE expression was slightly up-regulated 
(log2 fold change = 0.63).  It has been shown that expression of rpoE is up-regulated upon 
misfolding of OM proteins, as well as in response to various forms of membrane stress 228,229.  The 
induction of rpoE can further up-regulate rpoH (the heat-shock sigma factor), which can further act 
to respond to misfolded membrane proteins 230.  Activation of rpoE expression plays a role in 
amplifying the rate of formation of double stranded DNA breaks and triggering induction of 
mutagenesis systems, which might facilitate E. coli’s ability to adapt and evolve in high-stress 
environments 231.  Ultimately, the activation of the σE sigma factor can improve the stability of the 
outer membrane by inducing the expression of genes that can re-fold membrane proteins, reduce 
the expression of new outer membrane proteins, and rapidly modify the cell envelope upon sensing 
stress 232. 
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4.3.8 Cell Envelope Modification 
Since aromatic chemicals and other solvents are known to cause stress and damage to the cell 
envelope, adjustments made to its structure and composition have thus accordingly been found to 
significantly influence tolerance 233-238.  Numerous genes associated with several GO terms related 
to the cellular envelope were highly DE, including from “membrane” (GO:0016020; 47% of 181 total 
genes), “gram-negative-bacterium-type cell outer membrane assembly” (GO:0043165; 73% of 11 
total genes), and “outer membrane-bounded periplasmic space” (GO:0030288; 34% of 154 total 
genes).  Additionally, KEGG pathways which showing significant overrepresentation includes 
“lipopolysaccharide biosynthesis” (eco00540; 65% of 31 total genes) and “protein export” 
(eco03060; 74% of 19 total genes).  One important component of the cell envelope stress response 
concerns the use of mechanisms to maintain proper cross-linking of the peptidoglycan (PG) layer.  
This can include intermolecular cross-linking via DacC, cross-linking of the PG to the OM lipoprotein 
(Lpp) via LdtC, or removal of intermolecular cross-linking via AmiA.  Significant upregulated 
expression of both lpp and ldtC (log2-fold change = 0.70 and 3.84, respectively) resulted following 
styrene exposure, suggesting that cells are attempting to increase production of Lpp while also 
decreasing the amount of free Lpp by anchoring it to PG 239.  This same mechanism has been 
reported to maintain or increase stability of the cell wall in response to penicillin-exposure and/or 
induction of the Cpx system 239-241.  Lpp plays an important role in the properties of the OM.  Deleting 
lpp, for example, causes an increase in OM permeability 242, and has been shown to facilitate the 
uptake of the very hydrophobic organophosphorus compound coumaphos (logKow = 4.13 versus 
2.95 for styrene) 242.  If the opposite is also true, E. coli’s response to styrene appears to perhaps 
include the use of strategies aimed at reducing membrane permeability and further stabilizing the 
OM to protect the cell from styrene-induced damage. 
Overall, it has often been found that the composition and structure of the OM is a strong determinant 
of tolerance, especially in the case of hydrophobic solvents 178,234,243,244.  One of most important 
regulators of OM composition is the two-component signal transduction system composed of ompR 
and envZ 245 (log2 fold change for A of 0.80 and 0.51, respectively), both of whose expression was 
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upregulated in the case of A.  One function of this system has been shown to be its ability to provide 
variable control over the expression of two small RNAs (sRNAs) omrA and omrB 246, as well as the 
OM porins ompF and ompC, which it does in response to changes including those in osmolarity, 
pH or temperature 247.  Activation of omrA and omrB has previously been reported following 
exposure to several other bioproducts, including butanol, furfural, geraniol and succinic acid 248.  
OmpF, meanwhile, belongs to the General Bacterial Porin (GBP) family and facilitates the diffusion 
of various small (600 Da or less; note: styrene is ~104 Da) molecules (e.g., ions, antibiotics, small 
proteins) through the OM 249,250.  In addition to its function as a porin, meanwhile, OmpF has also 
been reported to impose a significant impact on membrane composition, hydrophobicity and, 
ultimately, solvent tolerance 251.  For example, ompF expression was repressed in a series of 
isolated mutants with enhanced tolerance to a variety of hydrophobic solvents (e.g., cyclohexane, 
xylene) 252. In a follow-up study, however, ompF-null mutants showed no improvement in solvent 
tolerance 251, suggesting that its relative abundance is a key factor.  However, others have utilized 
the deletion of ompF with an overexpression of fadL, an OM ligand gated channel, to increase 
integrity of the membrane and consequently improve production of fatty acids by ~53% 253.  Here, 
expression of ompF was significantly downregulated following styrene exposure (log2-fold change 
= -1.89).  Furthermore, translation of ompF has been shown to be inhibited by an increase in 
expression of the sRNA micF, which concurrently was found to be upregulated in the case of A 
(log2-fold change = 2.02).   
Another of the most highly upregulated genes, meanwhile, was bhsA (log2-fold change = 5.03), 
which encodes an OM protein.  Induction of bhsA expression has often been associated with biofilm 
formation, and has been observed in response to various stresses (e.g., hydrogen peroxide 186, 
cadmium 254 and salicylate 184).  Null mutants of bhsA, meanwhile, have been found to suffer from 
increased sensitivity to acid, hydrogen peroxide and heat treatment, while displaying upregulation 
of a significant number of membrane proteins and downregulation several genes encoding cell 
surface proteins, ultimately leading to significant increases in both cell hydrophobicity and 
aggregation 255.  In contrast, overexpression of bhsA has been shown to reduce cell surface 
hydrophobicity, which lead to improved tolerance to and production of octanoic acid 256.  Separately, 
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while investigating several E. coli mutants tolerant to different organic solvents (e.g., n-hexane, p-
xylene, cyclohexane), it was similarly reported that the cell surfaces of the more tolerant mutants 
were less hydrophobic then the parent strain (K-12) 252.  While several mechanisms remain to be 
elucidated, these collective observations at least suggest that E. coli is attempting to increase 
styrene tolerance via a multi-level strategy designed strengthen the membrane by modifying its 
structure and composition while also limiting styrene diffusion into the cell. 
4.3.9 Efflux Transporters 
One mechanism commonly utilized by various microbes to overcome the toxicity associated with 
small molecules involves the use of multi-drug resistant (MDR) efflux transporters to export species 
across the cell membrane and into the extracellular medium 257.  One of the most well-studied 
families of MDR transporters, in particular with respect to solvent-like hydrocarbons, are the RND 
(Resistance-Nodulation-Division) efflux pumps.  In particular, it was previously reported that strains 
lacking acrB exhibited inhibited growth profiles when exposed to various concentrations of styrene 
relative to the wild-type control 258.  In another studies, E. coli strains which showing improved 
tolerance to added toluene showed 2.8- and 5.2-fold increases in transcript levels of acrA and acrB, 
respectively 259.  Interestingly, however in the case of A, of all known RND efflux transporters in E. 
coli, only 1 component was DE upon styrene addition (acrB) and transcript levels were, in fact, 
reduced relative to the control (log2-fold change = -0.84).  Since efflux transporters activation 
typically involves by a transcription factor via a toxin dosage response 260,261, it is possible that 
intracellular styrene levels did not surpass the characteristic minima necessary for upregulation of 
RND transporters under the conditions examined.   
Furthermore, the long-term exposure to styrene in this case may play a role in the lack of expression 
of RND efflux pumps as Molina-Santiago et al. demonstrated that in a toluene-sensitive strain (P. 
putida KT2440), transcriptional changes in efflux pump expression after short-term (one hour) 
exposure to toluene, were of a much higher magnitude compared to the long-term (several hours) 
exposure 262.  Furthermore, many efflux pumps which showed no DE upon short-term exposure, 
were subsequently DE after long-term exposure while many of the upregulated pumps in the short-
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term demonstrated no DE after long-term exposure 262.  Therefore, the expression profile seen here 
under styrene exposure may be quite different from that seen directly after a sudden styrene shock 
as cells may utilize different mechanisms to survive a short-term exposure to styrene compared to 
a long-term exposure.  An argument could be made that the utility of RND efflux transporters as a 
tolerance strategy is only feasible in the short-term due to consumption of energy (i.e., ATP) for 
molecule export. 
One accessory protein related to active efflux that was upregulated upon styrene addition (log2-fold 
change = 1.43) is the 49 amino acid-long small protein  AcrZ, which was found to associate with 
AcrB in the AcrAB-TolC complex 263.  Researchers have shown that removal of the acrZ gene could 
negatively impact the minimum inhibitory concentrations (MIC) of chloramphenicol, for example, 
where while deletion of acrB may have lowered the MIC from 8 to 1 µg/mL, deletion of acrZ alone 
reduced the MIC from 8 to 4 µg/mL 263.  Not all AcrB-dependent compounds saw enhanced toxicity 
upon deletion of acrZ, however, including erythromycin and fusidic acid.  Nevertheless, it is likely 
that AcrZ plays a noteworthy role in the AcrAB-TolC-dependent efflux of some compounds, and it 
has been suggested that AcrZ perhaps aids in determining substrate specificity and may serve as 
an interesting target for future engineering efforts. 
The transcriptional responses of other MDR transporters were analyzed and most MDR pumps 
were not responsive to either external exposure of styrene.  The expression of genes such as emrE, 
fsr, ynfM, emrY, ydiM, and ydeA, which encode for transporters, was increased upon styrene 
external exposure.  Table 4.1 shows a list of DE genes encoding for a variety of MDR efflux pumps 
and other transporters of interest in E. coli when cells were exposed to styrene via both modes.  Of 
transporter-encoding genes which were upregulated under both modes of styrene exposure, ydeA 
and mdtG, which encode for a known L-arabinose exporter and a MDR efflux pump, respectively, 
are of particular interest.  These results may indicate that the ydeA and mdtG promoters in E. coli 
have a natural positive response to styrene exposure. 
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Table 4.1 Differentially Expressed Efflux Transporters upon Styrene Exposure. 
List of membrane transporter-encoding genes which were up- or down-regulated for each condition 
comparison (A or P) along with the efflux transporter family of each gene. The log2 fold change 
(L2FC) is also listed next to each gene along with a ‘-‘ if there was no significant DE of the gene in 
that condition.  Only genes which showed a p-value < 0.5 in at least one condition when compared 
to the no styrene control were included.  ABC = ATP-binding cassette, MATE = Multi antimicrobial 
extrusion, MFS = Major facilitator superfamily, SMR = Small multidrug resistance, RND = 
Resistance-nodulation-cell division, OM = Outer membrane. 
UP Efflux 
Family 
DOWN 
A P Gene Gene A P 
0.60 1.23 mdlA 
ABC 
macA - -1.15 
 macB - -1.17 
mdlB -0.59 - 
- 0.93 mdtK MATE   
0.59 - fsr 
MFS 
emrK -0.72 - 
1.15 1.02 mdtG emrD -0.98 - 
 0.81 mdtH yajR - -0.92 
1.88 0.85 ynfM 
 
0.90 - emrY 
1.43 - ydiM 
1.83 2.23 ydeA 
- 0.83 yebQ 
- 0.95 yghB 
- 0.70 yqjA 
0.94 - emrE 
SMR 
sugE -0.89 - 
  mdtI -0.72 - 
  RND acrB -0.84 - 
0.55 1.52 ompX 
OM Porins/  
Proteins 
ompW -1.15 - 
- 1.61 slp pal -1.05 -0.63 
- 1.14 ompA ompF -1.89 -2.55 
0.76 1.05 tehA 
Other 
Exporters 
setA -0.59 - 
1.09 - rhtC ybjE -0.62 - 
1.01 1.41 yahN dauA -0.84 - 
1.11 - yhjX rhtA -0.90 - 
0.80 - aroP dcuB -1.08 -1.44 
0.69 - ygaZ dctA - -1.05 
1.83 2.23 ydeA potG -0.84 - 
0.76 1.58 eamA manX - -1.29 
0.66 - cydC 
 
1.11 - cydD 
0.57 - yhjE 
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4.3.10 Comparing E. coli’s Response to Styrene Addition versus Styrene Production  
One motivation in this study was to identify similarities and differences in the transcriptional 
response when cells were exposed to styrene via exogenous addition versus when cells internally 
produced styrene.  Overall, the responses identified were largely the same with slight differences.  
Responses such as up-regulation of phage shock response, DNA damage response and cell 
envelope-altering genes as well as down-regulation of ribosomal and nucleotide biosynthesis 
genes were consistent between the two modes of exposure. 
Although, the DE profile of genes in the two modes of exposure contain many similarities in terms 
of responses, a difference emerged in terms of the magnitude of DE between certain gene sets in 
the production and addition mechanisms of exposure.  As discussed in section 4.3.1, the magnitude 
of DE for up-regulated genes was significantly higher in P compared to A.  Among genes which 
were up-regulated under both modes of exposure, the average log2-fold changes for P and A were 
1.58 and 1.38, respectively.  When analyzing specific genes, these differences can become even 
larger.  Among the highly up-regulated genes involved in the phage shock response (i.e., 
pspABCDE, pspG), the average log2-fold changes for P and A were 7.33 and 5.45, respectively.  
This was also prevalent in terms of cellular response to DNA damage mechanisms such as the 
SOS response.  Genes such as recA and sulA showed increased responsiveness in styrene 
producing cells (recA: P log2-fold change = 0.90, A log2-fold change = 0.46; sulA: P log2-fold change 
= 1.90, A log2-fold change = 0.86).  Other genes of interest saw similar DE magnitude differences 
such as marA (P log2-fold change = 2.52, A log2-fold change = 1.08), lpp (P log2-fold change = 
1.77, A log2-fold change = 0.70), and micF (P log2-fold change = 2.75, A log2-fold change = 2.02).  
Additionally, up-regulation of genes associated with the heat shock response seem to be more 
prevalent upon styrene addition as log2-fold changes were 111% and 108% higher for ibpA and 
ibpB, respectively, than in production strains.  Additionally, while rpoH was up-regulated (log2-fold 
change = 1.48) in the addition mode of exposure, it showed no DE in cells producing styrene. 
A further difference between the two conditions is seen among amino acid biosynthesis.  Overall, 
in the KEGG pathway “biosynthesis of amino acids” (eco01230; 118 genes total), the A condition 
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showed 22% of genes up-regulated and 19% of genes down-regulated.  Conversely, in the P 
condition, only 9% of genes were up-regulated while 33% of genes in this KEGG pathway were 
down-regulated.  While the expression of genes involved in the biosynthesis of some amino acids 
shows a similar profile (e.g., arginine biosynthesis, phenylalanine, tyrosine and tryptophan 
biosynthesis), there are larger differences among others.  For example, in the KEGG pathway for 
“valine, leucine and isoleucine biosynthesis” (eco00290; 16 genes total), seven genes (44%) were 
DE for the A condition, with all of them being induced upon styrene addition.  However, in the P 
condition, only one gene was induced in this KEGG pathway while 5 (31%) were repressed. 
Exposure to certain aromatic compounds (e.g., p-coumaric acid) has previously been shown to 
result in DNA binding and damage 198.  In section 4.3.2, data showing the impact of styrene 
exposure to E. coli cells on DNA damage and repair mechanisms was illustrated.  However, one 
key difference (namely, expression of dps) in this regard was identified between styrene-producing 
cells and cells where styrene was exogenously added.  Dps is an important DNA-binding protein 
that works to protect DNA from a variety of stresses (most critically, oxidative stress) via prevention 
of DNA breakage, iron sequestration and ferroxidase activity 264.  Its encoding gene (dps) has been 
reported as one the most commonly DE genes, appearing in over 70 separate transcriptomic 
studies investigating the effects of exposure to compounds such as isobutanol, salicylate, and a 
variety of acids 187,209. Interestingly, in the present study, dps showed no DE for A although it was 
up-regulated for P (log2-fold change = 1.95).  Thus, the inhibition caused by styrene exposure is 
not likely due to any significant effect that it has on DNA damage. 
As seen in Figure 4.2C, there were 33 genes which showed significant DE in opposite directions 
for the two modes of styrene exposure.  These genes, as well as the log2 fold change in each 
condition is listed in Table 4.2.  One gene of note is mepS which encodes for a DD-endopeptidase 
which functions to help expand the peptidoglycan layer by abolishing current cross-links to allow 
for incorporation of further peptidoglycan 265,266.  This is a vital process during growth and a 
reduction of MepS levels in the cell can inhibit synthesis of peptidoglycan (allow it is suggested that 
MepM/H are redundant of MepS in E. coli) 265,266.  Here, expression of mepS was significantly 
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repressed upon styrene addition while induced upon styrene production (log2-fold change of -1.94 
and 1.45, respectively).  The expression of mtgA, which encodes for a peptidoglycan 
glycosyltransferase 267, shows a similar profile (log2-fold change of -0.93 and 1.44 for A and P, 
respectively).  The enzyme MtgA works to polymerize lipid II molecules for further synthesis of 
peptidoglycan 268.  This interesting expression of these two genes may indicate that, in production 
strains, cells are actually attempting to produce and incorporate more peptidoglycan even though 
cell division mechanisms are seemingly shutting down. 
One interesting difference between the two modes of styrene exposure involves the various cold 
shock proteins found in E. coli.  Overall, components of the CspA family of cold shock proteins 
were found to be down-regulated in cells exposed to exogenous styrene while up-regulated in cells 
producing styrene (Table 4.2).  For example, cold shock proteins encoded by cspB and cspG were 
up-regulated in P (log2-fold changes of 1.44 and 1.53, respectively) while showing down-regulation 
in A (log2-fold changes of -1.37 and -2.84, respectively).  Further differences were seen among 
genes in this family such as with the cases of cspA (log2-fold change = -4.17 for A, no DE for P) 
and cspE (no DE for A, log2-fold change = 1.72 for P). 
Interestingly, expression of ompT (which encodes for an OM protease) was slightly down-regulated 
in the presence of styrene in the case of A, but up-regulated in the case of P (Table 4.2).  Others 
have demonstrated that expression of ompT is often repressed upon up-regulation of omrA/B 246.  
However, as OmpT has also been shown to be highly abundant in strains overexpressing 
recombinant proteins 269,270, this discrepant behavior may be an artifact of expressing the styrene 
pathway in P, and be unrelated to differences in the toxic action of styrene. 
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Table 4.2 Genes DE in Opposite Directions upon Styrene Addition or Production. 
List of genes that were DE under both modes of styrene exposure but show DE in opposite 
directions (compared to the control).  The log2-fold change of expression between the styrene 
addition (A) or styrene production (P) compared to the no styrene control strain from our RNA-seq 
results is listed. 
 log2-fold change 
Gene A P 
ilvM 0.85 -3.79 
ilvE 0.66 -2.76 
ilvX 0.80 -2.33 
metQ 0.74 -1.40 
mepS -1.94 1.45 
cspG -2.84 1.53 
ompT -0.63 1.33 
patA -1.03 1.20 
yeiH 0.82 -1.17 
aceB 0.66 -1.18 
rstA -1.81 1.16 
uxuA 0.56 -1.08 
yeaQ -0.73 0.97 
ybgS -0.69 1.17 
csrC 0.76 -2.34 
csrB 1.11 -2.24 
elaB -1.49 0.86 
gadB -1.05 1.17 
hdeA -1.04 1.31 
gatY 0.80 -0.79 
dacC -0.58 0.87 
yoaC -0.74 0.82 
yjdN -0.52 0.91 
yodD -1.03 0.81 
mgrB -0.88 1.51 
ybgA -0.82 0.89 
ycgB -0.73 0.73 
otsB -1.29 0.84 
mnmE 0.92 -0.75 
cspB -1.37 1.44 
mtgA -0.93 1.44 
tusD 0.59 -0.75 
thrU -1.48 1.06 
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4.4 Discussion 
While the present study represents the first to report on the transcriptome-wide response of E. coli 
to styrene, others have explored the impacts of other hydrophobic solvents on E. coli as well as 
different aromatic chemicals on other microorganisms.  In terms of aromatic chemicals, Jin et al. 
recently performed a transcriptomic analysis of Saccharomyces cereviasiae following 2-
phenylethanol exposure 191, whereas Molina-Santiago et al. previously compared the 
transcriptional response of two P. putida strains (KT2440 and DOT-T1E) to toluene exposure 262 
and Yung et al. investigated the effect of sub-lethal levels of toluene on the transcriptome of E. coli 
188. 
As a result of styrene exposure, the collective responses demonstrate that E. coli alters expression 
of numerous membrane-related functions, the likes of which likely represent a concerted effort by 
the cell to repair and alter the membrane composition in order to minimize direct harmful 
interactions with or other indirect effects of styrene.  This type of survival strategy is common across 
bacteria.  For instance, in the case of toluene exposure to P. putida KT2440 and DOT-T1E (toluene 
tolerant), whereas the more tolerant DOT-T1E strain mostly altered the expression of “intracellular 
parts”, the more sensitive KT2440 strain differentially expressed a greater number of genes 
involved with a variety of different membrane functions, especially those encompassing energy 
generation and iron uptake 262.  As with styrene and E. coli, this response postulated to constitute 
an overall effort by the cell to alter membrane permeability and protect the cell from the membrane-
damaging effects of toluene.   Meanwhile, to provide the energy and material resources needed to 
repair, stabilize, and alter the membrane, cells must also divert and reallocate such resources from 
elsewhere in the cell.  In the case of KT2440, it was seen that energy-intensive processes such as 
flagellar assembly were highly down-regulated (unlike in DOT-T1E), allowing more resources to be 
focused on stress management 262.  A similar picture emerged for styrene and E. coli, as cells seem 
to have worked to shut down processes which require significant energy such as cell division and 
nucleotide and protein biosynthesis to focus efforts on global stress responses and membrane 
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altering strategies.  Overall, these findings underscore the importance of developing engineering 
strategies aimed at increasing the robustness and reducing the permeability of the cell membrane. 
Accordingly, many tolerance engineering strategies have been investigated to improve the fitness 
of cells when exposed to solvent-like chemicals.  For example, tolerance engineering has led to 
successful improvements in product yields such as with ethanol production in S. cerevisiae 271,272, 
as well as both limonene 257 and isopentenol 273 in E. coli.  Furthermore, by incorporating 
heterologous parts from solvent-tolerant sources, tolerance of E. coli towards industrially relevant 
chemicals can be obtained.  Tan et al. improved the growth rate of E. coli in the presence of a 
variety of compounds (e.g., styrene, toluene, succinate, butanol, hexanoic acid) and stresses (e.g., 
heat shock, osmotic pressure) by expressing the heterologous cis-trans isomerase (cti) from 
Pseudomonas aeruginosa 234.  This enzyme introduces the non-native process of producing trans 
unsaturated fatty acids into E. coli and incorporating this into the membrane to alter membrane 
properties.  This group further demonstrated the utility of membrane engineering by overexpressing 
the native phosphatidylserine synthase (encoded by pssA in E. coli) which increased the 
abundance of the phosphoethanolamine head group in the membrane 237.  This change led to 
differences in membrane integrity and fluidity along with surface potential and hydrophobicity.  
Ultimately, this strain showed improved growth rates in the presence of styrene, toluene, vanilic 
acid, ferulic acid, 4-hydroxybenzoate and several others.  These examples demonstrate the 
importance of identifying and developing mechanisms that can alter important membrane 
properties to protect cells against cell envelope-damaging compounds. 
The importance of multi-drug resistant efflux transporters to maintain or improve tolerance to a 
variety of compounds has been shown for several organisms, including E. coli 
69,90,92,189,257,260,261,274,275.  Furthermore, the intracellular accumulation of toxic compounds can have 
a significant impact on the expression of different efflux transporters by their associated hosts.  For 
example, pumps such as AcrAB-TolC (from E. coli), TtgABC and SrpABC (from P. putida) have all 
been shown to become induced upon solvent exposure to minimize intracellular concentrations 276.  
In the case of styrene exposure, it is difficult to isolate any single efflux transporter or system that 
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shows high up-regulation in the presence of styrene (at least in the long-term).  Interestingly, only 
one member of the RND families of efflux pumps in E. coli showed any differential expression upon 
styrene exposure (i.e., acrB: log2 fold change of -0.84 in A).  Previously, the AcrAB-TolC efflux 
transporter was implicated as an important part of E. coli growth in the presence of styrene and 
removal of this transporter inhibited both growth and production of styrene in NST74 258. 
Interestingly, a recent evolution of E. coli K-12 to improve tolerance to the aromatic acid benzoate 
showed that cells with higher tolerance actually lost of MDR efflux pumps (e.g., emrA/Y, mdtEF) 
and important regulators of MDR pump expression (e.g., marRAB) 277.  This may help indicate that 
specific efflux transporters are needed for improved chemical tolerance and the energy-intensive 
expression and subsequent placement of transporters which have limited or no activity on said 
chemical is ultimately counter-productive.  This makes the isolation and engineering of specific 
efflux pumps with high activity for individual compounds of interest (such as styrene) vital to reduce 
toxicity through efflux transporter-mediated methods.  Several examples have previously been 
demonstrated through the expression of heterologous RND-family efflux transporters in E. coli to 
improve the tolerance of cells to n-butanol 236, limonene, geraniol and others 257. 
Even considering these successful examples, it may be that significant improvements in tolerance 
for many biochemicals (i.e., enough to allow for economically viable production levels), may not be 
obtained simply through expression of one, highly active and specific efflux transporter.  In the 
toluene and styrene tolerant P. putida strain DOT-T1E, three main RND efflux transporters 
(TtgABC, TtgDEF, TtgGHI) are up-regulated upon exposure to toluene or styrene and play a role 
in the strain’s significant tolerance to organic solvents 278,279.  Researchers found that removal of 
even one of these efflux systems led to at least a two order-of-magnitude reduction in cell survival 
278.  Additionally, other efflux transporters in this strain have been found to play a role in DOT-T1E 
tolerance towards toluene 280 along with differences in fatty acid biosynthesis 281 further implicating 
a complex mechanism in overcoming solvent toxicity.  Therefore, engineering efforts which focus 
on multiple strategies and genes may be the most effective method for future tolerance 
improvements endeavors, as has been suggested elsewhere 233. 
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As it will likely be important to sense and respond to membrane stress caused by styrene to improve 
tolerance in this case, the engineering of global regulators which can affect change in the 
membrane composition and properties may be useful.  For example, researchers saw a 3.19-fold 
increase in cell viability in the presence of toxic levels of the aromatic phloroglucinol when 
overexpressing the chaperone-encoding groESL (production of phloroglucinol was also improved 
by 39.5% utilizing this strategy) 282.  The sigma factor encoded by rpoE, which responds to cell 
envelope stress, has previously been mutated to provide a more robust and rapid response, 
allowing the cell to repair defects and alter the cellular envelope composition 283.  Incorporating this 
mutation may be useful in improving tolerance towards membrane-damaging compounds such as 
styrene. 
A key aspect of this study is the transcriptional analysis of long-term exposure of E. coli cells to 
styrene.  This allows for better understanding of how cells are attempting to survive styrene-induced 
toxicity after long periods of contact.  However, there is a dearth of data and knowledge regarding 
the temporal effects of styrene exposure.  As the styrene exposure time in this study is hours, rather 
than minutes, only certain conclusions can be made regarding the transcriptional response of E. 
coli to styrene.  It may be that responses to styrene exposure in the short-term and long-term are 
similar, perhaps only changing in magnitude of response.  However, it may be more likely that an 
entirely different expression profile is observed between the two cases.  In the aforementioned 
study regarding exposure of P. putida KT2440 and DOT-T1E to toluene, the transcriptional 
response between both short-term and long-term was analyzed for both strains 262.  In this case, 
the number of DE genes and the magnitude of fold change in KT2440 was higher in the short-term 
compared to the long-term. 
Although the current dataset does not enable delineation of a clear timeline of events, several 
styrene-induced behaviors support a response model that includes cell envelope damage, 
inhibition of cell wall biosynthesis, and disruption of normal cell division.  I theorize that the cells 
are attempting to shuttle resources and energy from a “growth” mode before styrene addition to a 
“survival” mode once they have been stressed.  For the most part, cells reduce the expression of 
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genes involved in DNA and protein biosynthesis to allow the cell to focus on mechanisms necessary 
to stop cell death induced by styrene.  Stress response systems such the phage shock response, 
stress-responsive sigma factors and the MarA-mediated response are all turned on to respond to 
the damage caused by styrene.  Furthermore, by up-regulating bhsA, ompR, ldtC and the sRNAs 
omrA/B and micF, it is proposed that the cell is attempting to significantly alter the membrane 
composition, rigidity and fluidity in order to survive in the presence of styrene.  By focusing on these 
areas, future engineering strategies to improve the tolerance of E. coli to aromatics such as styrene, 
and perhaps even other hydrophobic compounds, may prove to be successful.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
CHAPTER 5. FUTURE WORK AND DISCUSSION 
 
 
Abstract 
Biochemical production metrics are often limited by end-product and/or intermediate-induced 
toxicity to the cell.  At this time, for many chemicals (e.g., styrene, 2-phenylethanol, phenol), current 
improvements in production levels are entirely or partially impeded by low tolerance to these 
compounds by bacteria, especially E. coli.  In an effort to discover mechanisms to improve the 
tolerance of E. coli to toxic aromatics, this chapter discusses potential future work to utilize a high-
throughput method to isolate mutant strains which harbor increased tolerance towards compounds 
of interest.  Additionally, proposed works will involve the engineering of a highly tolerant strain of 
P. putida (i.e., DOT-T1E), to over-produce the aromatic amino acid, L-phenylalanine, and express 
heterologous enzymes for the production of styrene.  Further engineering efforts will focus on 
constructing an efficient sucrose-utilizing strain of this styrene producer to allow for improved yields 
and titers. 
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5.1 Furthering the Understanding of Aromatic Toxicity in E. coli and Improving 
Tolerance towards Aromatics Using High-Throughout Methods 
There is interest in further understanding and improving the ability of E. coli to produce toxic 
aromatics and one of the first steps is comprehending how cells respond to this toxicity.   While the 
RNA-seq results and analysis generated for Chapter 4 of this dissertation is a useful guide to 
understand the impact of styrene-induced toxicity in E. coli, it is insufficient evidence for the 
complete understanding of aromatic-based tolerance mechanisms in E. coli.  This research gives 
a starting point for constructing a model for aromatic toxicity but certainly does not tell the whole 
story.  More research is needed to determine which of the mechanisms induced by styrene toxicity 
(e.g., phage shock response, membrane alterations) are conserved over other aromatics and which 
are not.  It is likely that there will be some overlap here but that there will be many responses that 
are activated upon styrene exposure but lie dormant when exposed to other aromatics and vice 
versa. 
Towards the aim of broadening the understanding of aromatic tolerance in E. coli, several studies 
are here proposed. 
5.1.1 Transcriptomic Analysis of E. coli for Various Toxic Aromatics 
To better understand the broad transcriptional response of E. coli to a broad number of aromatic 
species, additional and complementary methods are needed.  To this end, a previously developed 
GFP-based promoter library represents a useful tool.  This library could be utilized to investigate 
the transcriptional response of specific E. coli genes identified from the styrene RNA-seq data 
obtained and analyzed in Chapter 4 from the above enrichment screens to each of various aromatic 
species of industrial interest (e.g., styrene oxide, 2PE, phenol, naringenin) along with controls (e.g., 
antibiotics, butanol, ethanol).  Although, the results in Chapter 4 indicate that some native genes 
are up-regulated upon exposure to styrene, it is not known if, naturally, these responses are 
aromatic-specific or respond to other stresses. 
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One method that is often used to understand promoter dynamics, is the fusion of that promoter to 
a reporter (e.g., GFP, mCherry) and tracking the expression of that reporter under various 
conditions.  Therefore, by fusing the promoters for each gene of interest to a reporter such as GFP 
and exposing the cells to various aromatics at different concentrations, the response of that 
promoter can easily be observed utilizing a fluorescent plate reader.  Fortunately, a library of 
fluorescent transcriptional reporters was constructed with over 2,000 different promoters fused to 
GFP on a low copy plasmid 284.  A model study was done here to demonstrate utility of the library, 
illustrating differences in promoter activity in a glucose-lactose diauxic shift.  This library allows for 
a more high-throughput manner of analyzing transcriptional response and can be utilized to 
understand promoter dynamics under aromatic toxicity conditions. 
This data will provide us with information regarding the evolutionary progression of various stress 
response genes and how E. coli activates them.  Genes that are “turned on” under a variety of 
aromatic exposure, will help to illustrate how these stress response mechanisms have evolved to 
help alleviate toxicity brought on by these chemicals.  Alternatively, genes that show no up-
regulation under these conditions may indicate that transcriptional elements that control these 
genes are not responsive to these aromatics but are affected by some styrene-induced stress.  
Styrene-responsive transcriptional elements from P. putida S12 have previously been identified 69 
along with the regulator DmpR from Pseudomonas CF600 which is responsive to phenol 285. 
Unfortunately, not all promoters in E. coli are part of this GFP library so, therefore, plasmids 
harboring missing promoters from this library (e.g., PpspA) can be constructed (in a manner 
analogous to others in the library).  Screening can be completed utilizing high-throughput 
microplate assays, where increases to induction ratio (as determined by RFUs vs. no aromatics 
controls and promoterless plasmids) can be used to indicate and quantify expression levels. 
Furthermore, as the knowledge gained via RNA-seq regarding styrene exposure to E.coli, as 
discussed in Chapter 4, only concerns styrene exposure at one concentration and is limited to a 
single point in time, utilization of this library will allow for the elucidation of promoter dynamics 
throughout the course of culturing and with different concentrations.  Furthermore, these 
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experiments could help determine if the up- or down-regulated genes/operons found in the Chapter 
4 are consistent amongst other aromatics, different time points in culturing and varying 
concentrations of toxin. 
5.1.2 Directed Evolution Strategies to Improve Tolerance of E. coli to Aromatics 
While the utilization of such methods as adaptive laboratory evolution allows for the broad 
perturbation of an entire genome, it can often be a slow, labor-intensive process that necessitates 
the investment of many research hours 286-289.  However, as the amount of knowledge about the 
functionality of proteins in E. coli and the ways in which compounds impart toxicity onto cells is 
amplified, other high-throughput methods can be utilized to elucidate mechanisms by which cells 
can gain tolerance.  One such process involves directed evolution where a single, target single (or 
multiple genes) are altered either randomly, or at specific sites, to generate an altered phenotype 
290.   
One method for directed evolution is in vitro replication.  Here, an error-prone polymerase is utilized 
to perform a polymerase chain reaction (PCR) over a specific length of DNA (often, a single gene) 
291,292.  Due to the low fidelity of the polymerase, mutations are inserted into the sequence.  The 
degenerate DNA is then introduced into the strain with the desired outcome of a changes in 
phenotype due to a mutation.  One drawback of this method is that it can be limited by 
transformation efficiency as the mutated DNA must be put back into the desired strain, often via a 
selection step.  Therefore, the speed of experimentation and library size of mutations is often 
restricted by the transformation and selection step which can hinder the ability to obtain phenotypic 
changes. 
In an effort to eliminate the limiting step in error-prone PCR methods, an in vivo strategy for directed 
evolution has recently been demonstrated.  The method, EvolvR, generates mutations in vivo 
utilizing a nicking-variant of Cas9 (nCas9) fused to a DNA polymerase with lowered fidelity to first 
introduce nicks into a DNA sequence followed by nick repair via the error-prone DNA polymerase 
(PolI3M) 293,294.  This system allows for the user to target a specific region of their choice while 
diversifying the nucleotide composition over a range of DNA.  In the initial study, Halperin et al. 
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demonstrated the utility of this system to reintroduce the resistance capabilities of the 
spectinomycin resistance gene after it had been inactivated with a specific mutation.  By plating 
cells that had been subjected to EvolvR on spectinomycin plates and comparing the number of 
strains which harbored spectinomycin resistance to the original number of cells, a mutation rate 
could be determined.  Here, they determined that the mutation rate of wild-type E. coli cells was 
10-10 mutations per nucleotide per generations, whereas the mutation rates of cells utilizing EvolvR 
were calculated from 24,500-fold to 7,770,000-fold higher (depending on if mutations were 
incorporated into nCas9 or PolI3M) at the target DNA location.  In fact, the researchers suggest 
that 1 μL of cells expressing the EvolvR variant, enCas9-PolI3M-TBD, for 16 hours will contain all 
substitution possibilities in a 60-nucleotide window with over ten-fold coverage.  While the tunable 
window over which mutations can be generated is not long (max of 350 bp from PAM start site), 
the high number of mutations that can be introduced in this range and the ease by which the window 
can be moved simply with a change in gRNA sequence, makes this a potentially valuable tool to 
directly evolve bacteria cells. 
To introduce mutations to improve tolerance towards a variety of aromatics, specific genes in 
interest in E. coli will be targeted for mutagenesis utilizing high-throughput methods – chief among 
them, the EvolvR technique.  As the EvolvR technology is relatively new in the biotechnological 
landscape, this will represent a novel use and may have implications for its utility in future tolerance 
engineering endeavors.  By combining the high-throughput aspects of EvolvR with the growth-
based selection process utilized to identify strains with improved tolerance, novel mutations will be 
identified which can help improve understanding of bacterial aromatic toxicity and mechanisms 
through which microbes survive.  Plasmid parts of the EvolvR system are available on Addgene 
(pEvolvR-enCas90PolI5M – ID113078 and pEvolvR-enCas90PolI5M-TBD – ID113077) and will be 
purchased.  The targeting gRNA part of this plasmid will be constructed for each separate gene 
target utilizing CPEC (Circular Polymerase Extension Cloning) 295.  A basic outline for the proposed 
protocol is illustrated in Figure 5.1.  This will involve transformation of EvolvR plasmid with 
designed gRNA(s) expressed targeting region(s)/gene(s) of interest.  The EvolvR system will be 
induced to generate a library of genetic variants.  These variants will then be subjected to serial 
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transfers of increasing chemical (e.g., styrene) concentrations to kill any cells which have neutral 
or deleterious effects and eventually isolate those mutants which provide beneficial traits to the 
cells when exposed to the toxic compound (e.g., styrene).  Variants can then be sequenced and 
tested further in terms of improving cell viability and growth as well as various structural protein 
changes that may be of interest to investigate. 
 
Figure 5.1 Proposed Protocol for Utilization of EvolvR System to Identify Genetic Mutants which 
Improve Tolerance to Biochemicals. 
Procedure to utilize EvolvR to identify useful mutations that improve the tolerance of strains towards 
toxic chemicals of interest.  This involves transforming the desired strain with the pEvolvR plasmid 
containing a gRNA targeting a gene of interest.  Then, EvolvR will be induced and mutated strains 
will be exposed to the toxic compound, followed by growth and serial transfers in increasing 
concentrations of the toxin.  Mutated strain growth will be compared to a control (e.g., strain 
harboring pEvolvR plasmid with a nonsense gRNA) followed by isolation and sequencing of useful 
mutants. 
In Chapter 4, several genes were identified via RNA-seq which may serve an important role in the 
survival of E. coli to styrene.  While not comprehensive or necessarily applicable to all aromatics, 
a survey of these genes will serve as a starting point for genes to target for mutagenesis.  As these 
genes were identified in a screen against styrene, and styrene represents an important chemical 
upon which production in E. coli has reached near toxicity limits, it will serve as the initial compound 
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for screening this method.  However, as this tool can be utilized for the entire genome in E. coli, 
this procedure could be optimized for other compounds such as antibiotics (to better understand 
mechanisms behind antibacterial resistances) and industrially relevant biochemicals (in efforts to 
improve tolerance and production). 
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Table 5.1 Genes to Investigate with EvolvR to Improve E. coli Tolerance Towards Styrene. 
List of genes of interest identified in RNA-seq results of styrene-exposed cells.  The length of gene 
in terms of bp in E. coli is listed along with regions of interest in the gene (as identified by UniProt 
296) and the functionality of the gene product in E. coli. 
Gene 
Name 
Gene 
Length (bp) 
Regions of interest 
(#'s are bp from gene start) 
Functionality 
rpoE 576 
144 -> 183 (Polymerase core 
binding) 
Sigma Factor E 
rpoH 855 
159 -> 366 (Sigma-70 factor 
domain-2) 
Sigma Factor H 
pdhR 765 111 -> 168 (DNA binding region) Transcriptional dual regulator  
omrA 88 None 
sRNA affecting outer 
membrane composition 
omrB 82 None 
sRNA affecting outer 
membrane composition 
micF 93 None 
sRNA affecting outer 
membrane composition 
ompR 720 405 -> 702 (DNA binding region) 
Member of EnvZ-OmpR signal 
transduction system; 
responsive to osmotic stress 
marA 384 
87 -> 150, 231-> 300 (DNA binding 
regions) 
Stress responsive 
transcriptional regulator 
soxS 324 72 -> 129 (DNA binding region) 
Transcriptional dual regulator 
related stress response (e.g., 
superoxide, antibiotics) 
acrR 648 99 -> 156 (DNA binding region) 
Transcriptional repressor 
related to multidrug transport 
fadR 720 
102 -> 207 (DNA binding region); 
645 -> 690 (acyl-CoA binding 
region) 
Transcriptional dual regulator 
related to fatty acid degradation 
lexA 609 84 -> 144 (DNA binding region) 
Transcriptional repressor 
related to SOS response 
rcsB 651 504 -> 561 (DNA binding region) 
Transcriptional activator related 
to the Rcs-phosphorelay 
system 
bhsA 258 1 -> 66 (Signal peptide) 
Stress responsive outer 
membrane protein 
pspA 669 None Phage shock protein 
acrZ 150 None 
small protein affecting AcrAB-
TolC 
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A potential list of genes is listed in Table 5.1 along with the length of gene and the functionality of 
the gene product in E. coli.  Furthermore, as the most effective mutation window of EvolvR is ~60 
nucleotides, and many of genes selected are multiple folds longer than this window, judicious 
choice of PAM site is critical.  Towards this end, some important enzymatic functionality sites are 
listed in Table 5.1 as potential locations in the gene where mutations may produce the largest 
phenotypic impact.  Additionally, it is proposed that multiple windows be targeted in each gene 
listed here (either in parallel strains or simultaneously in the same strain) in an effort to ensure 
significant coverage in each gene. 
Of the genes listed, many are global regulators (e.g., rpoE, rpoH), specific transcriptional regulators 
(e.g., marA, ompR) or sRNA’s (e.g, omrAB) and thus, it is more likely that changes in these genes 
will have wide ranging effects on all aspects of the cell.  As it is probable that significant 
improvements in E. coli tolerance will arise from a broad change in cellular activity, rather than a 
deletion or mutation in one enzyme or transporter, the potential for full scale changes resulting from 
mutations in a regulator increases the chances of developing phenotypic changes which will 
improve tolerance.  While chances are improved to isolate mutants with improved tolerances using 
these regulators, the task of determining the exact biochemical cause of phenotype changes is 
rendered more difficult.  As these regulators affect the expression of many genes in E. coli, it may 
be necessary to utilize further RNA-seq or qPCR studies (compared to the wild-type control) to 
understand the total impact of these changes.  To hedge against potential difficulties that may arise 
here, some genes whose products have fewer global effects will be investigated (e.g., pspA, acrZ). 
5.1.3 Directed Evolution of Small Protein AcrZ for Modified Substrate Specificity of E. coli Efflux 
Pump AcrAB 
One gene of interest that will be further investigated utilizing mutagenesis to explore changes in 
phenotype is acrZ.  Many proteins exist that directly impact the translation and integration of efflux 
pumps into the membrane as well as substrate specificity/activity of these transporters (e.g., 
transcriptional regulators such as MarA and SoxS in E. coli) 69.  AcrZ is one of these proteins which 
was recently discovered in E. coli and was found to associate with AcrB in the AcrAB-TolC complex 
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as seen in Figure 5.2 263.  This 49 amino acid-long small protein (E. coli contains ~60 known small 
proteins 297) is highly conserved among enterobacteria such as Shigella and Klebsiella sp and 
maintains a helical transmembrane domain.  Additionally, transcription of acrZ is regulated by the 
same proteins as acrAB and tolC, namely, MarA, Rob and SoxS 263. 
Furthermore, researchers showed that removal of the acrZ gene could negatively impact the 
minimum inhibitory concentrations (MIC) of several compounds.  Concerning chloramphenicol, for 
example, while deletion of acrB may have lowered the MIC from 8 to 1 µg/mL, deletion of just acrZ 
alone reduced the MIC from 8 to 4 µg/mL 263.  Not all AcrB-dependent compounds saw enhanced 
toxicity upon deletion of acrZ, however, including erythromycin and fusidic acid.  Nevertheless, it is 
apparent that AcrZ plays a noteworthy role in the AcrAB-TolC-dependent efflux of some 
compounds, and it has been suggested that AcrZ perhaps aids in determining substrate specificity.  
Researchers proposed two methods of action for AcrZ-mediated efflux activity – firstly, the binding 
of AcrZ confers conformational changes in AcrB, causing alterations in substrate specificity or 
secondly, AcrZ cooperates with other AcrB-interacting proteins to deliver chemicals to AcrAB-TolC 
for further efflux.  Additionally, I believe that AcrZ may have an important role in mediating tolerance 
of certain aromatics such as styrene.  In transcriptome-level experiments presented in the next 
chapter, expression of acrZ was up-regulated when exposed to styrene (log2-fold changes ranging 
from +1.43 to +1.78 depending on the mode of exposure). 
With the goal of further investigating the role of AcrZ in bacterial tolerance, I propose to use EvolvR 
to examine if AcrZ-derived mutants with improved specificity towards aromatic substrates can be 
isolated.  As AcrZ is such a small protein (49 amino acids long), the number of iterations needed 
to cover a large part of the fitness landscape is relatively small.  Firstly, acrZ strains will be tested 
against wild-type strains to assess tolerance to a variety of aromatic chemicals such as styrene, 2-
phenylethanol and phenol.  Plasmid-based expression of acrZ will then be tested with chemicals 
that show enhanced sensitivity in the ΔacrZ strain, to test if native tolerance levels can be restored 
via plasmid-based complementation.  Here, induction levels will be titrated to 1) analyze the effect 
of variations in AcrZ expression levels and 2) determine the optimal induction level that allows for 
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similar tolerance for most compounds.  Finally, EvolvR will be utilized to generate a genomic 
“library” of acrZ mutants which will subsequently be used to screen for tolerance improvements. 
 
Figure 5.2 Interaction of AcrZ with the AcrAB-TolC Efflux Pump in E. coli. 
 
As the desired phenotype is directly tied to improved growth under otherwise inhibitory conditions, 
enrichment screens with serial dilutions will be utilized.  Controls will include: 1) ΔacrZ mutant strain 
and 2) wild-type E. coli.  Ideally, cells harboring the acrZ “library” will display improved growth at 
inhibitory concentrations relative to both of these controls.  Following enrichments, mutants will be 
isolated and sequenced to determine which acrZ mutations confer improved tolerance.  As not 
much is known regarding AcrZ and its role in substrate specificity, these enrichments can be 
applied to toxins beyond the aromatic class such as antibiotics and compounds that have been 
linked to AcrAB-TolC mediated efflux (e.g., 1-hexene 258 and octane 298).  If AcrZ is indeed directly 
tied to substrate specificity of AcrAB-TolC, this screen may help to identify mutants which can shift 
the activity of the efflux pump from one chemical class to another.  Additionally, another protein, 
YajC (part of the SecDF-YajC complex), was found to interact with AcrB, although, the extent of its 
107 
 
effect on bacterial tolerance was not examined thoroughly (strains harboring ΔyajC mutants 
showed decreased tolerance to β-lactam antibiotics) 299.  Depending on time constraints and the 
success seen by evolving AcrZ, further directed evolution of YajC may be investigated. 
5.2 Engineering of a Solvent Tolerant Organism as a Host for Aromatic Bioproduction 
With end-product toxicity representing a significant bottleneck in production of many industrially 
relevant chemicals, the previous sections of this chapter have focused on the engineering of E. coli 
for improved fitness when exposed to these compounds.  Due to its ease of genetic manipulation 
and the demonstration of high levels of bioproduction in E. coli strains, it is sensible to explore 
avenues to enhance tolerance in these strains.  On the other hand, there are bacterial species that 
have naturally evolved to grow in toxic environments and thrive in the presence of many solvents.  
Rather than engineering tolerance in product-making strains, pathways can be constructed in 
strains that already have high tolerance.  As microbial tolerance is almost always not strictly limited 
to one mechanism (e.g., efflux pumps, membrane stabilization), but rather a multitude of factors, 
utilizing an already tolerant host for bioproduction is often the better path forward 300. 
Perhaps the most well-known species of aromatic-tolerant microorganisms is the soil bacterium, 
Pseudomonas putida.  Many strains of this species that thrive when exposed to a variety of solvents 
have been isolated, such as a strain of P. putida, IH-2000, which can grow in up to 50% (v/v) 
toluene (most bacteria cannot grow in higher than 0.3% (v/v) toluene) 301.  For many of these 
strains, efflux pumps play a crucial role, especially those in the RND family.  The three RND 
complexes of note are TtgABC, TtgDEF and TtgGHI and are found in various combinations in 
different strains of P. putida.  The solvent tolerant strain DOT-T1E278 has all three while F1 has two 
(TtgABC and TtgDEF) and KT2440 only has one (TtgABC) of the three 301.  There seems to be 
significant variation in the transcriptional response of these strains when exposed to toluene, for 
example.  With DOT-T1E, ~54% of the up-regulated genes under toluene exposure are not part of 
the core P. putida genome indicating that accessory proteins and their response under stressful 
conditions play a major role in solvent tolerance 301.  Additionally, many of these strains can utilize 
these solvents as a carbon source such as P. putida S12 which maintains the styABCDE operon, 
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allowing for styrene to be catabolized, providing the cells with carbon as well as reducing 
concentrations of the toxic solvent 125,302. 
The utilization of P. putida as a chassis for production of industrially relevant biochemicals has 
recently garnered significant interest.  While the use of E. coli and S. cerevisiae is much more 
prevalent in biochemical production processes due to the fast growth and breadth of knowledge 
regarding each species, the exploitation of P. putida has some advantages.  As a bacterium 
isolated from soil, many P. putida strains have faced stresses and toxins from their naturally 
surrounding environment that make these members of these species tolerant to a variety of toxic 
compounds.  Additionally, while not nearly at the levels of those for E. coli, a wide array of genetic 
tools has been developed for use in P. putida 303.  These include inducer-based expression systems 
such as NahR/Psal (induced by salicylate) 304, MtlR/PmtlE (induced by mannitol) 305 and more 
common systems such as LacI/Plac 306 and PT7 307 (induced by IPTG).  Further genetic tools, such 
as the utilization of plasmids for gene overexpression 308 and the ability to “knockout” genes utilizing 
I-SceI 309,310 have been demonstrated as well as a method to incorporate heterologous expression 
cassettes onto the chromosome of P. putida via yTREX 311.  Furthermore, the incorporation of 
CRISPR/Cas9-based tools into the P. putida toolbox has led to other metabolic engineering 
strategies being possible including targeted chromosomal mutagenesis 312, targeted down-
regulation 313,314 and plasmid curing 315.  The review by Martínez-García and Lorenzo outlines some 
of the recent advances in this field 316. 
The continuous development and demonstration of genetic tools for P. putida engineering purposes 
has led to the established production of a variety of biochemicals.  As many strains of P. putida are 
tolerant to aromatics and maintain aromatic-degrading mechanisms, a vast number of aromatic 
production studies have been demonstrated.  One of the earliest uses of P. putida to produce 
aromatics was by Wierckx et al., engineering P. putida S12 for the production of phenol from 
glucose 26.  Here, a heterologous tyrosine phenol lyase from Pantoea agglomerans was expressed 
via plasmid to convert tyrosine into phenol.  Then, flux towards tyrosine was improved via 
overexpression of aroF-1 and random mutagenesis by introducing anti-metabolites for 
109 
 
phenylalanine and tyrosine.  In batch culture, up to 1.5 mM phenol was produced while fed-batch 
runs led to accumulation of up to 5 mM phenol (~320 mg/L phenol; at this concentration, end-
product toxicity limited further production).  Additionally, researchers produced 1.73 g/L 4-
hydroxybenzoic acid via the endogenous metabolite chorismate from glucose in P. putida KT2440 
317.  To improve flux towards chorismate (and ultimately, 4-hydroxybenzoic acid), the feedback 
resistant mutant of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from E. coli 
(aroGD146N) was overexpressed and the E4P supply was improved via deletion of hexR, a negative 
repressor of glucose metabolism.  In P. putida S12, Verhoef et al. demonstrated the production of 
p-hydroxystyrene from glucose by expressing pal and pdc from Rhodosporidium toruloides and 
Lactobacillus plantarum, respectively 318.  These are just a few of the examples of bioproduction in 
Pseudomonads with many more referenced and discussed in section 1.3.3 of this dissertation. 
5.2.1 Engineering of Pseudomonas putida DOT-T1E for the Production of Styrene 
As DOT-T1E is a highly tolerant strain when exposed to aromatics such as toluene and styrene 319 
and has no known styrene degradation mechanism, it is an attractive option to produce styrene.  
Some work has already been done to engineer DOT-T1E for the production of phenylalanine 
through toxic analog mutation, deletion of off-stream pathways and overexpression of feedback-
resistant mutant enzymes in the phenylalanine production pathway 308.  Here, ~870 mg/L 
phenylalanine was produced from 1.5% (v/v) glucose in minimal media and the introduction of 
heterologous enzymes allowed for the production of 180 and 200 mg/L 2-phenylethanol and trans-
cinnamic acid, respectively.  Additionally, researchers demonstrated the enhanced tolerance of 
DOT-T1E to other aromatics of interest with 2-, 2-, 4- and 2- times higher MICs compared to E. coli 
(DH5α) for phenylalanine, 2-PE, phenylacetaldehyde and trans-cinnamic acid.  While the titers 
obtained are not high compared to similar production in other organisms, these production levels 
are not near reaching completely inhibitory levels for P. putida or E. coli.   
Towards the end of further demonstrating the potential of P. putida for efficient bioproduction, DOT-
T1E will be engineered to first, overproduce the native aromatic precursor, L-phenylalanine, and 
second, introduce heterologous pathway enzymes to produce styrene, serving as a model for other 
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toxic aromatics.  As styrene has a much lower toxicity limit (~300 mg/L) in E. coli and toxicity is 
likely the main bottleneck for improved production in this organism, transferring the styrene 
production pathway to DOT-T1E has high potential benefits.  Additionally, previous researchers in 
the David Nielsen lab attempted to engineering P. putida S12 to overproduce styrene, however, 
deletion of the gene encoding the first step in styrene degradation, styA, removed any tolerance 
advantages it maintained over E. coli production strains (data not shown).  This may indicate that 
the improved tolerance of P. putida S12 to styrene is mostly (or fully) due to the styrene degradation 
machinery in this strain.  As DOT-T1E has no known styrene degradation-encoding genes, it is 
likely that tolerance is due solely to structural differences in DOT-T1E compared to other strains 
and is a superior potential host for styrene production.  Figure 5.3 shows the metabolism of 
aromatic amino acids (with specific details regarding phenylamine) as well as inherent 
phenylalanine catabolism processes present in DOT-T1E. 
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Figure 5.3 Pathway Map of Phenylalanine Biosynthesis and Metabolism in P. putida DOT-T1E. 
A pathway map for P. putida DOT-T1E for aromatic amino acid biosynthesis and metabolism.  
Native enzymatic steps are shown as black arrows while proposed heterologous steps towards 
styrene production are shown as red arrows with proposed genes (and sources) listed.  Genes 
which, upon deletion, it is believed will enhance to production of phenylalanine are shown with a 
red ‘X’ listed on the enzymatic step arrow.  The insert in the upper right corner illustrates an 
enzymatic step for pyruvate kinase in central metabolism which is proposed to be deleted. 
As phenylalanine is catabolized through several reactions in DOT-T1E, flux from phenylalanine to 
2-hydroxy-phenylacetate, tyrosine and phenylacetamide must be reduced or removed.  This 
includes the deletion of at least 5 genes in DOT-T1E: T1E_0122 and T1E_3356 (products catalyze 
the reaction from phenylpyruvate to 2-hydroxy-phenylacetate), T1E_1753 (product catalyzes the 
reaction from phenylalanine to phenylacetamide), T1E_1616 (product catalyzes the reaction from 
phenylacetaldehyde to phenylacetate) and T1E_4057 (product catalyzes the reaction from 
phenylalanine to tyrosine).  Previously, Molina-Santiago et al. deleted these 5 genes from a DOT-
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T1E mutant to improve production of phenylalanine by ~45% 308.  Figure 5.3 shows the enzymatic 
deletions that will be investigated in DOT-T1E to enhance flux towards phenylalanine (and 
ultimately, styrene) along with the genes that produce enzymes associated with those reactions. 
Other enzymes which consume phenylalanine will also be investigated and, if found, subsequently 
deleted. One reaction pathway of note is that from phenylalanine to phenylethylamine which can 
further be converted into phenylacetate.  This will encompass one method to improve production 
of phenylalanine.  Previous studies have made significant usage of toxic anti-metabolites (e.g., p-
fluoro-DL-phenylalanine) along with chemical-induced mutagenesis to produce mutants which 
exhibit higher than normal levels of aromatic amino acids  26,308.  Additionally, through 
overexpression of genes encoding for limiting pathway enzymes (as well as feedback resistant 
mutants of such enzymes) such as aroG 317, further improvements in flux towards aromatic amino 
acid biosynthesis have been made.  The incorporation of these methods into a phenylalanine 
overproducing strain of DOT-T1E will be investigated.  Figure 5.4 illustrates some of the methods 
that will be utilized to produce this strain. 
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Figure 5.4 Overview of Procedure to Engineer P. putida DOT-T1E to Overproduce Phenylalanine. 
The proposed procedure to develop a phenylalanine overproducer from DOT-T1E.  Three 
strategies will be used which are shown in the grey boxes. 
While previous studies have demonstrated the enhanced tolerance of DOT-T1E towards styrene  
319, further toxicity assays will be done to confirm previous results and investigate the effect of 
styrene on DOT-T1E in production-like conditions.  Additionally, a comparison between wild-type 
DOT-T1E and the mutants engineered for enhanced phenylalanine production will be completed to 
investigate changes in tolerance towards styrene and other aromatics of interest (e.g., 2-
phenylethanol, phenol).  Further studies will be done to investigate the capacity of DOT-T1E (and 
its mutants) to catabolize important compounds in the biosynthesis of styrene (i.e., phenylalanine, 
trans-cinnamate, styrene).  If degradation of any of the above compounds is observed, further 
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studies into possible enzymatic reactions which consume these compounds will be done and 
identified genes will be deleted. 
Subsequently, PAL2 from A. thaliana or FDC1 from S. cerevisiae will be overexpressed in the final 
phenylalanine production strain to investigate the efficiency of conversion of phenylalanine to trans-
cinnamate (for PAL2) and trans-cinnamate to styrene (for FDC1).  Here, cells will be grown up 
expressing the heterologous enzyme and then resuspended in PBS buffer.  Precursor 
(phenylalanine or trans-cinnamate) will be fed to cells and conversion will be tracked over time.  
This will allow for the confirmation of proper enzymatic expression in the cells.  Additionally, utilizing 
random mutagenesis or codon-optimization strategies for P. putida, variants of each enzyme can 
easily be interrogated to achieve improved conversion.  Once discovery of the most effective 
enzyme variant for each heterologous pathway is confirmed, both genes will be introduced in the 
production strain via several methods – overexpression via both heterologous (e.g., T7, lacI/Plac) 
and native (e.g., XylS/Pm, NahR/Psal) expression systems using both plasmid-based expression 
and chromosomal integration strategies. 
5.2.2 Utilization of Alternative Substrates for Styrene Production in P. putida DOT-T1E 
The usage and development of tools for catabolizing alternative feedstocks is a significant field of 
study in the quest to make bioprocesses cost-effective and economical.  Significant work has gone 
into demonstrating this for E. coli and S. cerevisiae, where cells have been engineered to introduce 
and/or improve utilization a variety of feedstocks such as starch 320, cellulose 321, lactose 322, 
sucrose 160,323, xylose 154, glycerol 324, and fructose 325.  
While the utilization of glucose for biochemical production in P. putida has dominated, there is 
significant interest in incorporating alternative feedstocks.  In fact, there are many studies which 
have illustrated the potential of utilizing other substrates as carbon sources.  One such example is 
that of glycerol which has been used as a feedstock for P. putida fermentations due to its low cost 
and fewer carbons which need to be oxidized compared to glucose 326.  Kenny et al., for example, 
utilized glycerol to produce up to 6.3 g/L polyhydroxyalkanoate (PHA) in a fed-batch scenario in the 
P. putida strain GO16 327.  PHA has been one of the most widely produced compounds from 
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glycerol in P. putida strains due to the fact that many Pseudomonads already produce PHA 
naturally and the structure of the monomer can be tuned depending on the carbon feedstock 
selection and availability 328,329.  Meanwhile, the demonstration of glycerol-conversion to aromatics 
of interest in P. putida strains has also been accomplished.  Utilizing fed-batch principles, up to 1.8 
g/L p-hydroxybenzoate was produced at a molar carbon yield of 8.5% from glycerol in P. putida 
S12 330 while phenol has also been produced (0.4 g/L) in a Pseudomonas taiwanensis strain from 
glycerol 30. 
One carbon source of high interest to the viability of future microbial bioproduction endeavors is 
sucrose (a disaccharide composed of one fructose residue and one glucose residue).   As one of 
the major byproducts of the sugar industry, sucrose is inexpensive and there are vast, unused 
amounts available for biochemical conversion processes 331,332.  Furthermore, it can easily be fed 
to microbes as either the raw juice from sugarcane or as refined molasses (via sugar production) 
160,333.  While P. putida is unable to naturally metabolize sucrose, previous studies have shown the 
high potential of using sucrose for bioproduction as theoretical yields for the production of 
rhamnolipids were higher for sucrose compared to glucose 334.  Therefore, Löwe et al. worked to 
engineer P. putida to metabolize sucrose by incorporating sucrose-utilizing enzymes from E. coli 
W 331.  The genes cscA and cscB (encoding for a sucrose hydrolase and permease, respectively) 
from E. coli W were expressed in P. putida KT2440 to allow for metabolization of sucrose into 
central metabolism.  However, the growth rate of this engineered strain on sucrose was significantly 
lower than on a mixture of glucose and fructose (0.27 and 0.45 h-1, respectively).  Therefore, to 
improve sucrose utilization rates, Löwe et al. demonstrated another method to introduce sucrose 
into the metabolism of P. putida 335.  Here, researchers identified a sucrose-utilizing gene cluster 
from Pseudomonas protegens Pf-5 which was composed of four genes named cscR (AKA 
PFL_3236; encoding for a repressor of genes encoding for sucrose-utilizing proteins), cscA (AKA 
PFL_3237; encoding for a sucrose hydrolase), cscB (AKA PFL_3238; encoding for a sucrose/H+ 
symporter) and cscY (AKA PFL_3239; encoding for a sucrose-specific porin) 335.  The gene cluster 
from P. protogens Pf-5 as well as the functionality of the gene products in P. putida metabolism are 
shown in Figure 5.5.  Compared to the E. coli-derived sucrose utilization system, the cscRABY 
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system allowed for much higher growth rates on sucrose.  Furthermore, the importance of the porin 
for sucrose metabolism was here demonstrated (when cscY was absent, growth rates decreased 
significantly) as researchers hypothesized that the outer membrane of P. putida was not permeable 
to sucrose.  Unlike E. coli, which has broad-spectrum porins (e.g., OmpC, OmpF), porins in P. 
putida are more specific and less permeable which may account for the high level of solvent 
tolerance present in Pseudomonads 336. 
Utilizing similar methods to those implemented by Löwe et al. in the aforementioned study 335, 
sucrose metabolism will be incorporated in the phenylalanine overproducing variant of P. putida 
DOT-T1E constructed in section 5.3.1 above.  This will involve cloning the sucrose metabolism 
gene cluster from P. protogens Pf-5 into a plasmid suitable for P. putida (e.g., pSEVA221) for initial 
examination of whether or not this system will function in the engineered DOT-T1E strain.  
Following initial testing, the gene cluster will be transferred to a plasmid which can easily be 
manipulated to incorporate this cluster onto the genome.  This can be done via conjugation 
methods with DNA transfer from E. coli 335 or utilizing a recent method to incorporate heterologous 
expression cassettes onto the chromosome of P. putida with yTREX, as previously mentioned 311.  
Once onto the genome, the effect of the presence of the gene cluster will be compared to 
expression from the plasmid to evaluate differences in growth rate and sugar consumption.  
Additionally, comparisons between the two scenarios will be evaluated for phenylalanine 
production titers and yields.  Furthermore, these metrics will be utilized to compare the engineered 
phenylalanine-overproducing DOT-T1E strain for production on sucrose versus other carbon 
sources, especially glucose. 
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Figure 5.5 Sucrose Metabolism Gene Cluster cscRABY from P. protogens pf-5 and Potential 
Metabolism of Sucrose with CscRABY in P. putida DOT-T1E. 
(Top) The sucrose-utilizing operon(s) cscRABY from P. protogens pf-5 is shown. (Bottom) The 
proteins and enzymes encoded by cscRABY are shown when implemented in DOT-T1E.  The cscY 
encodes for a sucrose-specific porin, cscB encodes for a sucrose/H+ symporter, cscA encodes for 
a sucrose hydrolase, cscR encodes for a regulator of the previous three genes.  The mechanism 
to uptake fructose and glucose into central metabolism in this strain is also shown utilizing a 
heterologous fructokinase and native glucokinase, respectively. 
Additionally, further engineering efforts can be done to improve sucrose utilization in P. putida.  One 
phenomenon of interest observed by Löwe et al. was the accumulation of fructose in the culture 
media during cell growth 335.  This supports the fact that P. putida has no known fructokinase activity  
(although it does maintain a native glucokinase) and can only incorporate fructose into the 
metabolism via a native phosphotransferase system 336.  Therefore, to uptake fructose into central 
metabolism, it must first be exported outside the cell, before it can then be imported via the fructose-
PTS system 336.  This is undesirable for two reasons: 1) the process of first importing sucrose, 
hydrolyzing it into fructose and glucose, exporting the fructose and then importing it is an inefficient 
process and 2) the utilization of PEP in the fructose-PTS system for fructose import limits the 
availability of PEP that can be converted into phenylalanine.  Therefore, to improve utilization of 
fructose derived from sucrose hydrolyzation, I propose implementing a heterologous fructokinase 
into the engineered DOT-T1E strain.  In the sucrose-utilizing gene cluster in E. coli W, the gene 
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cscK encodes for a fructokinase which could be expressed in P. putida DOT-T1E alongside the 
cscRABY gene cluster to efficiently import fructose into the central metabolism.  Figure 5.5 
illustrates the full metabolism of sucrose into central metabolism in DOT-T1E upon expression of 
cscRABY along with a functional fructokinase (e.g., cscK).  The expression of these genes in a 
phenylalanine overproducing variant of DOT-T1E will allow for efficient utilization of the inexpensive 
feedstock sucrose to produce phenylalanine and demonstrate the utility of sucrose as a valuable 
potential carbon source for future efforts to produce value-added aromatics in P. putida.  
Alternatively, cscRABY and fructokinase gene can be placed into the native DOT-T1E strain before 
phenylalanine engineering strategies are utilized.  By incorporating sucrose importing genes both 
before and after the engineering of phenylalanine over-production, the most efficient utilizer of 
sucrose and producer of phenylalanine can be isolated. 
5.3 Conclusions 
The above proposed works demonstrate the potential to utilize synthetic biology and metabolic 
engineering principles and strategies to overcome end-product-induced toxicity.  By utilizing high 
throughput methods to engineer and isolate mutants of strains (e.g., E. coli NST74) which already 
maintain the capacity to highly produce industrially relevant compounds (or intermediates for those 
compounds), inherent stress response mechanisms in these strains can be improved upon to allow 
for enhanced tolerance and production metrics.  Alternatively, strains which already possess the 
capacity to be highly tolerant to these compounds (e.g., P. putida DOT-T1E) can be engineered to 
over-produce important biochemicals such as styrene.  By utilizing both methods in parallel, there 
is a greater chance for success.  Through tolerance engineering strategies, greater knowledge can 
be gained about native mechanisms to overcome toxicity and what systems may have the most 
impact on tolerance towards toxic compounds.  By using metabolic engineering strategies, highly 
tolerant microbes can not only be engineered to produce deadly biochemicals in large quantities, 
but greater insight on best practices to engineer lightly used strains such as DOT-T1E and further 
understanding strategies to broadly allow these types of strains to become versatile chassis for 
biochemical production can be gained. 
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